Product# | Name | Target | Pathway | Phenotype | Therapeutic Area |
1 | 4-1BB | Protein | Others | T Cell Activation | Immuno-Oncology |
2 | ADAM10 | Protein | Amyloid Processing | AD Pathology | CNS |
3 | Alpha-synuclein | Protein | Others | PD Pathology | CNS |
4 | Amyloid Precursor Protein | Protein | Others | AD Pathology | CNS |
5 | Amyloid-Beta 1-40 | Protein | Others | AD Pathology | CNS |
6 | Amyloid-Beta 1-42 | Protein | Others | AD Pathology | CNS |
7 | ApoA-I | Protein | Others | PD Pathology | CNS |
8 | APOE | Protein | Biosynthesis and Anabolic Pathways | AD Pathology | CNS |
9 | ARG1 | Protein | Biosynthesis and Anabolic Pathways | Immune Suppression | CNS |
10 | ARG1 | Protein | Biosynthesis and Anabolic Pathways | Immune Suppression | Immuno-Oncology |
11 | ATG12 | Protein | Autophagy | Others | Cardiovascular |
12 | ATG5 | Protein | Autophagy | Others | Cardiovascular |
13 | B7-H3 | Protein | Others | Immune Checkpoint | Immuno-Oncology |
14 | BACE1 | Protein | Amyloid Processing | AD Pathology | CNS |
15 | BAD | Protein | Apoptosis | Cellular Growth Factor | Oncology |
16 | BAG3 | Protein | Autophagy | Others | Cardiovascular |
17 | Bcl-2 | Protein | Apoptosis | Pan-Tumor | Oncology |
18 | BCL6 | Protein | Apoptosis | Others | Oncology |
19 | BCLXL | Protein | Apoptosis | Others | Oncology |
20 | Beta-2-microglobulin | Protein | Others | Antigen Presentation | Immuno-Oncology |
21 | BIM | Protein | Apoptosis | Others | Oncology |
22 | BRAF | Protein | FGFR Signaling | Immunity and Inflammation | Cardiovascular |
23 | BRAF | Protein | FGFR Signaling | Immunity and Inflammation | Inflammation |
24 | C4B | Protein | Others | Astrocyte | CNS |
25 | Calbindin | Protein | Others | PD Pathology | CNS |
26 | Caspase-3 cleaved | Protein | Others | Others | Others |
27 | CCR6 | Protein | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
28 | CD10 | Protein | Others | Others | Others |
29 | CD106 | Protein | Others | Others | Others |
30 | CD11b | Protein | Others | Microglia | CNS |
31 | CD11c | Protein | Others | Glial Cell Subtyping | CNS |
32 | CD127 | Protein | Others | Immune Activation Status | Immuno-Oncology |
33 | CD138 | Protein | Others | Others | Others |
34 | CD14 | Protein | Apoptosis | Antigen Presentation | Immuno-Oncology |
35 | CD14 | Protein | Apoptosis | Antigen Presentation | Oncology |
36 | CD16 | Protein | Others | Others | Others |
37 | CD163 | Protein | EMT | Immune Cell Typing | Immuno-Oncology |
38 | CD163 | Protein | EMT | Immune Cell Typing | Oncology |
39 | CD20 | Protein | Others | B Cell Function | Immuno-Oncology |
40 | CD204 | Protein | Others | Others | Others |
41 | CD21 | Protein | Others | Others | Others |
42 | CD24 | Protein | Cell Proliferation | Adhesion and Migration | CNS |
43 | CD25 | Protein | Others | Immune Activation Status | Immuno-Oncology |
44 | CD27 | Protein | Costimulatory Signaling | B Cell Exhaustion | Immuno-Oncology |
45 | CD3 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
46 | CD31 | Protein | Others | Neural Cell Typing | CNS |
47 | CD34 | Protein | Cell Proliferation | Adhesion and Migration | CNS |
48 | CD38 | Protein | Others | B Cell Function | Immuno-Oncology |
49 | CD39 | Protein | Others | Inflammation | Inflammation |
50 | CD4 | Protein | Costimulatory Signaling | Antigen Presentation | Immuno-Oncology |
51 | CD40 | Protein | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
52 | CD44 | Protein | Angiogenesis | Adhesion and Migration | CNS |
53 | CD44 | Protein | Angiogenesis | Adhesion and Migration | Cardiovascular |
54 | CD45 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
55 | CD45RB | Protein | TCR Signaling | Others | Immuno-Oncology |
56 | CD45RO | Protein | Others | Immune Activation Status | Immuno-Oncology |
57 | CD56 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
58 | CD66b | Protein | Others | Immune Cell Typing | Immuno-Oncology |
59 | CD68 | Protein | DNA Damage Repair | Immune Cell Typing | Epigenic and Nuclear Signaling |
60 | CD68 | Protein | DNA Damage Repair | Immune Cell Typing | Immuno-Oncology |
61 | CD8 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
62 | CD80 | Protein | Costimulatory Signaling | B Cell Function | Immuno-Oncology |
63 | CD9 | Protein | Myelination | Glial Cell Subtyping | CNS |
64 | CD95/Fas | Protein | Apoptosis | Others | Oncology |
65 | CLEC7A | Protein | Others | Glial Cell Subtyping | CNS |
66 | Collagen Type I | Protein | Others | Others | Others |
67 | CSF1R | Protein | Cytokine and Chemokine Signaling | Glial Cell Subtyping | Immuno-Oncology |
68 | CSF1R | Protein | Cytokine and Chemokine Signaling | Glial Cell Subtyping | CNS |
69 | CTLA4 | Protein | Costimulatory Signaling | B Cell Function | Immuno-Oncology |
70 | CTSD | Protein | Nutrient Capture and Catabolic Pathways | Glial Cell Subtyping | Metabolic Diseases |
71 | CTSD | Protein | Nutrient Capture and Catabolic Pathways | Glial Cell Subtyping | CNS |
72 | CXCR3 | Protein | Angiogenesis | B Cell Exhaustion | Cardiovascular |
73 | EMP1 | Protein | Others | Astrocyte | CNS |
74 | CXCR3 | Protein | Angiogenesis | B Cell Exhaustion | Immuno-Oncology |
75 | EpCAM | Protein | Cell Proliferation | Pan-Tumor | CNS |
76 | EpCAM | Protein | Cell Proliferation | Pan-Tumor | Oncology |
77 | ER-alpha | Protein | ER Signaling | Pan-Tumor | Oncology |
78 | Fibronectin | Protein | Others | Immune Cell Typing | Immuno-Oncology |
79 | Flt3 ligand | Protein | Others | Others | Others |
80 | Flt3/Flk-2/CD135 | Protein | Others | Others | Others |
81 | FOXP3 | Protein | Epigenic and Transcriptional Regulation | Cytokines | Epigenic and Nuclear Signaling |
82 | FOXP3 | Protein | Epigenic and Transcriptional Regulation | Cytokines | Immuno-Oncology |
83 | FUS | Protein | Others | Axon and Dendrite Structure | CNS |
84 | GAPDH | Protein | Biosynthesis and Anabolic Pathways | Immune Cell Typing | CNS |
85 | GAPDH | Protein | Biosynthesis and Anabolic Pathways | Immune Cell Typing | Immuno-Oncology |
86 | GATA3 | Protein | DNA Damage Repair | Immune Activation Status | Epigenic and Nuclear Signaling |
87 | GATA3 | Protein | DNA Damage Repair | Immune Activation Status | Immuno-Oncology |
88 | GBA | Protein | Autophagy | Immunity and Inflammation | Cardiovascular |
89 | GBA | Protein | Autophagy | Immunity and Inflammation | Inflammation |
90 | GFAP | Protein | Others | Astrocyte | CNS |
91 | GITR | Protein | Others | T Cell Activation | Immuno-Oncology |
92 | GPNMB | Protein | Others | Glial Cell Subtyping | CNS |
93 | GzB | Protein | Others | Others | Others |
94 | GZMA | Protein | Apoptosis | Immune Activation Status | Oncology |
95 | GZMA | Protein | Apoptosis | Immune Activation Status | Immuno-Oncology |
96 | GZMB | Protein | Apoptosis | Immune Activation Status | Oncology |
97 | GZMB | Protein | Apoptosis | Immune Activation Status | Immuno-Oncology |
98 | HER2 | Protein | Others | Pan-Tumor | Oncology |
99 | Histone H3 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
100 | HLA-DR | Protein | Others | Antigen Presentation | Immuno-Oncology |
101 | HSC70 | Protein | Autophagy | Others | Cardiovascular |
102 | IBA1 | Protein | Others | Microglia | CNS |
103 | ICOS | Protein | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
104 | IDE | Protein | Amyloid Processing | AD Pathology | CNS |
105 | IDO1 | Protein | Biosynthesis and Anabolic Pathways | Cytokines | CNS |
106 | IDO1 | Protein | Biosynthesis and Anabolic Pathways | Cytokines | Immuno-Oncology |
107 | IgD | Protein | Others | Others | Others |
108 | INPP4B | Protein | PI3K-AKT | Others | Oncology |
109 | Ki-67 | Protein | Proliferation | Immune Cell Typing | Immuno-Oncology |
110 | Ki-67 | Protein | Proliferation | Immune Cell Typing | Oncology |
111 | LAG3 | Protein | Costimulatory Signaling | Immune Cell Typing | Immuno-Oncology |
112 | LAMP2A | Protein | Autophagy | Others | Cardiovascular |
113 | LC3B | Protein | Autophagy | Others | Cardiovascular |
114 | LRRK2 | Protein | Epigenic and Transcriptional Regulation | Axon and Dendrite Structure | CNS |
115 | LRRK2 | Protein | Epigenic and Transcriptional Regulation | Axon and Dendrite Structure | Epigenic and Nuclear Signaling |
116 | MAP2 | Protein | Others | Axon and Dendrite Structure | CNS |
117 | MART1 | Protein | Others | Pan-Tumor | Oncology |
118 | MERTK | Protein | Others | Glial Cell Subtyping | CNS |
119 | MET | Protein | Cell Proliferation | Cellular Growth Factor | CNS |
120 | MET | Protein | Cell Proliferation | Cellular Growth Factor | Oncology |
121 | MPO | Protein | Cell Stress | Others | CNS |
122 | Ms IgG1 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
123 | Ms IgG2a | Protein | Others | Immune Cell Typing | Immuno-Oncology |
124 | Myelin basic protein | Protein | Others | Neural Cell Typing | CNS |
125 | Neprilysin | Protein | Amyloid Processing | AD Pathology | CNS |
126 | NeuN | Protein | Others | Neural Cell Typing | CNS |
127 | Neurofilament light | Protein | Others | Neural Cell Typing | CNS |
128 | NF1 | Protein | Apoptosis | Axon and Dendrite Structure | Oncology |
129 | NF1 | Protein | Apoptosis | Axon and Dendrite Structure | CNS |
130 | NRGN | Protein | Others | AD Pathology | CNS |
131 | NY-ESO-1 | Protein | Others | Pan-Tumor | Oncology |
132 | Olig2 | Protein | Myelination | Neural Cell Typing | CNS |
133 | OX40L | Protein | Others | Myeloid Compartment | CNS |
134 | P2RX7 | Protein | Others | Immunity and Inflammation | Inflammation |
135 | P2ry12 | Protein | Others | Immunity and Inflammation | Inflammation |
136 | P62 | Protein | Autophagy | Others | Cardiovascular |
137 | Pan-AKT | Protein | PI3K-AKT | Others | Oncology |
138 | PanCk | Protein | EMT | Immune Cell Typing | Oncology |
139 | PanCk | Protein | EMT | Immune Cell Typing | Immuno-Oncology |
140 | Pan-Keratin | Protein | Others | Others | Others |
141 | pan-RAS | Protein | MAPK | Others | Cardiovascular |
142 | Park5 | Protein | Others | PD Pathology | CNS |
143 | Park7 | Protein | Oxydative Stress | Axon and Dendrite Structure | Inflammation |
144 | Park7 | Protein | Oxydative Stress | Axon and Dendrite Structure | CNS |
145 | PARP | Protein | Apoptosis | Others | Oncology |
146 | PD-1 | Protein | Others | Immune Activation Status | Immuno-Oncology |
147 | PD-L1 | Protein | Others | Immune Activation Status | Immuno-Oncology |
148 | PD-L2 | Protein | Others | Immune Activation Status | Immuno-Oncology |
149 | Phospho-Alpha-synuclein (S129) | Protein | Others | PD Pathology | CNS |
150 | Phospho-GSK3B (S9) | Protein | PI3K-AKT | Others | Oncology |
151 | Phospho-JNK (T183/Y185) | Protein | MAPK | Others | Cardiovascular |
152 | Phospho-MEK1 (S217/S221) | Protein | MAPK | Others | Cardiovascular |
153 | Phospho-p44/42 MAPK ERK1/2 (T202/Y204) | Protein | MAPK | Others | Cardiovascular |
154 | Phospho-p90 RSK (T359/S363) | Protein | MAPK | Others | Cardiovascular |
155 | Phospho-Tau (S199) | Protein | Others | Cytoskeleton | CNS |
156 | Phospho-Tau (S214) | Protein | Others | Cytoskeleton | CNS |
157 | Phospho-Tau (S396) | Protein | Others | Cytoskeleton | CNS |
158 | Phospho-Tau (S404) | Protein | Others | Cytoskeleton | CNS |
159 | Phospho-Tau (T231) | Protein | Others | Cytoskeleton | CNS |
160 | Phospho-Tdp-43 (S409/S410) | Protein | Others | Others | Others |
161 | Phospho-Tuberin (T1462) | Protein | PI3K-AKT | Others | Oncology |
162 | PINK1 | Protein | Oxydative Stress | Axon and Dendrite Structure | Inflammation |
163 | PINK1 | Protein | Oxydative Stress | Axon and Dendrite Structure | CNS |
164 | PLCG1 | Protein | PI3K-AKT | Cellular Growth Factor | Oncology |
165 | PNAd | Protein | Others | Others | Others |
166 | podoplanin | Protein | Others | Others | Others |
167 | PR | Protein | ER Signaling | Pan-Tumor | Oncology |
168 | PSEN1 | Protein | Amyloid Processing | Axon and Dendrite Structure | CNS |
169 | Rb IgG | Protein | Others | Immune Cell Typing | Immuno-Oncology |
170 | S100B | Protein | Others | Astrocyte | CNS |
171 | S6 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
172 | SMA | Protein | Others | Immune Cell Typing | Immuno-Oncology |
173 | STAT 3 | Protein | Others | Others | Others |
174 | STIM1 | Protein | Others | Immune Activation Status | Immuno-Oncology |
175 | STING | Protein | Interferon Signaling | Others | Immuno-Oncology |
176 | Synaptophysin | Protein | Others | Neural Cell Typing | CNS |
177 | Tau | Protein | Others | Cytoskeleton | CNS |
178 | Tbet | Protein | Others | Others | Others |
179 | Tdp-43 | Protein | Others | Others | Others |
180 | TFEB | Protein | Autophagy | Others | Cardiovascular |
181 | TIM3 | Protein | Others | Others | Others |
182 | Tim-3 | Protein | Others | Immune Checkpoint | Immuno-Oncology |
183 | TMEM119 | Protein | Others | Immunity and Inflammation | Inflammation |
184 | TSLP | Protein | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
185 | Tyrosine Hydroxylase | Protein | Others | PD Pathology | CNS |
186 | Ubiquitin | Protein | Others | Others | Others |
187 | Vimentin | Protein | Others | Astrocyte | CNS |
188 | VISTA | Protein | Others | Immune Checkpoint | Immuno-Oncology |
189 | VPS35 | Protein | Autophagy | Others | Cardiovascular |
190 | A2M | RNA | Matrix Remodeling and Metastases | Chemokines | CNS |
191 | A2M | RNA | Matrix Remodeling and Metastases | Chemokines | Immuno-Oncology |
192 | AADAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
193 | AAMP | RNA | Angiogenesis | Others | Cardiovascular |
194 | AANAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
195 | ABAT | RNA | Transmitter Synthesis | Transmitter Release | CNS |
196 | ABCA1 | RNA | Others | Others | Others |
197 | ABCA8 | RNA | Others | Others | Others |
198 | ABCB1 | RNA | Others | Others | Others |
199 | ABCB11 | RNA | Others | Others | Others |
200 | ABCC1 | RNA | Others | Others | Others |
201 | ABCC3 | RNA | Others | Immunity and Inflammation | Inflammation |
202 | ABCC4 | RNA | Androgen Signaling | Others | Oncology |
203 | ABCC8 | RNA | Others | Immunity and Inflammation | Inflammation |
204 | ABCF1 | RNA | Others | Others | Others |
205 | ABCG2 | RNA | Others | Others | Others |
206 | ABI3BP | RNA | Others | Others | Others |
207 | ABL1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
208 | ACAA1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
209 | ACAA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
210 | ACACA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
211 | ACACB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
212 | ACAD10 | RNA | Others | Others | Others |
213 | ACAD9 | RNA | Others | Others | Others |
214 | ACADL | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
215 | ACADVL | RNA | Others | Others | Others |
216 | ACAP2 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
217 | ACAT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
218 | ACAT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
219 | ACE | RNA | Others | Others | Others |
220 | ACHE | RNA | Cell Proliferation | Neural Connectivity | CNS |
221 | ACIN1 | RNA | Others | Others | Others |
222 | ACKR2 | RNA | Others | Others | Others |
223 | ACKR3 | RNA | Others | Others | Others |
224 | ACKR4 | RNA | Others | Others | Others |
225 | ACMSD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
226 | ACOT1/2 | RNA | Others | Others | Others |
227 | ACOT12 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
228 | ACOT2 | RNA | Others | Others | Others |
229 | ACOX1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
230 | ACOX2 | RNA | Others | Others | Others |
231 | ACP5 | RNA | Others | Others | Others |
232 | ACSF2 | RNA | Others | Others | Others |
233 | ACSF3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
234 | ACSL1 | RNA | Others | Others | Others |
235 | ACSL3 | RNA | Androgen Signaling | Others | Oncology |
236 | ACSL4 | RNA | Others | Others | Others |
237 | ACSL5 | RNA | Others | Others | Others |
238 | ACSL6 | RNA | Others | Others | Others |
239 | ACSM3 | RNA | Others | Others | Others |
240 | ACTA2 | RNA | Others | Others | Others |
241 | ACTB | RNA | Others | Others | Others |
242 | ACTG2 | RNA | Others | Others | Others |
243 | ACTN1 | RNA | Others | Neuronal Cytoskeleton | CNS |
244 | ACTR1A | RNA | Others | Others | Others |
245 | ACTR1B | RNA | Others | Others | Others |
246 | ACTR3B | RNA | Others | Others | Others |
247 | ACVR1 | RNA | Cellular Differentiation | Cellular Growth Factor | Oncology |
248 | ACVR1B | RNA | TGF Beta Signaling | Others | Oncology |
249 | ACVR1C | RNA | Proliferation | Cellular Growth Factor | Oncology |
250 | ACVR2A | RNA | Others | Others | Others |
251 | ACVRL1 | RNA | Angiogenesis | Axon and Dendrite Structure | Cardiovascular |
252 | ACVRL1 | RNA | Angiogenesis | Axon and Dendrite Structure | CNS |
253 | ACY1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
254 | ADA | RNA | Biosynthesis and Anabolic Pathways | B Cell Function | CNS |
255 | ADA | RNA | Biosynthesis and Anabolic Pathways | B Cell Function | Immuno-Oncology |
256 | ADA2 | RNA | Others | Others | Others |
257 | ADAL | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
258 | ADAM10 | RNA | Amyloid Processing | Neural Connectivity | CNS |
259 | ADAM12 | RNA | Others | Others | Others |
260 | ADAM15 | RNA | Angiogenesis | Others | Cardiovascular |
261 | ADAM17 | RNA | Cell Proliferation | Cellular Growth Factor | Oncology |
262 | ADAM17 | RNA | Cell Proliferation | Cellular Growth Factor | CNS |
263 | ADAM28 | RNA | Matrix Remodeling and Metastases | Others | CNS |
264 | ADAM8 | RNA | Angiogenesis | Others | Cardiovascular |
265 | ADAM9 | RNA | Matrix Remodeling and Metastases | Cellular Growth Factor | CNS |
266 | ADAM9 | RNA | Matrix Remodeling and Metastases | Cellular Growth Factor | Oncology |
267 | ADAMTS1 | RNA | Cell Proliferation | Others | CNS |
268 | ADAMTS12 | RNA | Matrix Remodeling and Metastases | Others | CNS |
269 | ADAMTS16 | RNA | Others | Immunity and Inflammation | Inflammation |
270 | ADAMTS8 | RNA | Cell Proliferation | Others | CNS |
271 | ADAP1 | RNA | Others | Others | Others |
272 | ADAR | RNA | Others | Others | Others |
273 | ADCY5 | RNA | Others | Transmitter Release | CNS |
274 | ADCY7 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
275 | ADCY8 | RNA | Others | Transmitter Release | CNS |
276 | ADCY9 | RNA | ER Signaling | Axon and Dendrite Structure | Oncology |
277 | ADCY9 | RNA | ER Signaling | Axon and Dendrite Structure | CNS |
278 | ADCYAP1 | RNA | Transmitter Synthesis | Axon and Dendrite Structure | CNS |
279 | ADD1 | RNA | Cellular Differentiation | Others | Oncology |
280 | ADGRE1 | RNA | Others | Others | Others |
281 | ADGRE5 | RNA | Others | Others | Others |
282 | ADGRG3 | RNA | Others | Others | Others |
283 | ADH1A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
284 | ADH1A/B/C | RNA | Others | Others | Others |
285 | ADH1B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
286 | ADH1C | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
287 | ADH4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
288 | ADH6 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
289 | ADH7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
290 | ADIPOQ | RNA | Others | Others | Others |
291 | ADIPOR1 | RNA | Others | Others | Others |
292 | ADK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
293 | ADM | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
294 | ADM2 | RNA | Angiogenesis | Others | Cardiovascular |
295 | ADORA1 | RNA | Others | Axon and Dendrite Structure | CNS |
296 | ADORA2A | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
297 | ADORA2B | RNA | Others | Immune Suppression | Immuno-Oncology |
298 | ADPGK | RNA | Others | Others | Others |
299 | ADRA2A | RNA | Others | Immunity and Inflammation | Inflammation |
300 | ADRA2B | RNA | Angiogenesis | Cellular Growth Factor | Cardiovascular |
301 | ADRA2B | RNA | Angiogenesis | Cellular Growth Factor | Oncology |
302 | ADRB2 | RNA | Others | Axon and Dendrite Structure | CNS |
303 | AEBP1 | RNA | Cellular Differentiation | Others | Oncology |
304 | AFDN | RNA | Others | Others | Others |
305 | AFMID | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
306 | AGER | RNA | Oxydative Stress | Axon and Dendrite Structure | Inflammation |
307 | AGER | RNA | Oxydative Stress | Axon and Dendrite Structure | CNS |
308 | AGGF1 | RNA | Angiogenesis | Others | Cardiovascular |
309 | AGK | RNA | Others | Others | Others |
310 | AGO2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
311 | AGO4 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Epigenic and Nuclear Signaling |
312 | AGO4 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Inflammation |
313 | AGR2 | RNA | EMT | Others | Oncology |
314 | AGRN | RNA | Others | Others | Others |
315 | AGT | RNA | Proliferation | Cellular Growth Factor | Oncology |
316 | AGTR1 | RNA | Others | Others | Others |
317 | AGXT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
318 | AGXT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
319 | AHNAK | RNA | Others | Others | Others |
320 | AHR | RNA | Others | Immune Suppression | Immuno-Oncology |
321 | AICDA | RNA | Others | Others | Others |
322 | AIF1 | RNA | Oxydative Stress | Others | Inflammation |
323 | AIFM1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
324 | AIM2 | RNA | Others | Others | Others |
325 | AIMP2 | RNA | Myc | Others | Oncology |
326 | AIRE | RNA | Others | Others | Others |
327 | AK1 | RNA | Others | Immunity and Inflammation | Inflammation |
328 | AK3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
329 | AK4 | RNA | Others | Others | Others |
330 | AKAP1 | RNA | Others | Others | Others |
331 | AKAP12 | RNA | Others | Others | Others |
332 | AKAP2 | RNA | Others | Others | Others |
333 | AKR1B10 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
334 | AKR1C4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
335 | AKT1 | RNA | Apoptosis | Immune Activation Status | Oncology |
336 | AKT1 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
337 | AKT1S1 | RNA | Carbohydrate Metabolism | Others | CNS |
338 | AKT2 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
339 | AKT2 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
340 | AKT3 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
341 | AKT3 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
342 | ALAD | RNA | Others | Others | Others |
343 | ALAS1 | RNA | Others | Others | Others |
344 | ALAS2 | RNA | Others | Others | Others |
345 | ALB | RNA | Others | Others | Others |
346 | ALCAM | RNA | Others | Others | Others |
347 | ALDH1A1 | RNA | Others | Immune Suppression | Immuno-Oncology |
348 | ALDH1A3 | RNA | Androgen Signaling | Immune Suppression | Oncology |
349 | ALDH1A3 | RNA | Androgen Signaling | Immune Suppression | Immuno-Oncology |
350 | ALDH1B1 | RNA | Others | Others | Others |
351 | ALDH1L1 | RNA | Others | Others | Others |
352 | ALDH1L2 | RNA | Others | Others | Others |
353 | ALDH2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
354 | ALDH3A1 | RNA | Others | Others | Others |
355 | ALDH3A2 | RNA | Others | Others | Others |
356 | ALDH3B2 | RNA | Others | Others | Others |
357 | ALDH7A1 | RNA | Others | Others | Others |
358 | ALDH8A1 | RNA | Others | Others | Others |
359 | ALDH9A1 | RNA | Others | Others | Others |
360 | ALDOA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
361 | ALDOB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
362 | ALDOC | RNA | Others | Others | Others |
363 | ALK | RNA | Others | Others | Others |
364 | ALKBH2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
365 | ALKBH3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
366 | ALOX12 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
367 | ALOX15 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
368 | ALOX5 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
369 | ALOX5 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
370 | ALOX5AP | RNA | Others | Others | Others |
371 | ALPK1 | RNA | Others | Others | Others |
372 | ALPL | RNA | Others | Others | Others |
373 | AMBP | RNA | Others | Others | Others |
374 | AMBRA1 | RNA | Others | Others | Others |
375 | AMDHD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
376 | AMER1 | RNA | Others | Others | Others |
377 | AMH | RNA | Others | Cellular Growth Factor | Oncology |
378 | AMICA1 | RNA | Others | Others | Others |
379 | AMIGO1 | RNA | Myelination | Axon and Dendrite Structure | CNS |
380 | AMIGO2 | RNA | Others | Others | Others |
381 | AMMECR1L | RNA | Others | Others | Others |
382 | AMOTL1 | RNA | Others | Others | Others |
383 | AMOTL2 | RNA | Hippo Signaling | Others | CNS |
384 | AMPD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
385 | AMPD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
386 | AMPD3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
387 | AMPH | RNA | Others | Neural Connectivity | CNS |
388 | ANAPC1 | RNA | Others | Others | Others |
389 | ANAPC10 | RNA | Others | Others | Others |
390 | ANAPC15 | RNA | Others | Others | Others |
391 | ANAPC4 | RNA | Others | Immune Activation Status | Immuno-Oncology |
392 | ANAPC7 | RNA | Others | Others | Others |
393 | ANG | RNA | Angiogenesis | Others | Cardiovascular |
394 | ANGPT1 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular |
395 | ANGPT1 | RNA | Angiogenesis | Immune Activation Status | Immuno-Oncology |
396 | ANGPT2 | RNA | Angiogenesis | Others | Cardiovascular |
397 | ANGPTL2 | RNA | Others | Others | Others |
398 | ANGPTL4 | RNA | Angiogenesis | Others | Cardiovascular |
399 | ANKRD28 | RNA | Others | Others | Others |
400 | ANLN | RNA | Apoptosis | Others | Oncology |
401 | ANP32B | RNA | Others | Others | Others |
402 | ANPEP | RNA | Angiogenesis | Others | Cardiovascular |
403 | ANXA1 | RNA | Others | Others | Others |
404 | ANXA2P2 | RNA | Angiogenesis | Others | Cardiovascular |
405 | ANXA9 | RNA | ER Signaling | Others | Oncology |
406 | AOC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
407 | AOC3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
408 | AOX1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
409 | AP1B1 | RNA | Others | Others | Others |
410 | AP1G1 | RNA | Others | Others | Others |
411 | AP1M1 | RNA | Others | Others | Others |
412 | AP1M2 | RNA | Others | Others | Others |
413 | AP1S1 | RNA | Others | Neural Connectivity | CNS |
414 | AP1S2 | RNA | Others | Others | Others |
415 | AP2A1 | RNA | Others | Others | Others |
416 | AP2A2 | RNA | Transmitter Synthesis | Others | CNS |
417 | AP2B1 | RNA | Transmitter Synthesis | Others | CNS |
418 | AP2M1 | RNA | Others | Others | Others |
419 | AP2S1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
420 | AP3M2 | RNA | Others | Others | Others |
421 | AP3S1 | RNA | Others | Others | Others |
422 | AP4S1 | RNA | Others | Others | Others |
423 | APAF1 | RNA | Others | Others | Others |
424 | APBB1IP | RNA | Others | Others | Others |
425 | APC | RNA | Apoptosis | Neural Connectivity | Oncology |
426 | APC | RNA | Apoptosis | Neural Connectivity | CNS |
427 | APCS | RNA | Others | Others | Others |
428 | APEX1 | RNA | Others | Others | Others |
429 | APH1A | RNA | Others | Immune Suppression | Immuno-Oncology |
430 | APH1B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
431 | API5 | RNA | Others | Others | Others |
432 | APLNR | RNA | Others | Others | Others |
433 | APLP2 | RNA | Others | Others | Others |
434 | APOA1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
435 | APOA2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
436 | APOA4 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
437 | APOB | RNA | Adenosine Pathway | Immune Activation Status | Immuno-Oncology |
438 | APOBEC3G | RNA | Others | Others | Others |
439 | APOC2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
440 | APOC3 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
441 | APOD | RNA | Angiogenesis | Cellular Growth Factor | Oncology |
442 | APOD | RNA | Angiogenesis | Cellular Growth Factor | Cardiovascular |
443 | APOE | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS |
444 | APOE | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | Inflammation |
445 | APOH | RNA | Cell Proliferation | Others | CNS |
446 | APOL6 | RNA | Others | Others | Others |
447 | APOM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
448 | APP | RNA | Adenosine Pathway | Neural Connectivity | Immuno-Oncology |
449 | APP | RNA | Adenosine Pathway | Neural Connectivity | CNS |
450 | APRT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
451 | AQP1 | RNA | Others | Others | Others |
452 | AQP4 | RNA | Others | Others | Others |
453 | AQP7 | RNA | Others | Others | Others |
454 | AQP8 | RNA | Others | Others | Others |
455 | AQP9 | RNA | Metabolism Stress | Others | Metabolic Diseases |
456 | AR | RNA | Androgen Signaling | Others | Oncology |
457 | ARAF | RNA | Others | Others | Others |
458 | ARAP2 | RNA | Others | Others | Others |
459 | ARC | RNA | Others | Neural Connectivity | CNS |
460 | AREG | RNA | Cell Proliferation | Cellular Growth Factor | CNS |
461 | AREG | RNA | Cell Proliferation | Cellular Growth Factor | Oncology |
462 | ARF1 | RNA | Others | Others | Others |
463 | ARF5 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
464 | ARG1 | RNA | Biosynthesis and Anabolic Pathways | Immune Suppression | CNS |
465 | ARG1 | RNA | Biosynthesis and Anabolic Pathways | Immune Suppression | Immuno-Oncology |
466 | ARG2 | RNA | Others | Others | Others |
467 | ARHGAP24 | RNA | Others | Immunity and Inflammation | Inflammation |
468 | ARHGAP32 | RNA | Others | Others | Others |
469 | ARHGAP35 | RNA | Others | Others | Others |
470 | ARHGAP44 | RNA | Others | Neural Connectivity | CNS |
471 | ARHGDIB | RNA | Others | Others | Others |
472 | ARHGEF1 | RNA | Others | Others | Others |
473 | ARHGEF10 | RNA | Myelination | Others | CNS |
474 | ARHGEF2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
475 | ARHGEF6 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
476 | ARID1A | RNA | Androgen Signaling | Others | Oncology |
477 | ARID1B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
478 | ARID2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
479 | ARID4A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
480 | ARID4B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
481 | ARNT | RNA | Others | Others | Others |
482 | ARNT2 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
483 | ARPC4 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
484 | ARRB1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
485 | ARRB2 | RNA | Others | Neural Connectivity | CNS |
486 | ARSA | RNA | Lipid Metabolism | Others | Metabolic Diseases |
487 | ASB2 | RNA | Others | Immunity and Inflammation | Inflammation |
488 | ASB4 | RNA | Others | Immune Activation Status | Immuno-Oncology |
489 | ASCL1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
490 | ASH1L | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
491 | ASH2L | RNA | Others | Others | Others |
492 | ASL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
493 | ASMT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
494 | ASNS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
495 | ASPA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
496 | ASPG | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
497 | ASPH | RNA | Others | Immunity and Inflammation | Inflammation |
498 | ASPM | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
499 | ASPN | RNA | EMT | Cellular Growth Factor | Oncology |
500 | ASS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
501 | ASXL1 | RNA | Others | Others | Others |
502 | ASXL2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
503 | ATAD2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
504 | ATCAY | RNA | Others | Neural Connectivity | CNS |
505 | ATF1 | RNA | Others | Others | Others |
506 | ATF2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
507 | ATF3 | RNA | Others | Immunity and Inflammation | Inflammation |
508 | ATF4 | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular |
509 | ATF4 | RNA | AP1 Signaling | Immune Activation Status | Immuno-Oncology |
510 | ATF6 | RNA | Others | Others | Others |
511 | ATF7 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
512 | ATF7IP | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
513 | ATG10 | RNA | Others | Others | Others |
514 | ATG101 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
515 | ATG12 | RNA | Autophagy | Others | Cardiovascular |
516 | ATG13 | RNA | Others | Others | Others |
517 | ATG14 | RNA | Others | Others | Others |
518 | ATG16L1 | RNA | Others | Others | Others |
519 | ATG2B | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
520 | ATG3 | RNA | Others | Others | Others |
521 | ATG4A | RNA | Others | Others | Others |
522 | ATG4B | RNA | Others | Others | Others |
523 | ATG5 | RNA | Others | Immunity and Inflammation | Inflammation |
524 | ATG7 | RNA | Others | Immunity and Inflammation | Inflammation |
525 | ATG9A | RNA | Others | Others | Others |
526 | ATM | RNA | DNA Damage Repair | Immune Activation Status | Epigenic and Nuclear Signaling |
527 | ATM | RNA | DNA Damage Repair | Immune Activation Status | Immuno-Oncology |
528 | ATOX1 | RNA | Cell Stress | Others | CNS |
529 | ATP10B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
530 | ATP11C | RNA | Others | Others | Others |
531 | ATP13A2 | RNA | Oxydative Stress | Others | Inflammation |
532 | ATP2A2 | RNA | Others | Others | Others |
533 | ATP2B3 | RNA | Others | Transmitter Release | CNS |
534 | ATP5F1D | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
535 | ATP5ME | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
536 | ATP5MF | RNA | Others | Others | Others |
537 | ATP5MG | RNA | Others | Others | Others |
538 | ATP5PD | RNA | Others | Others | Others |
539 | ATP6AP2 | RNA | Others | Others | Others |
540 | ATP6V0A1 | RNA | Others | Others | Others |
541 | ATP6V0C | RNA | Transmitter Synthesis | Others | CNS |
542 | ATP6V0D1 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
543 | ATP6V0E1 | RNA | Transmitter Synthesis | Immunity and Inflammation | CNS |
544 | ATP6V0E1 | RNA | Transmitter Synthesis | Immunity and Inflammation | Inflammation |
545 | ATP6V0E2 | RNA | Transmitter Synthesis | Others | CNS |
546 | ATP6V1A | RNA | Transmitter Synthesis | Immunity and Inflammation | CNS |
547 | ATP6V1A | RNA | Transmitter Synthesis | Immunity and Inflammation | Inflammation |
548 | ATP6V1B2 | RNA | Others | Others | Others |
549 | ATP6V1C2 | RNA | Others | Others | Others |
550 | ATP6V1D | RNA | Transmitter Synthesis | Others | CNS |
551 | ATP6V1E1 | RNA | Transmitter Synthesis | Others | CNS |
552 | ATP6V1F | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
553 | ATP6V1G2 | RNA | Transmitter Synthesis | Others | CNS |
554 | ATP6V1G3 | RNA | Others | Immune Activation Status | Immuno-Oncology |
555 | ATP6V1H | RNA | Transmitter Synthesis | Others | CNS |
556 | ATP7A | RNA | Oxydative Stress | Others | Inflammation |
557 | ATP8A2 | RNA | Others | Others | Others |
558 | ATPIF1 | RNA | Angiogenesis | Others | Cardiovascular |
559 | ATR | RNA | p53 Signaling | Immune Activation Status | Oncology |
560 | ATR | RNA | p53 Signaling | Immune Activation Status | Immuno-Oncology |
561 | ATRN | RNA | Myelination | Others | CNS |
562 | ATRX | RNA | Others | Others | Others |
563 | ATXN2 | RNA | Others | Others | Others |
564 | ATXN3 | RNA | Others | Vesicle Trafficking | CNS |
565 | ATXN7 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
566 | AURKA | RNA | Cell Cycle | Others | Oncology |
567 | AURKB | RNA | Cell Cycle | Others | Oncology |
568 | AVP | RNA | Others | Others | Others |
569 | AXIN1 | RNA | Wnt Signaling | Others | CNS |
570 | AXIN2 | RNA | Wnt Signaling | Others | CNS |
571 | AXL | RNA | Hippo Signaling | Immunity and Inflammation | CNS |
572 | AXL | RNA | Hippo Signaling | Immunity and Inflammation | Inflammation |
573 | B2M | RNA | Interferon Signaling | Others | Immuno-Oncology |
574 | B3GAT1 | RNA | Others | Others | Others |
575 | B3GNT3 | RNA | EMT | Others | Oncology |
576 | B3GNT5 | RNA | Others | Others | Others |
577 | B4GALNT1 | RNA | Others | Others | Others |
578 | B4GALT1 | RNA | Androgen Signaling | Immune Suppression | Oncology |
579 | B4GALT1 | RNA | Androgen Signaling | Immune Suppression | Immuno-Oncology |
580 | B4GALT6 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
581 | BABAM1 | RNA | Others | Others | Others |
582 | BACE1 | RNA | Amyloid Processing | Others | CNS |
583 | BAD | RNA | Apoptosis | Cellular Growth Factor | Oncology |
584 | BAG1 | RNA | Others | Others | Others |
585 | BAG2 | RNA | Others | Others | Others |
586 | BAG3 | RNA | Autophagy | Others | Cardiovascular |
587 | BAG4 | RNA | Others | Immunity and Inflammation | Inflammation |
588 | BAGE | RNA | Others | Others | Others |
589 | BAI1 | RNA | Cell Proliferation | Others | CNS |
590 | BAI3 | RNA | Others | Others | Others |
591 | BAIAP2L1 | RNA | Others | Others | Others |
592 | BAIAP3 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
593 | BAK1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
594 | BAMBI | RNA | TGF Beta Signaling | Others | Oncology |
595 | BANF1 | RNA | Others | Others | Others |
596 | BAP1 | RNA | Others | Others | Others |
597 | BARD1 | RNA | Others | Others | Others |
598 | BATF | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular |
599 | BATF | RNA | AP1 Signaling | Immune Activation Status | Immuno-Oncology |
600 | BATF3 | RNA | Others | Others | Others |
601 | BAX | RNA | Apoptosis | Immune Activation Status | Oncology |
602 | BAX | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
603 | BBC3 | RNA | Apoptosis | Others | Oncology |
604 | BBOX1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
605 | BBS1 | RNA | Others | Others | Others |
606 | BCAP31 | RNA | Others | Others | Others |
607 | BCAS1 | RNA | EMT | Neural Connectivity | Oncology |
608 | BCAS1 | RNA | EMT | Neural Connectivity | CNS |
609 | BCAS2 | RNA | Others | Others | Others |
610 | BCAT1 | RNA | Others | Others | Others |
611 | BCHE | RNA | Carbohydrate Metabolism | Vesicle Trafficking | CNS |
612 | BCL10 | RNA | TCR Signaling | Immunity and Inflammation | Immuno-Oncology |
613 | BCL10 | RNA | TCR Signaling | Immunity and Inflammation | Inflammation |
614 | BCL11A | RNA | Others | Others | Others |
615 | BCL2 | RNA | Apoptosis | Immune Activation Status | Oncology |
616 | BCL2 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
617 | BCL2A1 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Epigenic and Nuclear Signaling |
618 | BCL2A1 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Inflammation |
619 | BCL2L1 | RNA | Apoptosis | Immune Activation Status | Oncology |
620 | BCL2L1 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
621 | BCL2L11 | RNA | Others | Others | Others |
622 | BCL2L2 | RNA | Others | Others | Others |
623 | BCL3 | RNA | Others | Others | Others |
624 | BCL6 | RNA | Apoptosis | Others | Oncology |
625 | BCL6B | RNA | Angiogenesis | Others | Cardiovascular |
626 | BCLAF1 | RNA | Others | Others | Others |
627 | BCOR | RNA | Others | Others | Others |
628 | BCR | RNA | Others | Others | Others |
629 | BDKRB1 | RNA | Others | Others | Others |
630 | BDKRB2 | RNA | Others | Others | Others |
631 | BDNF | RNA | MAPK | Transmitter Response and Reuptake | Cardiovascular |
632 | BDNF | RNA | MAPK | Transmitter Response and Reuptake | CNS |
633 | BECN1 | RNA | Others | Others | Others |
634 | BGN | RNA | Others | Others | Others |
635 | BHLHE40 | RNA | mTOR Signaling | Others | Oncology |
636 | BHMT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
637 | BHMT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
638 | BICC1 | RNA | Others | Others | Others |
639 | BID | RNA | Apoptosis | Immune Activation Status | Oncology |
640 | BID | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
641 | BIK | RNA | Others | Others | Others |
642 | BIN1 | RNA | Others | Immunity and Inflammation | Inflammation |
643 | BIRC2 | RNA | Others | Immunity and Inflammation | Inflammation |
644 | BIRC3 | RNA | Apoptosis | Immunity and Inflammation | Oncology |
645 | BIRC3 | RNA | Apoptosis | Immunity and Inflammation | Inflammation |
646 | BIRC5 | RNA | Apoptosis | Others | Oncology |
647 | BIRC7 | RNA | Others | Others | Others |
648 | BLK | RNA | Others | Immune Activation Status | Immuno-Oncology |
649 | BLM | RNA | Apoptosis | Others | Oncology |
650 | BLNK | RNA | Others | Immunity and Inflammation | Inflammation |
651 | BLVRA | RNA | Others | Others | Others |
652 | BMI1 | RNA | Others | Others | Others |
653 | BMP10 | RNA | Others | Others | Others |
654 | BMP2 | RNA | Hedgehog | Immune Suppression | CNS |
655 | BMP2 | RNA | Hedgehog | Immune Suppression | Immuno-Oncology |
656 | BMP4 | RNA | Cell Proliferation | Others | CNS |
657 | BMP5 | RNA | Proliferation | Others | Oncology |
658 | BMP6 | RNA | TGF Beta Signaling | Others | Oncology |
659 | BMP7 | RNA | Cell Proliferation | Others | CNS |
660 | BMP8A | RNA | TGF Beta Signaling | Others | Oncology |
661 | BMP8A/B | RNA | Others | Immune Suppression | Immuno-Oncology |
662 | BMPER | RNA | Cell Proliferation | Others | CNS |
663 | BMPR1A | RNA | Cell Proliferation | Others | CNS |
664 | BMPR1B | RNA | Proliferation | Others | Oncology |
665 | BMPR2 | RNA | Cell Proliferation | Others | CNS |
666 | BNC2 | RNA | EMT | Others | Oncology |
667 | BNIP3 | RNA | Autophagy | Immunity and Inflammation | Cardiovascular |
668 | BNIP3 | RNA | Autophagy | Immunity and Inflammation | Inflammation |
669 | BNIP3L | RNA | Others | Others | Others |
670 | BOK | RNA | Others | Others | Others |
671 | BOLA2 | RNA | Others | Immunity and Inflammation | Inflammation |
672 | BORCS7 | RNA | ER Signaling | Others | Oncology |
673 | BPI | RNA | Others | Immune Activation Status | Immuno-Oncology |
674 | BRAF | RNA | FGFR Signaling | Immunity and Inflammation | Cardiovascular |
675 | BRAF | RNA | FGFR Signaling | Immunity and Inflammation | Inflammation |
676 | BRCA1 | RNA | Androgen Signaling | Others | Oncology |
677 | BRCA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
678 | BRCC3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
679 | BRD2 | RNA | Others | Others | Others |
680 | BRD3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
681 | BRD4 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
682 | BRD7 | RNA | Others | Others | Others |
683 | BRIP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
684 | BRMS1 | RNA | Cell Proliferation | Others | CNS |
685 | BRMS1L | RNA | Others | Others | Others |
686 | BRPF3 | RNA | Others | Others | Others |
687 | BRWD1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
688 | BST1 | RNA | Others | Others | Others |
689 | BST2 | RNA | Others | Immune Activation Status | Immuno-Oncology |
690 | BTBD6 | RNA | Others | Others | Others |
691 | BTG1 | RNA | Cell Proliferation | Others | CNS |
692 | BTG2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
693 | BTK | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
694 | BTK | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
695 | BTLA | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
696 | BTRC | RNA | Others | Immune Activation Status | Immuno-Oncology |
697 | BUB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
698 | BUB1B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
699 | BYSL | RNA | Myc | Others | Oncology |
700 | C10orf76 | RNA | Others | Others | Others |
701 | C14orf166 | RNA | Others | Others | Others |
702 | C19orf40 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
703 | C1QA | RNA | Others | Immunity and Inflammation | Inflammation |
704 | C1QB | RNA | Others | Immunity and Inflammation | Inflammation |
705 | C1QBP | RNA | Others | Chemokines | Immuno-Oncology |
706 | C1QC | RNA | Others | Immunity and Inflammation | Inflammation |
707 | C1R | RNA | Others | Others | Others |
708 | C1S | RNA | Others | Others | Others |
709 | C2 | RNA | Others | Others | Others |
710 | C3 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
711 | C3 | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
712 | C3AR1 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
713 | C3AR1 | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
714 | C4A | RNA | Others | Others | Others |
715 | C4A/B | RNA | Others | Others | Others |
716 | C4B | RNA | Others | Glial Cell Subtyping | CNS |
717 | C4BPA | RNA | Others | Others | Others |
718 | C5 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
719 | C5AR1 | RNA | Others | Immunity and Inflammation | Inflammation |
720 | C5orf38 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
721 | C6 | RNA | Others | Immunity and Inflammation | Inflammation |
722 | C7 | RNA | Others | Others | Others |
723 | C8A | RNA | Others | Others | Others |
724 | C8B | RNA | Others | Others | Others |
725 | C8G | RNA | Others | Others | Others |
726 | C9 | RNA | Others | Others | Others |
727 | C9orf72 | RNA | Others | Others | Others |
728 | CA12 | RNA | Cell Stress | Others | CNS |
729 | CA2 | RNA | Others | Vesicle Trafficking | CNS |
730 | CA9 | RNA | Cell Stress | Others | CNS |
731 | CAB39 | RNA | Carbohydrate Metabolism | Others | CNS |
732 | CABLES1 | RNA | Others | Others | Others |
733 | CACNA1A | RNA | Signaling Affecting Cellular Metabolism | Neural Connectivity | Metabolic Diseases |
734 | CACNA1A | RNA | Signaling Affecting Cellular Metabolism | Neural Connectivity | CNS |
735 | CACNA1B | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
736 | CACNA1C | RNA | Others | Neural Connectivity | CNS |
737 | CACNA1D | RNA | MAPK | Transmitter Release | Cardiovascular |
738 | CACNA1D | RNA | MAPK | Transmitter Release | CNS |
739 | CACNA1E | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
740 | CACNA1F | RNA | Others | Transmitter Release | CNS |
741 | CACNA1G | RNA | Others | Others | Others |
742 | CACNA1H | RNA | MAPK | Others | Cardiovascular |
743 | CACNA1S | RNA | Others | Transmitter Release | CNS |
744 | CACNA2D1 | RNA | MAPK | Others | Cardiovascular |
745 | CACNA2D2 | RNA | Others | Others | Others |
746 | CACNA2D3 | RNA | MAPK | Others | Cardiovascular |
747 | CACNA2D4 | RNA | Others | Others | Others |
748 | CACNB2 | RNA | Others | Immune Activation Status | Immuno-Oncology |
749 | CACNB3 | RNA | Others | Others | Others |
750 | CACNB4 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
751 | CACNB4 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
752 | CACNG1 | RNA | MAPK | Others | Cardiovascular |
753 | CACNG2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
754 | CACNG3 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
755 | CACNG4 | RNA | MAPK | Others | Cardiovascular |
756 | CACNG6 | RNA | MAPK | Others | Cardiovascular |
757 | CACNG7 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
758 | CACYBP | RNA | mTOR Signaling | Others | Oncology |
759 | CAD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
760 | CADM1 | RNA | Others | Others | Others |
761 | CADM3 | RNA | Others | Others | Others |
762 | CADPS | RNA | Others | Neural Connectivity | CNS |
763 | CALB1 | RNA | Others | Neural Connectivity | CNS |
764 | CALB2 | RNA | Others | Neural Connectivity | CNS |
765 | CALCOCO2 | RNA | Others | Others | Others |
766 | CALCRL | RNA | Angiogenesis | Others | Cardiovascular |
767 | CALD1 | RNA | Others | Others | Others |
768 | CALM1 | RNA | Adenosine Pathway | Immune Activation Status | Immuno-Oncology |
769 | CALML3 | RNA | RAS | Others | Oncology |
770 | CALML5 | RNA | MAPK | Transmitter Release | Cardiovascular |
771 | CALML5 | RNA | MAPK | Transmitter Release | CNS |
772 | CALML6 | RNA | RAS | Others | Oncology |
773 | CALR | RNA | Others | Immunity and Inflammation | Inflammation |
774 | CAMK2A | RNA | Others | Others | Others |
775 | CAMK2B | RNA | Wnt Signaling | Neural Connectivity | CNS |
776 | CAMK2D | RNA | Cellular Differentiation | Immune Activation Status | Oncology |
777 | CAMK2D | RNA | Cellular Differentiation | Immune Activation Status | Immuno-Oncology |
778 | CAMK2G | RNA | Others | Transmitter Release | CNS |
779 | CAMK4 | RNA | Others | Transmitter Release | CNS |
780 | CAMP | RNA | Others | Others | Others |
781 | CAP1 | RNA | Others | Others | Others |
782 | CAPN1 | RNA | Others | Others | Others |
783 | CAPN2 | RNA | Others | Others | Others |
784 | CAPN5 | RNA | Others | Others | Others |
785 | CARD10 | RNA | Others | Others | Others |
786 | CARD11 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
787 | CARD11 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
788 | CARD16 | RNA | Others | Others | Others |
789 | CARD17 | RNA | Others | Others | Others |
790 | CARD8 | RNA | Others | Others | Others |
791 | CARD9 | RNA | Others | Others | Others |
792 | CASP1 | RNA | Apoptosis | Immunity and Inflammation | Oncology |
793 | CASP1 | RNA | Apoptosis | Immunity and Inflammation | Inflammation |
794 | CASP10 | RNA | Others | Others | Others |
795 | CASP12 | RNA | Others | Others | Others |
796 | CASP2 | RNA | Others | Immunity and Inflammation | Inflammation |
797 | CASP3 | RNA | Apoptosis | Immune Activation Status | Oncology |
798 | CASP3 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
799 | CASP4 | RNA | Others | Immunity and Inflammation | Inflammation |
800 | CASP5 | RNA | Others | Others | Others |
801 | CASP6 | RNA | Others | Others | Others |
802 | CASP7 | RNA | Others | Immunity and Inflammation | Inflammation |
803 | CASP8 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular |
804 | CASP8 | RNA | Angiogenesis | Immune Activation Status | Immuno-Oncology |
805 | CASP9 | RNA | Apoptosis | Immune Activation Status | Oncology |
806 | CASP9 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
807 | CASS4 | RNA | Others | Immunity and Inflammation | Inflammation |
808 | CAST | RNA | Others | Others | Others |
809 | CAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
810 | CAV1 | RNA | Angiogenesis | Others | Cardiovascular |
811 | CBFB | RNA | Others | Others | Others |
812 | CBL | RNA | Nutrient Capture and Catabolic Pathways | Immune Activation Status | Metabolic Diseases |
813 | CBL | RNA | Nutrient Capture and Catabolic Pathways | Immune Activation Status | Immuno-Oncology |
814 | CBLB | RNA | Others | Immune Activation Status | Immuno-Oncology |
815 | CBLC | RNA | Cytotoxicity | Others | Oncology |
816 | CBR4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
817 | CBX2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
818 | CC2D1B | RNA | Others | Others | Others |
819 | CCBE1 | RNA | Others | Others | Others |
820 | CCBP2 | RNA | Others | Others | Others |
821 | CCDC80 | RNA | Others | Others | Others |
822 | CCK | RNA | Others | Neural Connectivity | CNS |
823 | CCL1 | RNA | Others | Others | Others |
824 | CCL11 | RNA | Cell Proliferation | Others | CNS |
825 | CCL13 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
826 | CCL14 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
827 | CCL15 | RNA | Others | Others | Others |
828 | CCL16 | RNA | Others | Others | Others |
829 | CCL17 | RNA | Others | Others | Others |
830 | CCL18 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
831 | CCL19 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
832 | CCL2 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
833 | CCL20 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
834 | CCL21 | RNA | Cellular Differentiation | Immune Activation Status | Oncology |
835 | CCL21 | RNA | Cellular Differentiation | Immune Activation Status | Immuno-Oncology |
836 | CCL22 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
837 | CCL23 | RNA | Others | Others | Others |
838 | CCL24 | RNA | Others | Others | Others |
839 | CCL25 | RNA | Others | Others | Others |
840 | CCL26 | RNA | Others | Others | Others |
841 | CCL27 | RNA | Others | Others | Others |
842 | CCL28 | RNA | Others | Others | Others |
843 | CCL3 | RNA | Others | Immunity and Inflammation | Inflammation |
844 | CCL3/L1 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
845 | CCL3/L1/L3 | RNA | Others | Others | Others |
846 | CCL3L1 | RNA | Others | Cytokines | Immuno-Oncology |
847 | CCL4 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
848 | CCL4 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
849 | CCL4/L1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
850 | CCL4/L1/L2 | RNA | Others | Others | Others |
851 | CCL5 | RNA | Cytokine and Chemokine Signaling | Cytokines | Immuno-Oncology |
852 | CCL7 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
853 | CCL7 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
854 | CCL8 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
855 | CCL8 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
856 | CCN2 | RNA | Others | Others | Others |
857 | CCNA1 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
858 | CCNA1 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
859 | CCNA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
860 | CCNB1 | RNA | Cell Cycle | Immune Activation Status | Oncology |
861 | CCNB1 | RNA | Cell Cycle | Immune Activation Status | Immuno-Oncology |
862 | CCNB2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
863 | CCNB3 | RNA | Others | Immune Activation Status | Immuno-Oncology |
864 | CCNC | RNA | Others | Immune Suppression | Immuno-Oncology |
865 | CCND1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
866 | CCND2 | RNA | Angiogenesis | Others | Cardiovascular |
867 | CCND3 | RNA | JAK-STAT | Others | CNS |
868 | CCNE1 | RNA | Androgen Signaling | Others | Oncology |
869 | CCNE2 | RNA | Cell Cycle | Others | Oncology |
870 | CCNF | RNA | Cell Cycle | Others | Oncology |
871 | CCNG2 | RNA | Others | Others | Others |
872 | CCNH | RNA | Others | Others | Others |
873 | CCNI | RNA | Others | Others | Others |
874 | CCNK | RNA | Cell Cycle | Others | Oncology |
875 | CCNO | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
876 | CCNT1 | RNA | Cell Cycle | Immune Suppression | Oncology |
877 | CCNT1 | RNA | Cell Cycle | Immune Suppression | Immuno-Oncology |
878 | CCNT2 | RNA | Others | Immune Suppression | Immuno-Oncology |
879 | CCR1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
880 | CCR10 | RNA | Others | Others | Others |
881 | CCR2 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
882 | CCR3 | RNA | Cell Proliferation | Others | CNS |
883 | CCR4 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
884 | CCR5 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
885 | CCR6 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
886 | CCR7 | RNA | Others | Immune Activation Status | Immuno-Oncology |
887 | CCR8 | RNA | Others | Others | Others |
888 | CCR9 | RNA | Others | Others | Others |
889 | CCRL1 | RNA | Others | Others | Others |
890 | CCRL2 | RNA | Others | Others | Others |
891 | CCS | RNA | Oxydative Stress | Others | Inflammation |
892 | CD101 | RNA | Others | Immune Activation Status | Immuno-Oncology |
893 | CD109 | RNA | Others | Others | Others |
894 | CD14 | RNA | Apoptosis | Immune Activation Status | Oncology |
895 | CD14 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
896 | CD160 | RNA | Others | Immune Activation Status | Immuno-Oncology |
897 | CD163 | RNA | EMT | Immune Cell Typing | Oncology |
898 | CD163 | RNA | EMT | Immune Cell Typing | Immuno-Oncology |
899 | CD164 | RNA | Others | Others | Others |
900 | CD177 | RNA | Others | Others | Others |
901 | CD180 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
902 | CD180 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
903 | CD19 | RNA | PI3K-AKT | Immune Activation Status | Oncology |
904 | CD19 | RNA | PI3K-AKT | Immune Activation Status | Immuno-Oncology |
905 | CD1A | RNA | Others | Others | Others |
906 | CD1B | RNA | Others | Others | Others |
907 | CD1C | RNA | Others | Lymphoid Compartment | Immuno-Oncology |
908 | CD1D | RNA | Others | Others | Others |
909 | CD1E | RNA | Antigen Processing | Others | Immuno-Oncology |
910 | CD2 | RNA | Costimulatory Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
911 | CD200 | RNA | Others | Others | Others |
912 | CD200R1 | RNA | Others | Immune Checkpoint | Immuno-Oncology |
913 | CD207 | RNA | Others | Others | Others |
914 | CD209 | RNA | Others | Immune Cell Typing | Immuno-Oncology |
915 | CD22 | RNA | Others | Immune Activation Status | Immuno-Oncology |
916 | CD226 | RNA | Others | Immune Activation Status | Immuno-Oncology |
917 | CD24 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
918 | CD24 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
919 | CD244 | RNA | Others | Immune Activation Status | Immuno-Oncology |
920 | CD247 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
921 | CD27 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
922 | CD274 | RNA | Costimulatory Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
923 | CD276 | RNA | Signaling Affecting Cellular Metabolism | Immune Cell Adhesion and Migration | Metabolic Diseases |
924 | CD276 | RNA | Signaling Affecting Cellular Metabolism | Immune Cell Adhesion and Migration | Immuno-Oncology |
925 | CD28 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
926 | CD2AP | RNA | Others | Others | Others |
927 | CD300A | RNA | Metabolism Stress | Inflammation | Metabolic Diseases |
928 | CD300A | RNA | Metabolism Stress | Inflammation | Inflammation |
929 | CD300C | RNA | Others | Others | Others |
930 | CD300E | RNA | Others | Others | Others |
931 | CD300LF | RNA | Others | Immunity and Inflammation | Inflammation |
932 | CD33 | RNA | Others | Immune Activation Status | Immuno-Oncology |
933 | CD34 | RNA | Cell Proliferation | Immune Cell Typing | CNS |
934 | CD34 | RNA | Cell Proliferation | Immune Cell Typing | Immuno-Oncology |
935 | CD36 | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | CNS |
936 | CD36 | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | Inflammation |
937 | CD37 | RNA | Others | Others | Others |
938 | CD38 | RNA | Others | Immune Suppression | Immuno-Oncology |
939 | CD3D | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
940 | CD3E | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
941 | CD3EAP | RNA | Others | Others | Others |
942 | CD3G | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
943 | CD4 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
944 | CD40 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
945 | CD40LG | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
946 | CD44 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular |
947 | CD44 | RNA | Angiogenesis | Immune Activation Status | Immuno-Oncology |
948 | CD45R0 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
949 | CD45RA | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
950 | CD45RB | RNA | TCR Signaling | Others | Immuno-Oncology |
951 | CD45RO | RNA | Others | Immune Activation Status | Immuno-Oncology |
952 | CD46 | RNA | Others | Others | Others |
953 | CD47 | RNA | Cytotoxicity | Inflammation | Oncology |
954 | CD47 | RNA | Cytotoxicity | Inflammation | Inflammation |
955 | CD48 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
956 | CD5 | RNA | Others | Immune Activation Status | Immuno-Oncology |
957 | CD52 | RNA | Others | Others | Others |
958 | CD53 | RNA | Others | Inflammation | Inflammation |
959 | CD55 | RNA | Others | Others | Others |
960 | CD58 | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
961 | CD59 | RNA | Others | Others | Others |
962 | CD6 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
963 | CD63 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
964 | CD68 | RNA | DNA Damage Repair | Immune Cell Typing | Epigenic and Nuclear Signaling |
965 | CD68 | RNA | DNA Damage Repair | Immune Cell Typing | Immuno-Oncology |
966 | CD69 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
967 | CD7 | RNA | Others | Lymphoid Compartment | Immuno-Oncology |
968 | CD70 | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
969 | CD72 | RNA | Others | Immune Activation Status | Immuno-Oncology |
970 | CD74 | RNA | Others | Immunity and Inflammation | Inflammation |
971 | CD79A | RNA | Others | Lymphoid Compartment | Immuno-Oncology |
972 | CD79B | RNA | Others | Immune Activation Status | Immuno-Oncology |
973 | CD80 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
974 | CD81 | RNA | Others | Others | Others |
975 | CD82 | RNA | Others | Others | Others |
976 | CD83 | RNA | Others | Immunity and Inflammation | Inflammation |
977 | CD84 | RNA | Others | Immune Cell Typing | Immuno-Oncology |
978 | CD86 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
979 | CD8A | RNA | Antigen Processing | Immune Activation Status | Immuno-Oncology |
980 | CD8B | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
981 | CD8B | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
982 | CD9 | RNA | Myelination | Others | CNS |
983 | CD96 | RNA | Others | Immune Activation Status | Immuno-Oncology |
984 | CD97 | RNA | Others | Others | Others |
985 | CD99 | RNA | Others | Others | Others |
986 | CDA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
987 | CDC14A | RNA | Proliferation | Others | Oncology |
988 | CDC14B | RNA | Proliferation | Immune Activation Status | Oncology |
989 | CDC14B | RNA | Proliferation | Immune Activation Status | Immuno-Oncology |
990 | CDC16 | RNA | Others | Immune Activation Status | Immuno-Oncology |
991 | CDC20 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
992 | CDC20 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
993 | CDC25A | RNA | Cell Cycle | Immune Activation Status | Oncology |
994 | CDC25A | RNA | Cell Cycle | Immune Activation Status | Immuno-Oncology |
995 | CDC25B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
996 | CDC25C | RNA | Cell Cycle | Others | Oncology |
997 | CDC26 | RNA | Others | Others | Others |
998 | CDC27 | RNA | Others | Others | Others |
999 | CDC40 | RNA | Others | Others | Others |
1000 | CDC42 | RNA | Others | Immune Activation Status | Immuno-Oncology |
1001 | CDC6 | RNA | Proliferation | Others | Oncology |
1002 | CDC7 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1003 | CDCA5 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1004 | CDCA7L | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1005 | CDCA8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1006 | CDCP1 | RNA | Others | Others | Others |
1007 | CDH1 | RNA | Apoptosis | Immune Cell Adhesion and Migration | Oncology |
1008 | CDH1 | RNA | Apoptosis | Immune Cell Adhesion and Migration | Immuno-Oncology |
1009 | CDH11 | RNA | Others | Others | Others |
1010 | CDH13 | RNA | Cell Proliferation | Others | CNS |
1011 | CDH2 | RNA | EMT | Immune Cell Adhesion and Migration | Oncology |
1012 | CDH2 | RNA | EMT | Immune Cell Adhesion and Migration | Immuno-Oncology |
1013 | CDH3 | RNA | Others | Others | Others |
1014 | CDH5 | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Cardiovascular |
1015 | CDH5 | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Immuno-Oncology |
1016 | CDK1 | RNA | Cell Cycle | Others | Oncology |
1017 | CDK12 | RNA | p53 Signaling | Others | Oncology |
1018 | CDK14 | RNA | Others | Others | Others |
1019 | CDK2 | RNA | Cell Cycle | Others | Oncology |
1020 | CDK20 | RNA | Others | Others | Others |
1021 | CDK4 | RNA | Cell Cycle | Others | Oncology |
1022 | CDK5 | RNA | Others | Neural Connectivity | CNS |
1023 | CDK5R1 | RNA | Others | Neural Connectivity | CNS |
1024 | CDK5RAP3 | RNA | Others | Others | Others |
1025 | CDK6 | RNA | Cell Cycle | Others | Oncology |
1026 | CDK7 | RNA | Others | Others | Others |
1027 | CDK8 | RNA | Others | Others | Others |
1028 | CDK9 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1029 | CDKN1A | RNA | Cell Cycle | Immunity and Inflammation | Oncology |
1030 | CDKN1A | RNA | Cell Cycle | Immunity and Inflammation | Inflammation |
1031 | CDKN1B | RNA | PI3K-AKT | Others | Oncology |
1032 | CDKN1C | RNA | DNA Damage Repair | Immune Activation Status | Epigenic and Nuclear Signaling |
1033 | CDKN1C | RNA | DNA Damage Repair | Immune Activation Status | Immuno-Oncology |
1034 | CDKN2A | RNA | Cell Cycle | Others | Oncology |
1035 | CDKN2B | RNA | Metabolism Stress | Others | Metabolic Diseases |
1036 | CDKN2C | RNA | Proliferation | Immune Activation Status | Oncology |
1037 | CDKN2C | RNA | Proliferation | Immune Activation Status | Immuno-Oncology |
1038 | CDKN2D | RNA | Proliferation | Others | Oncology |
1039 | CDKN3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1040 | CDON | RNA | Others | Others | Others |
1041 | CDS1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1042 | CDY2A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1043 | CEACAM1 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular |
1044 | CEACAM1 | RNA | Angiogenesis | Immune Activation Status | Immuno-Oncology |
1045 | CEACAM3 | RNA | Others | Immune Cell Typing | Immuno-Oncology |
1046 | CEACAM5 | RNA | EMT | Others | Oncology |
1047 | CEACAM6 | RNA | EMT | Others | Oncology |
1048 | CEACAM8 | RNA | Others | Others | Others |
1049 | CEBPA | RNA | Others | Others | Others |
1050 | CEBPB | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular |
1051 | CEBPB | RNA | AP1 Signaling | Immune Activation Status | Immuno-Oncology |
1052 | CEBPD | RNA | Others | Immune Activation Status | Immuno-Oncology |
1053 | CEBPE | RNA | Others | Others | Others |
1054 | CENPA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1055 | CENPF | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1056 | CEP170 | RNA | Others | Others | Others |
1057 | CEP295 | RNA | Others | Others | Others |
1058 | CEP55 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1059 | CER1 | RNA | Others | Immune Suppression | Immuno-Oncology |
1060 | CERS1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1061 | CERS2 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1062 | CERS4 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1063 | CERS6 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1064 | CES3 | RNA | Angiogenesis | Others | Cardiovascular |
1065 | CETN2 | RNA | Proliferation | Others | Oncology |
1066 | CETP | RNA | Others | Others | Others |
1067 | CFB | RNA | Others | Others | Others |
1068 | CFD | RNA | Others | Others | Others |
1069 | CFH | RNA | Others | Others | Others |
1070 | CFHR1 | RNA | Others | Others | Others |
1071 | CFHR4 | RNA | Others | Others | Others |
1072 | CFHR5 | RNA | Others | Others | Others |
1073 | CFI | RNA | Others | Others | Others |
1074 | CFL1 | RNA | Others | Others | Others |
1075 | CFLAR | RNA | Others | Immunity and Inflammation | Inflammation |
1076 | CFP | RNA | Others | Others | Others |
1077 | CFTR | RNA | Others | Others | Others |
1078 | CGAS | RNA | Others | Others | Others |
1079 | CGN | RNA | Others | Others | Others |
1080 | CH25H | RNA | Others | Immunity and Inflammation | Inflammation |
1081 | CHAD | RNA | PI3K-AKT | Others | Oncology |
1082 | CHAT | RNA | Lipid Metabolism | Neural Connectivity | Metabolic Diseases |
1083 | CHAT | RNA | Lipid Metabolism | Neural Connectivity | CNS |
1084 | CHD4 | RNA | Others | Others | Others |
1085 | CHD8 | RNA | Others | Others | Others |
1086 | CHEK1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1087 | CHEK2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1088 | CHI3L1 | RNA | Others | Others | Others |
1089 | CHIT1 | RNA | Others | Others | Others |
1090 | CHL1 | RNA | Others | Others | Others |
1091 | CHMP2A | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1092 | CHMP2B | RNA | Others | Others | Others |
1093 | CHMP3 | RNA | Others | Others | Others |
1094 | CHMP4A | RNA | Others | Others | Others |
1095 | CHMP4B | RNA | Others | Others | Others |
1096 | CHMP6 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1097 | CHN2 | RNA | Others | Immunity and Inflammation | Inflammation |
1098 | CHP1 | RNA | Others | Others | Others |
1099 | CHP2 | RNA | Others | Others | Others |
1100 | CHRD | RNA | Others | Immune Suppression | Immuno-Oncology |
1101 | CHRDL1 | RNA | Others | Immune Suppression | Immuno-Oncology |
1102 | CHRM5 | RNA | Others | Neural Connectivity | CNS |
1103 | CHRNA5 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1104 | CHRNA7 | RNA | Cell Proliferation | Neural Connectivity | CNS |
1105 | CHRNB2 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
1106 | CHST8 | RNA | Others | Immunity and Inflammation | Inflammation |
1107 | CHUK | RNA | Costimulatory Signaling | Immunity and Inflammation | Immuno-Oncology |
1108 | CHUK | RNA | Costimulatory Signaling | Immunity and Inflammation | Inflammation |
1109 | CIB1 | RNA | Angiogenesis | Others | Cardiovascular |
1110 | CIC | RNA | Others | Others | Others |
1111 | CIDEA | RNA | Others | Others | Others |
1112 | CIDEB | RNA | Others | Others | Others |
1113 | CIITA | RNA | Others | Others | Others |
1114 | CISH | RNA | Others | Others | Others |
1115 | CKAP4 | RNA | Others | Others | Others |
1116 | CKAP5 | RNA | Others | Others | Others |
1117 | CKB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1118 | CKLF | RNA | Others | Others | Others |
1119 | CKMT1A | RNA | EMT | Others | Oncology |
1120 | CKS1B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1121 | CLCA1 | RNA | Others | Others | Others |
1122 | CLCF1 | RNA | Others | Immunity and Inflammation | Inflammation |
1123 | CLDN1 | RNA | Others | Others | Others |
1124 | CLDN15 | RNA | Others | Others | Others |
1125 | CLDN23 | RNA | Others | Others | Others |
1126 | CLDN3 | RNA | EMT | Others | Oncology |
1127 | CLDN4 | RNA | EMT | Others | Oncology |
1128 | CLDN5 | RNA | Myelination | Others | CNS |
1129 | CLDN7 | RNA | EMT | Others | Oncology |
1130 | CLEC14A | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Cardiovascular |
1131 | CLEC14A | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Immuno-Oncology |
1132 | CLEC2B | RNA | Others | Others | Others |
1133 | CLEC3B | RNA | Others | Others | Others |
1134 | CLEC4A | RNA | Others | Others | Others |
1135 | CLEC4C | RNA | Others | Others | Others |
1136 | CLEC4E | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
1137 | CLEC5A | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
1138 | CLEC6A | RNA | Others | Others | Others |
1139 | CLEC7A | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
1140 | CLECL1 | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
1141 | CLIC4 | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular |
1142 | CLIC4 | RNA | Angiogenesis | Immunity and Inflammation | Inflammation |
1143 | CLN3 | RNA | Others | Neural Connectivity | CNS |
1144 | CLN8 | RNA | Oxydative Stress | Neural Connectivity | Inflammation |
1145 | CLN8 | RNA | Oxydative Stress | Neural Connectivity | CNS |
1146 | CLOCK | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1147 | CLSPN | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1148 | CLSTN1 | RNA | Others | Immunity and Inflammation | Inflammation |
1149 | CLU | RNA | Cell Proliferation | Others | CNS |
1150 | CMA1 | RNA | Cellular Differentiation | Others | Oncology |
1151 | CMIP | RNA | Others | Others | Others |
1152 | CMKLR1 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
1153 | CMTM4 | RNA | Others | Others | Others |
1154 | CMTM6 | RNA | Others | Others | Others |
1155 | CMV UL83 | RNA | Others | Others | Others |
1156 | CNKSR2 | RNA | Others | Neural Connectivity | CNS |
1157 | CNN1 | RNA | Others | Others | Others |
1158 | CNN2 | RNA | Others | Others | Others |
1159 | CNOT10 | RNA | Others | Others | Others |
1160 | CNOT2 | RNA | Others | Others | Others |
1161 | CNOT4 | RNA | Others | Others | Others |
1162 | CNP | RNA | Others | Others | Others |
1163 | CNR1 | RNA | Others | Transmitter Response and Reuptake | CNS |
1164 | CNTF | RNA | Others | Others | Others |
1165 | CNTFR | RNA | Cytotoxicity | Others | Oncology |
1166 | CNTN1 | RNA | Others | Others | Others |
1167 | CNTN4 | RNA | Others | Vesicle Trafficking | CNS |
1168 | CNTNAP1 | RNA | Myelination | Others | CNS |
1169 | CNTNAP2 | RNA | Others | Others | Others |
1170 | COA5 | RNA | Others | Immunity and Inflammation | Inflammation |
1171 | COG7 | RNA | Others | Others | Others |
1172 | COL10A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1173 | COL11A1 | RNA | Matrix Remodeling and Metastases | Myeloid Compartment | CNS |
1174 | COL11A2 | RNA | Matrix Remodeling and Metastases | Others | CNS |
1175 | COL14A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1176 | COL16A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1177 | COL17A1 | RNA | Matrix Remodeling and Metastases | Myeloid Compartment | CNS |
1178 | COL18A1 | RNA | Angiogenesis | Others | Cardiovascular |
1179 | COL1A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1180 | COL1A2 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1181 | COL24A1 | RNA | Others | Others | Others |
1182 | COL27A1 | RNA | PI3K-AKT | Others | Oncology |
1183 | COL2A1 | RNA | PI3K-AKT | Others | Oncology |
1184 | COL3A1 | RNA | Cellular Differentiation | Others | Oncology |
1185 | COL4A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1186 | COL4A2 | RNA | Angiogenesis | Others | Cardiovascular |
1187 | COL4A3 | RNA | Others | Others | Others |
1188 | COL4A4 | RNA | Others | Others | Others |
1189 | COL4A5 | RNA | Matrix Remodeling and Metastases | Others | CNS |
1190 | COL4A6 | RNA | PI3K-AKT | Others | Oncology |
1191 | COL5A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1192 | COL5A2 | RNA | Cellular Differentiation | Others | Oncology |
1193 | COL5A3 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1194 | COL6A1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
1195 | COL6A2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
1196 | COL6A3 | RNA | Collagen Biosynthesis & Modification | Immunity and Inflammation | CNS |
1197 | COL6A3 | RNA | Collagen Biosynthesis & Modification | Immunity and Inflammation | Inflammation |
1198 | COL6A5 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1199 | COL6A6 | RNA | Others | Others | Others |
1200 | COL7A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1201 | COL9A3 | RNA | Others | Others | Others |
1202 | COLEC12 | RNA | Others | Others | Others |
1203 | COMP | RNA | Matrix Remodeling and Metastases | Others | CNS |
1204 | COMT | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
1205 | COP1 | RNA | Cell Cycle | Others | Oncology |
1206 | COPS6 | RNA | Cell Stress | Others | CNS |
1207 | COTL1 | RNA | Others | Immunity and Inflammation | Inflammation |
1208 | COX14 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1209 | COX16 | RNA | Others | Others | Others |
1210 | COX19 | RNA | Others | Others | Others |
1211 | COX4I1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1212 | COX4I2 | RNA | Others | Others | Others |
1213 | COX5A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1214 | COX5B | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS |
1215 | COX5B | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | Inflammation |
1216 | COX6A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1217 | COX6B1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1218 | COX6C | RNA | Others | Others | Others |
1219 | COX7A2 | RNA | Others | Others | Others |
1220 | COX7B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1221 | COX7C | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1222 | COX8A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1223 | CP | RNA | Others | Others | Others |
1224 | CPA3 | RNA | Others | Immune Cell Typing | Immuno-Oncology |
1225 | CPA4 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1226 | CPB2 | RNA | Others | Others | Others |
1227 | CPLX1 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
1228 | CPN1 | RNA | Others | Others | Others |
1229 | CPS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1230 | CPSF7 | RNA | Others | Others | Others |
1231 | CPT1A | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1232 | CPT1B | RNA | Carbohydrate Metabolism | Others | CNS |
1233 | CPT1C | RNA | Others | Others | Others |
1234 | CPT2 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1235 | CR1 | RNA | Others | Others | Others |
1236 | CR2 | RNA | Others | Others | Others |
1237 | CRABP2 | RNA | Others | Myeloid Compartment | CNS |
1238 | CRADD | RNA | Others | Others | Others |
1239 | CRCP | RNA | Others | Others | Others |
1240 | CREB1 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
1241 | CREB1 | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
1242 | CREB3 | RNA | Others | Others | Others |
1243 | CREB3L1 | RNA | Others | Others | Others |
1244 | CREB3L2 | RNA | Others | Others | Others |
1245 | CREB3L3 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
1246 | CREB3L4 | RNA | Others | Others | Others |
1247 | CREB5 | RNA | Others | Others | Others |
1248 | CREBBP | RNA | Chromatin Modification | Immune Suppression | Epigenic and Nuclear Signaling |
1249 | CREBBP | RNA | Chromatin Modification | Immune Suppression | Immuno-Oncology |
1250 | CREM | RNA | Others | Others | Others |
1251 | CRH | RNA | Others | Transmitter Release | CNS |
1252 | CRIP1 | RNA | Others | Immunity and Inflammation | Inflammation |
1253 | CRIP2 | RNA | Cell Proliferation | Others | CNS |
1254 | CRISPLD2 | RNA | Others | Others | Others |
1255 | CRK | RNA | Interleukin Signaling | Others | Immuno-Oncology |
1256 | CRKL | RNA | Others | Others | Others |
1257 | CRLF1 | RNA | Others | Others | Others |
1258 | CRLF2 | RNA | Others | Others | Others |
1259 | CRP | RNA | Others | Others | Others |
1260 | CRTAM | RNA | Others | Others | Others |
1261 | CRTC2 | RNA | Carbohydrate Metabolism | Others | CNS |
1262 | CRYAB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1263 | CRYBA4 | RNA | Others | Immunity and Inflammation | Inflammation |
1264 | CS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1265 | CSF1 | RNA | Cytokine and Chemokine Signaling | Immune Suppression | Immuno-Oncology |
1266 | CSF1R | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
1267 | CSF1R | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
1268 | CSF2 | RNA | Cytokine and Chemokine Signaling | Immune Suppression | Immuno-Oncology |
1269 | CSF2RA | RNA | Interleukin Signaling | Others | Immuno-Oncology |
1270 | CSF2RB | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
1271 | CSF2RB | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
1272 | CSF2RB | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
1273 | CSF3 | RNA | Cytokine and Chemokine Signaling | Immune Suppression | Immuno-Oncology |
1274 | CSF3R | RNA | Cytokine and Chemokine Signaling | Immune Cell Typing | Immuno-Oncology |
1275 | CSH2/GH2 | RNA | Others | Others | Others |
1276 | CSK | RNA | Others | Immunity and Inflammation | Inflammation |
1277 | CSNK1A1 | RNA | Others | Others | Others |
1278 | CSNK1D | RNA | Others | Others | Others |
1279 | CSNK1E | RNA | Others | Others | Others |
1280 | CSNK1G3 | RNA | Others | Others | Others |
1281 | CSNK2A1 | RNA | Others | Others | Others |
1282 | CSNK2B | RNA | Others | Others | Others |
1283 | CSPG4 | RNA | Angiogenesis | Others | Cardiovascular |
1284 | CST2 | RNA | Others | Others | Others |
1285 | CST7 | RNA | Others | Immunity and Inflammation | Inflammation |
1286 | CT45A1 | RNA | Others | Others | Others |
1287 | CTAG1A/B | RNA | Others | Others | Others |
1288 | CTAG1B | RNA | Others | Others | Others |
1289 | CTAGE1 | RNA | Others | Others | Others |
1290 | CTBP2 | RNA | Others | Immune Suppression | Immuno-Oncology |
1291 | CTCF | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1292 | CTCFL | RNA | Others | Others | Others |
1293 | CTF1 | RNA | Others | Others | Others |
1294 | CTLA4 | RNA | Costimulatory Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
1295 | CTLA4_all (common probe) | RNA | TCR Signaling | Others | Immuno-Oncology |
1296 | CTLA4-TM (membrane-bound form) | RNA | TCR Signaling | Others | Immuno-Oncology |
1297 | CTNNA1 | RNA | Hippo Signaling | Others | CNS |
1298 | CTNNB1 | RNA | Androgen Signaling | Immune Cell Adhesion and Migration | Oncology |
1299 | CTNNB1 | RNA | Androgen Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
1300 | CTNND1 | RNA | Others | Others | Others |
1301 | CTNS | RNA | Others | Others | Others |
1302 | CTPS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1303 | CTSA | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1304 | CTSB | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1305 | CTSC | RNA | Others | Others | Others |
1306 | CTSD | RNA | Nutrient Capture and Catabolic Pathways | Microglia | Metabolic Diseases |
1307 | CTSD | RNA | Nutrient Capture and Catabolic Pathways | Microglia | CNS |
1308 | CTSE | RNA | Others | Immunity and Inflammation | Inflammation |
1309 | CTSF | RNA | Others | Immunity and Inflammation | Inflammation |
1310 | CTSG | RNA | Cellular Differentiation | Others | Oncology |
1311 | CTSH | RNA | Cell Proliferation | Others | CNS |
1312 | CTSK | RNA | Others | Others | Others |
1313 | CTSL | RNA | Collagen Biosynthesis & Modification | Others | CNS |
1314 | CTSO | RNA | Others | Others | Others |
1315 | CTSS | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | CNS |
1316 | CTSS | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | Inflammation |
1317 | CTSW | RNA | Nutrient Capture and Catabolic Pathways | Immune Cell Typing | Metabolic Diseases |
1318 | CTSW | RNA | Nutrient Capture and Catabolic Pathways | Immune Cell Typing | Immuno-Oncology |
1319 | CTSZ | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1320 | CUL1 | RNA | Cell Proliferation | Immune Suppression | CNS |
1321 | CUL1 | RNA | Cell Proliferation | Immune Suppression | Immuno-Oncology |
1322 | CUL2 | RNA | Others | Others | Others |
1323 | CUL3 | RNA | Others | Others | Others |
1324 | CUL9 | RNA | Others | Others | Others |
1325 | CX3CL1 | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular |
1326 | CX3CL1 | RNA | Angiogenesis | Immunity and Inflammation | Inflammation |
1327 | CX3CR1 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
1328 | CX3CR1 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
1329 | CXADR | RNA | EMT | Others | Oncology |
1330 | CXCL1 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
1331 | CXCL1 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
1332 | CXCL1/2/3 | RNA | Others | Others | Others |
1333 | CXCL10 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
1334 | CXCL10 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
1335 | CXCL11 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
1336 | CXCL12 | RNA | Cell Proliferation | Immune Cell Adhesion and Migration | CNS |
1337 | CXCL12 | RNA | Cell Proliferation | Immune Cell Adhesion and Migration | Immuno-Oncology |
1338 | CXCL13 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
1339 | CXCL14 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
1340 | CXCL16 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
1341 | CXCL17 | RNA | Angiogenesis | Others | Cardiovascular |
1342 | CXCL2 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
1343 | CXCL2 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
1344 | CXCL3 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
1345 | CXCL3 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
1346 | CXCL5 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
1347 | CXCL5 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
1348 | CXCL6 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
1349 | CXCL6 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
1350 | CXCL8 | RNA | Angiogenesis | Immune Suppression | Cardiovascular |
1351 | CXCL8 | RNA | Angiogenesis | Immune Suppression | Immuno-Oncology |
1352 | CXCL9 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
1353 | CXCL9 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
1354 | CXCR1 | RNA | Others | Others | Others |
1355 | CXCR2 | RNA | Cell Proliferation | Others | CNS |
1356 | CXCR3 | RNA | Angiogenesis | Lymphoid Compartment | Cardiovascular |
1357 | CXCR3 | RNA | Angiogenesis | Lymphoid Compartment | Immuno-Oncology |
1358 | CXCR4 | RNA | Cytokine and Chemokine Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
1359 | CXCR5 | RNA | Others | Others | Others |
1360 | CXCR6 | RNA | Cytokine and Chemokine Signaling | M1 Activation | Immuno-Oncology |
1361 | CXCR6 | RNA | Cytokine and Chemokine Signaling | M1 Activation | CNS |
1362 | CXorf36 | RNA | Angiogenesis | Others | Cardiovascular |
1363 | CXXC1 | RNA | Others | Others | Others |
1364 | CXXC4 | RNA | Others | Others | Others |
1365 | CXXC5 | RNA | Others | Others | Others |
1366 | CYB561 | RNA | Others | Others | Others |
1367 | CYBA | RNA | Others | Others | Others |
1368 | CYBB | RNA | Cell Stress | Immune Cell Adhesion and Migration | CNS |
1369 | CYBB | RNA | Cell Stress | Immune Cell Adhesion and Migration | Immuno-Oncology |
1370 | CYC1 | RNA | Others | Others | Others |
1371 | CYCS | RNA | Oxydative Stress | Others | Inflammation |
1372 | CYFIP1 | RNA | Others | Inflammation | Inflammation |
1373 | CYFIP2 | RNA | Others | Others | Others |
1374 | CYLD | RNA | Others | Others | Others |
1375 | CYP19A1 | RNA | Others | Others | Others |
1376 | CYP1A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1377 | CYP1A2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1378 | CYP1B1 | RNA | Angiogenesis | Others | Cardiovascular |
1379 | CYP26A1 | RNA | Others | Immune Suppression | Immuno-Oncology |
1380 | CYP26C1 | RNA | Others | Immune Suppression | Immuno-Oncology |
1381 | CYP27A1 | RNA | Others | Immunity and Inflammation | Inflammation |
1382 | CYP2C19 | RNA | Others | Others | Others |
1383 | CYP2C8 | RNA | Others | Others | Others |
1384 | CYP2C9 | RNA | Others | Others | Others |
1385 | CYP2E1 | RNA | Others | Others | Others |
1386 | CYP2J2 | RNA | Others | Others | Others |
1387 | CYP4A11 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1388 | CYP4A11/22 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1389 | CYP4A22 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1390 | CYP4F3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1391 | CYP4X1 | RNA | Others | Transmitter Release | CNS |
1392 | CYP7A1 | RNA | Others | Others | Others |
1393 | CYP7B1 | RNA | Others | Immunity and Inflammation | Inflammation |
1394 | CYP8B1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1395 | CYSLTR1 | RNA | Others | Others | Others |
1396 | CYSLTR2 | RNA | Others | Others | Others |
1397 | CYSTM1 | RNA | Others | Others | Others |
1398 | CYTIP | RNA | Others | Immunity and Inflammation | Inflammation |
1399 | D2HGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1400 | DAB2 | RNA | Others | Immunity and Inflammation | Inflammation |
1401 | DAB2IP | RNA | Others | Others | Others |
1402 | DACH2 | RNA | Others | Others | Others |
1403 | DAG1 | RNA | Others | Others | Others |
1404 | DAGLA | RNA | Transmitter Synthesis | Transmitter Response and Reuptake | CNS |
1405 | DAO | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1406 | DAP3 | RNA | Others | Others | Others |
1407 | DAPK1 | RNA | Others | Others | Others |
1408 | DAPP1 | RNA | Others | Others | Others |
1409 | DAXX | RNA | Others | Others | Others |
1410 | DBH | RNA | Transmitter Synthesis | Vesicle Trafficking | CNS |
1411 | DCC | RNA | Others | Others | Others |
1412 | DCK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1413 | DCN | RNA | DNA Damage Repair | Immune Suppression | Epigenic and Nuclear Signaling |
1414 | DCN | RNA | DNA Damage Repair | Immune Suppression | Immuno-Oncology |
1415 | DCTN6 | RNA | Others | Others | Others |
1416 | DCX | RNA | Others | Others | Others |
1417 | DDAH2 | RNA | Others | Others | Others |
1418 | DDB2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1419 | DDC | RNA | Biosynthesis and Anabolic Pathways | Neural Connectivity | CNS |
1420 | DDIT3 | RNA | Oxydative Stress | Others | Inflammation |
1421 | DDIT4 | RNA | Others | Others | Others |
1422 | DDOST | RNA | Others | Others | Others |
1423 | DDR2 | RNA | EMT | Others | Oncology |
1424 | DDX23 | RNA | Others | Others | Others |
1425 | DDX24 | RNA | Others | Others | Others |
1426 | DDX39A | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1427 | DDX43 | RNA | Others | Others | Others |
1428 | DDX5 | RNA | Others | Others | Others |
1429 | DDX50 | RNA | Others | Others | Others |
1430 | DDX58 | RNA | Others | Immunity and Inflammation | Inflammation |
1431 | DECR1 | RNA | Others | Others | Others |
1432 | DEFA1 | RNA | Others | Others | Others |
1433 | DEFA4 | RNA | Others | Others | Others |
1434 | DEFB1 | RNA | Others | Others | Others |
1435 | DEFB103A | RNA | Others | Others | Others |
1436 | DEFB103A/B | RNA | Others | Others | Others |
1437 | DEFB103B | RNA | Others | Others | Others |
1438 | DEFB134 | RNA | Others | Others | Others |
1439 | DEFB4A | RNA | Others | Others | Others |
1440 | DENND5A | RNA | Others | Others | Others |
1441 | DENR | RNA | Cell Proliferation | Others | CNS |
1442 | DEPDC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1443 | DEPDC5 | RNA | Others | Others | Others |
1444 | DEPTOR | RNA | Autophagy | Others | Cardiovascular |
1445 | DERA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1446 | DERL1 | RNA | Others | Others | Others |
1447 | DERL2 | RNA | Others | Others | Others |
1448 | DES | RNA | Others | Neural Connectivity | CNS |
1449 | DESI1 | RNA | Others | Others | Others |
1450 | DGKA | RNA | Others | Others | Others |
1451 | DGKB | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1452 | DGKE | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1453 | DGKZ | RNA | Others | Others | Others |
1454 | DGLUCY | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1455 | DGUOK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1456 | DHFR2 | RNA | Others | Others | Others |
1457 | DHRS2 | RNA | Others | Others | Others |
1458 | DHRS3 | RNA | Others | Immune Suppression | Immuno-Oncology |
1459 | DHRS4 | RNA | Others | Others | Others |
1460 | DHX16 | RNA | Others | Others | Others |
1461 | DHX58 | RNA | Others | Others | Others |
1462 | DIABLO | RNA | Others | Others | Others |
1463 | DIAPH1 | RNA | Others | Others | Others |
1464 | DICER1 | RNA | Angiogenesis | Others | Cardiovascular |
1465 | DIPK2B | RNA | Others | Others | Others |
1466 | DKC1 | RNA | Cell Cycle | Others | Oncology |
1467 | DKK1 | RNA | Wnt Signaling | Others | CNS |
1468 | DKK2 | RNA | Wnt Signaling | Others | CNS |
1469 | DKK4 | RNA | Others | Others | Others |
1470 | DLAT | RNA | Carbohydrate Metabolism | Others | CNS |
1471 | DLC1 | RNA | Cellular Differentiation | Others | Oncology |
1472 | DLD | RNA | Carbohydrate Metabolism | Immune Suppression | CNS |
1473 | DLD | RNA | Carbohydrate Metabolism | Immune Suppression | Immuno-Oncology |
1474 | DLG1 | RNA | Cell Proliferation | Others | CNS |
1475 | DLG3 | RNA | Others | Neural Connectivity | CNS |
1476 | DLG4 | RNA | Others | Immunity and Inflammation | Inflammation |
1477 | DLGAP1 | RNA | Others | Neural Connectivity | CNS |
1478 | DLGAP5 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1479 | DLL1 | RNA | Notch | Others | Immuno-Oncology |
1480 | DLL3 | RNA | Notch | Immune Suppression | Immuno-Oncology |
1481 | DLL4 | RNA | Angiogenesis | Immune Suppression | Cardiovascular |
1482 | DLL4 | RNA | Angiogenesis | Immune Suppression | Immuno-Oncology |
1483 | DLX1 | RNA | Others | Others | Others |
1484 | DLX2 | RNA | Others | Others | Others |
1485 | DMBT1 | RNA | Others | Others | Others |
1486 | DMGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1487 | DNA2 | RNA | Cell Cycle | Others | Oncology |
1488 | DNAH1 | RNA | Others | Neuronal Cytoskeleton | CNS |
1489 | DNAJA2 | RNA | Others | Others | Others |
1490 | DNAJC10 | RNA | Others | Others | Others |
1491 | DNAJC12 | RNA | ER Signaling | Others | Oncology |
1492 | DNAJC14 | RNA | Others | Others | Others |
1493 | DNM1L | RNA | Others | Neural Connectivity | CNS |
1494 | DNM2 | RNA | Oxydative Stress | Neural Connectivity | Inflammation |
1495 | DNM2 | RNA | Oxydative Stress | Neural Connectivity | CNS |
1496 | DNMT1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1497 | DNMT3A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1498 | DNMT3B | RNA | Others | Others | Others |
1499 | DNMT3L | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1500 | DOCK1 | RNA | Others | Others | Others |
1501 | DOCK2 | RNA | Others | Inflammation | Inflammation |
1502 | DOCK9 | RNA | Others | Others | Others |
1503 | DOT1L | RNA | Others | Others | Others |
1504 | DPP4 | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
1505 | DPT | RNA | Cell Proliferation | Others | CNS |
1506 | DPYSL3 | RNA | Others | Others | Others |
1507 | DRAP1 | RNA | Others | Immune Suppression | Immuno-Oncology |
1508 | DRD1 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
1509 | DRD2 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
1510 | DRD4 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
1511 | DSC2 | RNA | EMT | Others | Oncology |
1512 | DSC3 | RNA | Others | Others | Others |
1513 | DSP | RNA | Others | Others | Others |
1514 | DST | RNA | Others | Immunity and Inflammation | Inflammation |
1515 | DTL | RNA | Cell Stress | Others | CNS |
1516 | DTX1 | RNA | Notch | Others | Immuno-Oncology |
1517 | DTX3 | RNA | Notch | Others | Immuno-Oncology |
1518 | DTX3L | RNA | Notch | Others | Immuno-Oncology |
1519 | DTX4 | RNA | Notch | Immune Suppression | Immuno-Oncology |
1520 | DUOX1 | RNA | Cell Stress | Others | CNS |
1521 | DUOX2 | RNA | Cell Stress | Others | CNS |
1522 | DUOXA1 | RNA | Others | Immunity and Inflammation | Inflammation |
1523 | DUSP1 | RNA | MAPK | Others | Cardiovascular |
1524 | DUSP10 | RNA | Others | Others | Others |
1525 | DUSP2 | RNA | MAPK | Others | Cardiovascular |
1526 | DUSP4 | RNA | MAPK | Others | Cardiovascular |
1527 | DUSP5 | RNA | MAPK | Others | Cardiovascular |
1528 | DUSP6 | RNA | MAPK | Others | Cardiovascular |
1529 | DUSP7 | RNA | Others | Immunity and Inflammation | Inflammation |
1530 | DUSP8 | RNA | Others | Others | Others |
1531 | DUSP9 | RNA | Others | Others | Others |
1532 | DVL1 | RNA | Others | Immune Suppression | Immuno-Oncology |
1533 | DVL2 | RNA | Others | Others | Others |
1534 | DYDC1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1535 | DYNLL1 | RNA | Others | Others | Others |
1536 | DYNLL2 | RNA | Others | Others | Others |
1537 | DYSF | RNA | Others | Others | Others |
1538 | E2F1 | RNA | Cell Cycle | Immune Suppression | Oncology |
1539 | E2F1 | RNA | Cell Cycle | Immune Suppression | Immuno-Oncology |
1540 | E2F2 | RNA | Cell Cycle | Others | Oncology |
1541 | E2F3 | RNA | Angiogenesis | Others | Cardiovascular |
1542 | E2F4 | RNA | Others | Others | Others |
1543 | E2F5 | RNA | Proliferation | Immune Suppression | Oncology |
1544 | E2F5 | RNA | Proliferation | Immune Suppression | Immuno-Oncology |
1545 | EBI3 | RNA | Others | Others | Others |
1546 | EBV LMP2 | RNA | Others | Others | Others |
1547 | ECHS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1548 | ECM1 | RNA | Angiogenesis | Others | Cardiovascular |
1549 | ECM2 | RNA | EMT | Others | Oncology |
1550 | ECSCR | RNA | Angiogenesis | Others | Cardiovascular |
1551 | ECSIT | RNA | Others | Others | Others |
1552 | EDC3 | RNA | Others | Others | Others |
1553 | EDN1 | RNA | Angiogenesis | Others | Cardiovascular |
1554 | EDNRB | RNA | Others | Others | Others |
1555 | EEA1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1556 | EED | RNA | Others | Others | Others |
1557 | EEF2K | RNA | Others | Immunity and Inflammation | Inflammation |
1558 | EFNA1 | RNA | RAS | Others | Oncology |
1559 | EFNA2 | RNA | RAS | Others | Oncology |
1560 | EFNA3 | RNA | MAPK | Others | Cardiovascular |
1561 | EFNA4 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
1562 | EFNA5 | RNA | MAPK | Others | Cardiovascular |
1563 | EFNB3 | RNA | Others | Others | Others |
1564 | EFR3A | RNA | Others | Others | Others |
1565 | EGF | RNA | Angiogenesis | Others | Cardiovascular |
1566 | EGFL7 | RNA | Angiogenesis | Others | Cardiovascular |
1567 | EGFR | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
1568 | EGFR | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
1569 | EGLN1 | RNA | Others | Others | Others |
1570 | EGLN2 | RNA | Proliferation | Others | Oncology |
1571 | EGLN3 | RNA | Cell Proliferation | Others | CNS |
1572 | EGR1 | RNA | Costimulatory Signaling | Immunity and Inflammation | Immuno-Oncology |
1573 | EGR1 | RNA | Costimulatory Signaling | Immunity and Inflammation | Inflammation |
1574 | EGR2 | RNA | Myelination | Vesicle Trafficking | CNS |
1575 | EHHADH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1576 | EHMT1 | RNA | Others | Others | Others |
1577 | EHMT2 | RNA | Others | Others | Others |
1578 | EIF1 | RNA | Others | Others | Others |
1579 | EIF2AK2 | RNA | Interferon Signaling | Others | Immuno-Oncology |
1580 | EIF2AK3 | RNA | Angiogenesis | Others | Cardiovascular |
1581 | EIF2B4 | RNA | Others | Others | Others |
1582 | EIF2S1 | RNA | Others | Others | Others |
1583 | EIF3B | RNA | ER Signaling | Others | Oncology |
1584 | EIF3F | RNA | Others | Others | Others |
1585 | EIF4A2 | RNA | Others | Others | Others |
1586 | EIF4B | RNA | Others | Others | Others |
1587 | EIF4E2 | RNA | Cellular Differentiation | Others | Oncology |
1588 | EIF4EBP1 | RNA | Hypoxia | Others | Cardiovascular |
1589 | EIF4G1 | RNA | mTOR Signaling | Others | Oncology |
1590 | EIF5AL1 | RNA | Others | Others | Others |
1591 | ELANE | RNA | Others | Others | Others |
1592 | ELAVL1 | RNA | Others | Others | Others |
1593 | ELF3 | RNA | EMT | Others | Oncology |
1594 | ELK1 | RNA | Others | Others | Others |
1595 | ELK3 | RNA | Angiogenesis | Others | Cardiovascular |
1596 | ELMO1 | RNA | Others | Others | Others |
1597 | ELN | RNA | Others | Others | Others |
1598 | ELOB | RNA | Others | Others | Others |
1599 | ELOVL2 | RNA | ER Signaling | Others | Oncology |
1600 | ELOVL3 | RNA | Others | Others | Others |
1601 | ELOVL4 | RNA | Others | Others | Others |
1602 | ELOVL5 | RNA | Androgen Signaling | Others | Oncology |
1603 | ELOVL6 | RNA | Others | Others | Others |
1604 | ELOVL7 | RNA | Others | Others | Others |
1605 | EMCN | RNA | Angiogenesis | Others | Cardiovascular |
1606 | EME1 | RNA | Cell Stress | Others | CNS |
1607 | EMILIN1 | RNA | Cellular Differentiation | Others | Oncology |
1608 | EMILIN3 | RNA | Others | Others | Others |
1609 | EMP1 | RNA | Others | Others | Others |
1610 | EMP2 | RNA | Others | Others | Others |
1611 | EMP3 | RNA | Cell Proliferation | Others | CNS |
1612 | ENDOG | RNA | Others | Others | Others |
1613 | ENG | RNA | Others | Others | Others |
1614 | ENO1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1615 | ENO2 | RNA | Others | Others | Others |
1616 | ENO3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1617 | ENPEP | RNA | Angiogenesis | Others | Cardiovascular |
1618 | ENPP2 | RNA | EMT | Others | Oncology |
1619 | ENPP6 | RNA | Others | Others | Others |
1620 | ENTPD1 | RNA | Others | Immune Suppression | Immuno-Oncology |
1621 | ENTPD2 | RNA | Others | Immune Suppression | Immuno-Oncology |
1622 | ENTPD4 | RNA | Others | Others | Others |
1623 | EOMES | RNA | Transcriptional Regulation | Immune Cell Typing | Epigenic and Nuclear Signaling |
1624 | EOMES | RNA | Transcriptional Regulation | Immune Cell Typing | Immuno-Oncology |
1625 | EP300 | RNA | DNA Damage Repair | Immunity and Inflammation | Epigenic and Nuclear Signaling |
1626 | EP300 | RNA | DNA Damage Repair | Immunity and Inflammation | Inflammation |
1627 | EP400 | RNA | Others | Others | Others |
1628 | EPAS1 | RNA | Angiogenesis | Others | Cardiovascular |
1629 | EPC1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1630 | EPCAM | RNA | Cell Proliferation | Pan-Tumor | CNS |
1631 | EPCAM | RNA | Cell Proliferation | Pan-Tumor | Oncology |
1632 | EPG5 | RNA | Others | Others | Others |
1633 | EPHA1 | RNA | Angiogenesis | Others | Cardiovascular |
1634 | EPHA2 | RNA | Angiogenesis | Others | Cardiovascular |
1635 | EPHA3 | RNA | Others | Others | Others |
1636 | EPHA4 | RNA | Others | Neural Connectivity | CNS |
1637 | EPHA5 | RNA | Others | Others | Others |
1638 | EPHA6 | RNA | Others | Others | Others |
1639 | EPHA7 | RNA | Others | Neural Connectivity | CNS |
1640 | EPHB1 | RNA | Angiogenesis | Others | Cardiovascular |
1641 | EPHB3 | RNA | Angiogenesis | Others | Cardiovascular |
1642 | EPHB4 | RNA | Angiogenesis | Others | Cardiovascular |
1643 | EPHX2 | RNA | Others | Others | Others |
1644 | EPM2AIP1 | RNA | Others | Others | Others |
1645 | EPN3 | RNA | Others | Others | Others |
1646 | EPO | RNA | Others | Others | Others |
1647 | EPOR | RNA | Others | Others | Others |
1648 | EPS8L1 | RNA | Others | Others | Others |
1649 | EPSTI1 | RNA | Others | Immunity and Inflammation | Inflammation |
1650 | ERAP2 | RNA | Others | Others | Others |
1651 | ERBB2 | RNA | EMT | Others | Oncology |
1652 | ERBB2IP | RNA | Others | Others | Others |
1653 | ERBB3 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
1654 | ERBB3 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
1655 | ERBB4 | RNA | Others | Others | Others |
1656 | ERC1 | RNA | Others | Others | Others |
1657 | ERCC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1658 | ERCC2 | RNA | DNA Damage Repair | Immunity and Inflammation | Epigenic and Nuclear Signaling |
1659 | ERCC2 | RNA | DNA Damage Repair | Immunity and Inflammation | Inflammation |
1660 | ERCC3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1661 | ERCC6 | RNA | Cell Stress | Others | CNS |
1662 | EREG | RNA | Angiogenesis | Others | Cardiovascular |
1663 | ERG | RNA | Others | Others | Others |
1664 | ERLEC1 | RNA | Others | Others | Others |
1665 | ERMP1 | RNA | Others | Others | Others |
1666 | ERN1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1667 | ERO1A | RNA | Metabolism Stress | Others | Metabolic Diseases |
1668 | ERP29 | RNA | Others | Others | Others |
1669 | ESAM | RNA | Others | Others | Others |
1670 | ESPL1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1671 | ESR1 | RNA | ER Signaling | Others | Oncology |
1672 | ESR2 | RNA | Others | Others | Others |
1673 | ESRP1 | RNA | FGFR Signaling | Others | Cardiovascular |
1674 | ESRP2 | RNA | FGFR Signaling | Others | Cardiovascular |
1675 | ETS1 | RNA | Others | Others | Others |
1676 | ETS2 | RNA | RAS | Immunity and Inflammation | Oncology |
1677 | ETS2 | RNA | RAS | Immunity and Inflammation | Inflammation |
1678 | ETV1 | RNA | Others | Others | Others |
1679 | ETV4 | RNA | Cell Proliferation | Others | CNS |
1680 | ETV7 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
1681 | EVI2A | RNA | Others | Others | Others |
1682 | EVL | RNA | Others | Others | Others |
1683 | EVPL | RNA | Others | Others | Others |
1684 | EWSR1 | RNA | Others | Others | Others |
1685 | EXO1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1686 | EYA1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1687 | EYA2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1688 | EYA4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1689 | EZH1 | RNA | Others | Others | Others |
1690 | EZH2 | RNA | Angiogenesis | Others | Cardiovascular |
1691 | F11R | RNA | Cellular Differentiation | Others | Oncology |
1692 | F12 | RNA | Others | Others | Others |
1693 | F13A1 | RNA | Others | Others | Others |
1694 | F2 | RNA | Others | Transmitter Response and Reuptake | CNS |
1695 | F2RL1 | RNA | Others | Lymphoid Compartment | Immuno-Oncology |
1696 | F3 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
1697 | F3 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
1698 | F5 | RNA | Others | Others | Others |
1699 | F8 | RNA | Others | Others | Others |
1700 | FA2H | RNA | Myelination | Others | CNS |
1701 | FAAP24 | RNA | Others | Others | Others |
1702 | FABP1 | RNA | Others | Others | Others |
1703 | FABP4 | RNA | Others | Others | Others |
1704 | FABP5 | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS |
1705 | FABP5 | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | Inflammation |
1706 | FADD | RNA | Apoptosis | Immunity and Inflammation | Oncology |
1707 | FADD | RNA | Apoptosis | Immunity and Inflammation | Inflammation |
1708 | FAH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1709 | FAHD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1710 | FAM124B | RNA | Angiogenesis | Others | Cardiovascular |
1711 | FAM126A | RNA | Myelination | Others | CNS |
1712 | FAM129C | RNA | Others | Others | Others |
1713 | FAM174B | RNA | Others | Others | Others |
1714 | FAM198B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1715 | FAM214A | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1716 | FAM30A | RNA | Others | Others | Others |
1717 | FAM83A | RNA | EGFR Signaling | Others | Oncology |
1718 | FAM83D | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1719 | FANCA | RNA | Cell Stress | Others | CNS |
1720 | FANCB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1721 | FANCC | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1722 | FANCD2 | RNA | Cell Stress | Others | CNS |
1723 | FANCE | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1724 | FANCF | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1725 | FANCG | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1726 | FANCI | RNA | Cell Stress | Others | CNS |
1727 | FANCL | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1728 | FAP | RNA | Angiogenesis | Others | Cardiovascular |
1729 | FAS | RNA | Apoptosis | Immunity and Inflammation | Oncology |
1730 | FAS | RNA | Apoptosis | Immunity and Inflammation | Inflammation |
1731 | FASLG | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
1732 | FASLG | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
1733 | FASN | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1734 | FBLIM1 | RNA | Others | Others | Others |
1735 | FBLL1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1736 | FBLN1 | RNA | Others | Others | Others |
1737 | FBLN2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
1738 | FBLN5 | RNA | Cellular Differentiation | Others | Oncology |
1739 | FBN1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
1740 | FBN2 | RNA | Others | Others | Others |
1741 | FBP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1742 | FBP2 | RNA | Others | Others | Others |
1743 | FBXO6 | RNA | Others | Others | Others |
1744 | FBXO7 | RNA | Others | Others | Others |
1745 | FBXW11 | RNA | Others | Others | Others |
1746 | FBXW4 | RNA | Others | Others | Others |
1747 | FBXW7 | RNA | Others | Others | Others |
1748 | FCAR | RNA | Others | Inflammation | Inflammation |
1749 | FCER1A | RNA | Others | Others | Others |
1750 | FCER1G | RNA | Others | Immunity and Inflammation | Inflammation |
1751 | FCER2 | RNA | Others | Immune Suppression | Immuno-Oncology |
1752 | FCF1 | RNA | Others | Others | Others |
1753 | FCGR1A | RNA | Interferon Signaling | Immunity and Inflammation | Immuno-Oncology |
1754 | FCGR1A | RNA | Interferon Signaling | Immunity and Inflammation | Inflammation |
1755 | FCGR1A/B | RNA | Others | Others | Others |
1756 | FCGR2A | RNA | Others | Others | Others |
1757 | FCGR2A/C | RNA | Others | Others | Others |
1758 | FCGR2B | RNA | Others | Immunity and Inflammation | Inflammation |
1759 | FCGR3A | RNA | Others | Immunity and Inflammation | Inflammation |
1760 | FCGR3A/B | RNA | Others | Inflammation | Inflammation |
1761 | FCGRT | RNA | Others | Others | Others |
1762 | FCN1 | RNA | Others | Myeloid Compartment | CNS |
1763 | FCRL1 | RNA | Others | Others | Others |
1764 | FCRL2 | RNA | Others | Others | Others |
1765 | FCRL3 | RNA | Others | Others | Others |
1766 | FCRL4 | RNA | Others | Others | Others |
1767 | FCRL5 | RNA | Others | Others | Others |
1768 | FCRLA | RNA | Others | Immunity and Inflammation | Inflammation |
1769 | FCRLB | RNA | Others | Immunity and Inflammation | Inflammation |
1770 | FDX1 | RNA | Cell Stress | Others | CNS |
1771 | FDXR | RNA | Cell Stress | Others | CNS |
1772 | FEN1 | RNA | Cell Cycle | Others | Oncology |
1773 | FERMT2 | RNA | Others | Others | Others |
1774 | FES | RNA | Others | Others | Others |
1775 | FEZ1 | RNA | Others | Others | Others |
1776 | FGA | RNA | Others | Others | Others |
1777 | FGB | RNA | Others | Others | Others |
1778 | FGCR2A/B | RNA | Others | Others | Others |
1779 | FGD2 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
1780 | FGD2 | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
1781 | FGF1 | RNA | MAPK | Others | Cardiovascular |
1782 | FGF10 | RNA | MAPK | Others | Cardiovascular |
1783 | FGF11 | RNA | RAS | Others | Oncology |
1784 | FGF12 | RNA | MAPK | Vesicle Trafficking | Cardiovascular |
1785 | FGF12 | RNA | MAPK | Vesicle Trafficking | CNS |
1786 | FGF13 | RNA | MAPK | Immunity and Inflammation | Cardiovascular |
1787 | FGF13 | RNA | MAPK | Immunity and Inflammation | Inflammation |
1788 | FGF14 | RNA | RAS | Vesicle Trafficking | Oncology |
1789 | FGF14 | RNA | RAS | Vesicle Trafficking | CNS |
1790 | FGF16 | RNA | RAS | Others | Oncology |
1791 | FGF17 | RNA | RAS | Others | Oncology |
1792 | FGF18 | RNA | Angiogenesis | Others | Cardiovascular |
1793 | FGF19 | RNA | RAS | Others | Oncology |
1794 | FGF2 | RNA | Cell Proliferation | Others | CNS |
1795 | FGF20 | RNA | RAS | Others | Oncology |
1796 | FGF21 | RNA | RAS | Others | Oncology |
1797 | FGF22 | RNA | RAS | Others | Oncology |
1798 | FGF23 | RNA | RAS | Others | Oncology |
1799 | FGF3 | RNA | RAS | Others | Oncology |
1800 | FGF4 | RNA | RAS | Others | Oncology |
1801 | FGF5 | RNA | RAS | Others | Oncology |
1802 | FGF6 | RNA | RAS | Others | Oncology |
1803 | FGF7 | RNA | FGFR Signaling | Others | Cardiovascular |
1804 | FGF8 | RNA | RAS | Others | Oncology |
1805 | FGF9 | RNA | Angiogenesis | Others | Cardiovascular |
1806 | FGFBP1 | RNA | FGFR Signaling | Others | Cardiovascular |
1807 | FGFR1 | RNA | Angiogenesis | Others | Cardiovascular |
1808 | FGFR2 | RNA | Angiogenesis | Others | Cardiovascular |
1809 | FGFR3 | RNA | Cell Proliferation | Others | CNS |
1810 | FGFR4 | RNA | Cell Proliferation | Others | CNS |
1811 | FGG | RNA | Others | Others | Others |
1812 | FGL2 | RNA | EMT | Immunity and Inflammation | Oncology |
1813 | FGL2 | RNA | EMT | Immunity and Inflammation | Inflammation |
1814 | FGR | RNA | Others | Others | Others |
1815 | FH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1816 | FHL1 | RNA | EMT | Others | Oncology |
1817 | FIGF | RNA | Angiogenesis | Others | Cardiovascular |
1818 | FKBP1A | RNA | Others | Others | Others |
1819 | FKBP5 | RNA | Others | Others | Others |
1820 | FLCN | RNA | Others | Others | Others |
1821 | FLG | RNA | Others | Others | Others |
1822 | FLI1 | RNA | EMT | Others | Oncology |
1823 | FLNA | RNA | Others | Others | Others |
1824 | FLNB | RNA | Interferon Signaling | Others | Immuno-Oncology |
1825 | FLNC | RNA | MAPK | Others | Cardiovascular |
1826 | FLRT3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1827 | FLT1 | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular |
1828 | FLT1 | RNA | Angiogenesis | Immunity and Inflammation | Inflammation |
1829 | FLT3 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
1830 | FLT3LG | RNA | Others | Others | Others |
1831 | FLT4 | RNA | Cell Proliferation | Others | CNS |
1832 | FMOD | RNA | Cellular Differentiation | Others | Oncology |
1833 | FMR1 | RNA | Others | Neural Connectivity | CNS |
1834 | FN1 | RNA | Angiogenesis | Others | Cardiovascular |
1835 | FNBP1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1836 | FNIP1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
1837 | FNIP2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
1838 | FOLH1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1839 | FOLH1B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1840 | FOLR1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1841 | FOLR3 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1842 | FOS | RNA | AP1 Signaling | Immunity and Inflammation | Cardiovascular |
1843 | FOS | RNA | AP1 Signaling | Immunity and Inflammation | Inflammation |
1844 | FOSB | RNA | Others | Others | Others |
1845 | FOSL1 | RNA | Wnt Signaling | Myeloid Compartment | CNS |
1846 | FOXA1 | RNA | Others | Others | Others |
1847 | FOXA2 | RNA | Others | Others | Others |
1848 | FOXC1 | RNA | Others | Others | Others |
1849 | FOXC2 | RNA | Cell Proliferation | Others | CNS |
1850 | FOXJ1 | RNA | Others | Others | Others |
1851 | FOXL2 | RNA | Others | Others | Others |
1852 | FOXM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1853 | FOXO1 | RNA | Others | Others | Others |
1854 | FOXO3 | RNA | Others | Others | Others |
1855 | FOXO4 | RNA | Cell Proliferation | Others | CNS |
1856 | FOXP1 | RNA | Androgen Signaling | Others | Oncology |
1857 | FOXP3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
1858 | FPR1 | RNA | Adenosine Pathway | Inflammation | Immuno-Oncology |
1859 | FPR1 | RNA | Adenosine Pathway | Inflammation | Inflammation |
1860 | FPR2 | RNA | Others | Others | Others |
1861 | FPR3 | RNA | Others | Myeloid Compartment | CNS |
1862 | FRAS1 | RNA | Cellular Differentiation | Others | Oncology |
1863 | FREM1 | RNA | Others | Others | Others |
1864 | FREM2 | RNA | Others | Others | Others |
1865 | FRMD6 | RNA | Hippo Signaling | Others | CNS |
1866 | FRMPD4 | RNA | Others | Neural Connectivity | CNS |
1867 | FRS2 | RNA | Others | Others | Others |
1868 | FSCN1 | RNA | Others | Immunity and Inflammation | Inflammation |
1869 | FST | RNA | TGF Beta Signaling | Others | Oncology |
1870 | FSTL1 | RNA | EMT | Others | Oncology |
1871 | FSTL3 | RNA | Angiogenesis | Others | Cardiovascular |
1872 | FTCD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1873 | FTSJ2 | RNA | Others | Others | Others |
1874 | FUBP1 | RNA | Others | Others | Others |
1875 | FURIN | RNA | Others | Others | Others |
1876 | FUS | RNA | Others | Neural Connectivity | CNS |
1877 | FUT3 | RNA | EMT | Others | Oncology |
1878 | FUT4 | RNA | Others | Others | Others |
1879 | FUT5 | RNA | Others | Others | Others |
1880 | FUT7 | RNA | Others | Leucocyte Function | Immuno-Oncology |
1881 | FUT8 | RNA | Others | Others | Others |
1882 | FXN | RNA | Oxydative Stress | Others | Inflammation |
1883 | FXYD2 | RNA | Others | Others | Others |
1884 | FXYD3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1885 | FXYD6 | RNA | Others | Others | Others |
1886 | FYN | RNA | Costimulatory Signaling | Immunity and Inflammation | Immuno-Oncology |
1887 | FYN | RNA | Costimulatory Signaling | Immunity and Inflammation | Inflammation |
1888 | FZD1 | RNA | Others | Others | Others |
1889 | FZD10 | RNA | Wnt Signaling | Others | CNS |
1890 | FZD2 | RNA | Others | Others | Others |
1891 | FZD3 | RNA | Others | Others | Others |
1892 | FZD4 | RNA | Others | Others | Others |
1893 | FZD5 | RNA | Others | Others | Others |
1894 | FZD6 | RNA | Others | Others | Others |
1895 | FZD7 | RNA | Wnt Signaling | Others | CNS |
1896 | FZD8 | RNA | Wnt Signaling | Others | CNS |
1897 | FZD9 | RNA | Wnt Signaling | Others | CNS |
1898 | G6PC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1899 | G6PD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1900 | GAA | RNA | Others | Others | Others |
1901 | GAB1 | RNA | Others | Others | Others |
1902 | GAB2 | RNA | Others | Others | Others |
1903 | GABARAP | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1904 | GABPA | RNA | Others | Others | Others |
1905 | GABRA1 | RNA | Others | Neural Connectivity | CNS |
1906 | GABRA4 | RNA | Others | Neural Connectivity | CNS |
1907 | GABRB2 | RNA | Others | Neural Connectivity | CNS |
1908 | GABRB3 | RNA | Others | Neural Connectivity | CNS |
1909 | GABRG2 | RNA | Others | Neural Connectivity | CNS |
1910 | GABRP | RNA | Others | Neural Connectivity | CNS |
1911 | GABRR1 | RNA | Others | Neural Connectivity | CNS |
1912 | GABRR3 | RNA | Others | Neural Connectivity | CNS |
1913 | GAD1 | RNA | Biosynthesis and Anabolic Pathways | Neural Connectivity | CNS |
1914 | GAD2 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
1915 | GADD45A | RNA | MAPK | Others | Cardiovascular |
1916 | GADD45B | RNA | MAPK | Others | Cardiovascular |
1917 | GADD45G | RNA | MAPK | Others | Cardiovascular |
1918 | GADL1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1919 | GAGE1 | RNA | Others | Others | Others |
1920 | GAL3ST1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1921 | GALC | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1922 | GALNT3 | RNA | FGFR Signaling | Others | Cardiovascular |
1923 | GALNT7 | RNA | Others | Others | Others |
1924 | GAPDH | RNA | Biosynthesis and Anabolic Pathways | Neural Cell Typing | CNS |
1925 | GAPDHS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1926 | GAPVD1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
1927 | GARS | RNA | Others | Others | Others |
1928 | GART | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1929 | GAS1 | RNA | Hedgehog | Others | CNS |
1930 | GATA1 | RNA | Others | Others | Others |
1931 | GATA2 | RNA | Others | Others | Others |
1932 | GATA3 | RNA | DNA Damage Repair | M2 Activation | Epigenic and Nuclear Signaling |
1933 | GATA3 | RNA | DNA Damage Repair | M2 Activation | CNS |
1934 | GATA4 | RNA | Proliferation | Others | Oncology |
1935 | GATA6 | RNA | Others | Others | Others |
1936 | GATM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1937 | GBA | RNA | Autophagy | Immunity and Inflammation | Cardiovascular |
1938 | GBA | RNA | Autophagy | Immunity and Inflammation | Inflammation |
1939 | GBP1 | RNA | Interferon Signaling | Others | Immuno-Oncology |
1940 | GBP2 | RNA | Interferon Signaling | Immunity and Inflammation | Immuno-Oncology |
1941 | GBP2 | RNA | Interferon Signaling | Immunity and Inflammation | Inflammation |
1942 | GBP3 | RNA | Others | Others | Others |
1943 | GBP4 | RNA | Interferon Signaling | Others | Immuno-Oncology |
1944 | GBP5 | RNA | Others | Others | Others |
1945 | GCA | RNA | Others | Others | Others |
1946 | GCDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1947 | GCK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1948 | GCKR | RNA | Others | Others | Others |
1949 | GCLC | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS |
1950 | GCLC | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | Inflammation |
1951 | GCNT1 | RNA | Others | Others | Others |
1952 | GDA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1953 | GDF15 | RNA | EMT | Others | Oncology |
1954 | GDF5 | RNA | Proliferation | Others | Oncology |
1955 | GDF6 | RNA | Others | Others | Others |
1956 | GDNF | RNA | Others | Transmitter Release | CNS |
1957 | GDPD2 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
1958 | GFAP | RNA | Others | Inflammation | Inflammation |
1959 | GFER | RNA | Others | Others | Others |
1960 | GFI1 | RNA | Others | Others | Others |
1961 | GFM1 | RNA | Others | Others | Others |
1962 | GFPT1 | RNA | Others | Others | Others |
1963 | GGA1 | RNA | Others | Others | Others |
1964 | GGH | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1965 | GGT1 | RNA | Carbohydrate Metabolism | Others | CNS |
1966 | GHDC | RNA | Others | Others | Others |
1967 | GHR | RNA | Cytotoxicity | Others | Oncology |
1968 | GIMAP4 | RNA | Others | Others | Others |
1969 | GIMAP6 | RNA | Others | Others | Others |
1970 | GJA1 | RNA | Others | Others | Others |
1971 | GJA5 | RNA | Angiogenesis | Others | Cardiovascular |
1972 | GJB1 | RNA | Myelination | Others | CNS |
1973 | GJB2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
1974 | GK | RNA | Others | Others | Others |
1975 | GLA | RNA | Others | Others | Others |
1976 | GLB1 | RNA | Others | Others | Others |
1977 | GLI1 | RNA | Hedgehog | Others | CNS |
1978 | GLI2 | RNA | Others | Others | Others |
1979 | GLI3 | RNA | Hedgehog | Others | CNS |
1980 | GLP1R | RNA | Adenosine Pathway | Others | Immuno-Oncology |
1981 | GLRB | RNA | Others | Neural Connectivity | CNS |
1982 | GLRX | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1983 | GLS | RNA | Biosynthesis and Anabolic Pathways | Transmitter Release | CNS |
1984 | GLS2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1985 | GLUD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1986 | GLUD1/2 | RNA | Others | Others | Others |
1987 | GLUD2 | RNA | Others | Others | Others |
1988 | GLUL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1989 | GLYAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1990 | GLYCTK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1991 | GLYR1 | RNA | Others | Others | Others |
1992 | GMIP | RNA | Others | Others | Others |
1993 | GMPR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1994 | GMPR2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1995 | GMPS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
1996 | GNA11 | RNA | Others | Others | Others |
1997 | GNA15 | RNA | Others | Immunity and Inflammation | Inflammation |
1998 | GNAI1 | RNA | Others | Transmitter Release | CNS |
1999 | GNAI2 | RNA | Others | Transmitter Release | CNS |
2000 | GNAI3 | RNA | Others | Inflammation | Inflammation |
2001 | GNAO1 | RNA | Oxydative Stress | Transmitter Release | Inflammation |
2002 | GNAO1 | RNA | Oxydative Stress | Transmitter Release | CNS |
2003 | GNAQ | RNA | Others | Transmitter Release | CNS |
2004 | GNAS | RNA | Others | Others | Others |
2005 | GNB1 | RNA | Others | Others | Others |
2006 | GNB4 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2007 | GNB5 | RNA | Others | Transmitter Release | CNS |
2008 | GNG10 | RNA | Others | Others | Others |
2009 | GNG12 | RNA | RAS | Others | Oncology |
2010 | GNG2 | RNA | Adenosine Pathway | Transmitter Release | Immuno-Oncology |
2011 | GNG2 | RNA | Adenosine Pathway | Transmitter Release | CNS |
2012 | GNG4 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2013 | GNG7 | RNA | RAS | Others | Oncology |
2014 | GNGT1 | RNA | RAS | Transmitter Release | Oncology |
2015 | GNGT1 | RNA | RAS | Transmitter Release | CNS |
2016 | GNLY | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2017 | GNLY | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2018 | GNPTAB | RNA | Others | Others | Others |
2019 | GNPTG | RNA | Others | Others | Others |
2020 | GNS | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
2021 | GOT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2022 | GOT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2023 | GP1BB | RNA | Others | Others | Others |
2024 | GPATCH3 | RNA | Others | Others | Others |
2025 | GPC4 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2026 | GPD1L | RNA | Lipid Metabolism | Others | Metabolic Diseases |
2027 | GPI | RNA | Angiogenesis | Others | Cardiovascular |
2028 | GPNMB | RNA | Others | Others | Others |
2029 | GPR124 | RNA | Others | Others | Others |
2030 | GPR160 | RNA | Others | Others | Others |
2031 | GPR183 | RNA | Others | Immunity and Inflammation | Inflammation |
2032 | GPR34 | RNA | Others | Immunity and Inflammation | Inflammation |
2033 | GPR37 | RNA | Oxydative Stress | Others | Inflammation |
2034 | GPR4 | RNA | Others | Others | Others |
2035 | GPR56 | RNA | Angiogenesis | Others | Cardiovascular |
2036 | GPR62 | RNA | Others | Others | Others |
2037 | GPR65 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2038 | GPR84 | RNA | Others | Immunity and Inflammation | Inflammation |
2039 | GPRASP1 | RNA | Others | Others | Others |
2040 | GPS1 | RNA | Cell Stress | Others | CNS |
2041 | GPSM3 | RNA | Others | Others | Others |
2042 | GPT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2043 | GPX1 | RNA | Angiogenesis | Others | Cardiovascular |
2044 | GPX2 | RNA | Others | Others | Others |
2045 | GPX3 | RNA | Others | Others | Others |
2046 | GPX4 | RNA | Cell Stress | Others | CNS |
2047 | GPX7 | RNA | Others | Others | Others |
2048 | GRAP | RNA | Others | Immunity and Inflammation | Inflammation |
2049 | GRAP2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2050 | GRB10 | RNA | Others | Others | Others |
2051 | GRB2 | RNA | JAK-STAT | Others | CNS |
2052 | GRB7 | RNA | ERBB2 Signaling | Others | Oncology |
2053 | GREM1 | RNA | EMT | Others | Oncology |
2054 | GREM2 | RNA | Others | Others | Others |
2055 | GRHL2 | RNA | Others | Others | Others |
2056 | GRIA1 | RNA | Others | Neural Connectivity | CNS |
2057 | GRIA2 | RNA | Others | Neural Connectivity | CNS |
2058 | GRIA3 | RNA | Transcriptional Misregulation | Neural Connectivity | Epigenic and Nuclear Signaling |
2059 | GRIA3 | RNA | Transcriptional Misregulation | Neural Connectivity | CNS |
2060 | GRIA4 | RNA | Others | Neural Connectivity | CNS |
2061 | GRIK2 | RNA | Others | Neural Connectivity | CNS |
2062 | GRIN1 | RNA | Biosynthesis and Anabolic Pathways | Neural Connectivity | CNS |
2063 | GRIN2A | RNA | MAPK | Immunity and Inflammation | Cardiovascular |
2064 | GRIN2A | RNA | MAPK | Immunity and Inflammation | Inflammation |
2065 | GRIN2B | RNA | RAS | Immunity and Inflammation | Oncology |
2066 | GRIN2B | RNA | RAS | Immunity and Inflammation | Inflammation |
2067 | GRIN2C | RNA | Others | Neural Connectivity | CNS |
2068 | GRIN2D | RNA | Others | Neural Connectivity | CNS |
2069 | GRIN3B | RNA | Others | Neural Connectivity | CNS |
2070 | GRK2 | RNA | Others | Others | Others |
2071 | GRK4 | RNA | Others | Others | Others |
2072 | GRK6 | RNA | Others | Others | Others |
2073 | GRM1 | RNA | Others | Neural Connectivity | CNS |
2074 | GRM2 | RNA | Others | Neural Connectivity | CNS |
2075 | GRM3 | RNA | Others | Others | Others |
2076 | GRM5 | RNA | Others | Neural Connectivity | CNS |
2077 | GRM8 | RNA | Others | Neural Connectivity | CNS |
2078 | GRN | RNA | Others | Immunity and Inflammation | Inflammation |
2079 | GRPEL1 | RNA | Others | Others | Others |
2080 | GSDMD | RNA | Others | Others | Others |
2081 | GSK3B | RNA | Biosynthesis and Anabolic Pathways | Neural Connectivity | CNS |
2082 | GSN | RNA | Others | Neuronal Cytoskeleton | CNS |
2083 | GSR | RNA | Androgen Signaling | Others | Oncology |
2084 | GSS | RNA | Carbohydrate Metabolism | Others | CNS |
2085 | GSTM1 | RNA | Others | Others | Others |
2086 | GSTM4 | RNA | Others | Inflammation | Inflammation |
2087 | GSTP1 | RNA | Oxydative Stress | Others | Inflammation |
2088 | GTF2A1 | RNA | Others | Others | Others |
2089 | GTF2B | RNA | Others | Others | Others |
2090 | GTF2H1 | RNA | Others | Others | Others |
2091 | GTF2H2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2092 | GTF2H3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2093 | GTF2I | RNA | Others | Others | Others |
2094 | GTF2IRD1 | RNA | Others | Transmitter Response and Reuptake | CNS |
2095 | GTF3C1 | RNA | Others | Others | Others |
2096 | GTSE1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2097 | GUCY1A1 | RNA | Others | Others | Others |
2098 | GUCY1B1 | RNA | Others | Others | Others |
2099 | GUCY1B3 | RNA | Oxydative Stress | Transmitter Response and Reuptake | Inflammation |
2100 | GUCY1B3 | RNA | Oxydative Stress | Transmitter Response and Reuptake | CNS |
2101 | GUSB | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
2102 | GYS2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2103 | GZMA | RNA | Apoptosis | Lymphoid Compartment | Oncology |
2104 | GZMA | RNA | Apoptosis | Lymphoid Compartment | Immuno-Oncology |
2105 | GZMB | RNA | Apoptosis | Lymphoid Compartment | Oncology |
2106 | GZMB | RNA | Apoptosis | Lymphoid Compartment | Immuno-Oncology |
2107 | GZMH | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2108 | GZMH | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2109 | GZMK | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2110 | GZMK | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2111 | GZMM | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2112 | GZMM | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2113 | H2AFX | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2114 | H2AFY2 | RNA | Others | Others | Others |
2115 | H2AX | RNA | Others | Others | Others |
2116 | H3-3A | RNA | Others | Others | Others |
2117 | H3-5 | RNA | Others | Others | Others |
2118 | H3C10 | RNA | Others | Others | Others |
2119 | H3C2 | RNA | Others | Others | Others |
2120 | H3C8 | RNA | Others | Others | Others |
2121 | H3F3A | RNA | Others | Others | Others |
2122 | H3F3C | RNA | Others | Others | Others |
2123 | H6PD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2124 | HAAO | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2125 | HACD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2126 | HACD4 | RNA | Others | Others | Others |
2127 | HADH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2128 | HADHA | RNA | Others | Others | Others |
2129 | HADHB | RNA | Others | Others | Others |
2130 | HAMP | RNA | Others | Others | Others |
2131 | HAP1 | RNA | Others | Neural Connectivity | CNS |
2132 | HAPLN1 | RNA | Others | Others | Others |
2133 | HAS1 | RNA | Others | Others | Others |
2134 | HAT1 | RNA | Others | Others | Others |
2135 | HAVCR1 | RNA | Others | Others | Others |
2136 | HAVCR2 | RNA | Costimulatory Signaling | Inflammation | Immuno-Oncology |
2137 | HAVCR2 | RNA | Costimulatory Signaling | Inflammation | Inflammation |
2138 | HBB | RNA | Others | Others | Others |
2139 | HCAR2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2140 | HCFC1 | RNA | Others | Others | Others |
2141 | HCK | RNA | Cytokine and Chemokine Signaling | Inflammation | Immuno-Oncology |
2142 | HCK | RNA | Cytokine and Chemokine Signaling | Inflammation | Inflammation |
2143 | HCN1 | RNA | Others | Transmitter Release | CNS |
2144 | HCST | RNA | Others | Others | Others |
2145 | HDAC1 | RNA | Androgen Signaling | Others | Oncology |
2146 | HDAC10 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2147 | HDAC11 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2148 | HDAC2 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2149 | HDAC3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2150 | HDAC4 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2151 | HDAC5 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2152 | HDAC6 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2153 | HDAC7 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2154 | HDAC8 | RNA | Others | Others | Others |
2155 | HDAC9 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2156 | HDC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2157 | HDHD3 | RNA | Others | Others | Others |
2158 | HEG1 | RNA | Cellular Differentiation | Others | Oncology |
2159 | HELLS | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2160 | HEMK1 | RNA | ER Signaling | Others | Oncology |
2161 | HERC1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2162 | HERC5 | RNA | Others | Others | Others |
2163 | HERC6 | RNA | Others | Others | Others |
2164 | HES1 | RNA | Notch | Others | Immuno-Oncology |
2165 | HES5 | RNA | Others | Others | Others |
2166 | HEXA | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
2167 | HEXB | RNA | Myelination | Others | CNS |
2168 | HEY1 | RNA | Angiogenesis | Others | Cardiovascular |
2169 | HEY2 | RNA | Others | Others | Others |
2170 | HFE | RNA | Others | Others | Others |
2171 | HGF | RNA | Cell Proliferation | Others | CNS |
2172 | HHEX | RNA | Others | Others | Others |
2173 | HHIP | RNA | Others | Others | Others |
2174 | HIF1A | RNA | Angiogenesis | T Cell Exhaustion | Cardiovascular |
2175 | HIF1A | RNA | Angiogenesis | T Cell Exhaustion | Immuno-Oncology |
2176 | HIF3A | RNA | Cell Stress | Others | CNS |
2177 | HIKESHI | RNA | Others | Others | Others |
2178 | HILPDA | RNA | Others | Others | Others |
2179 | HIPK1 | RNA | Cell Proliferation | Others | CNS |
2180 | HIPK2 | RNA | Cell Proliferation | Others | CNS |
2181 | HIRA | RNA | Others | Others | Others |
2182 | HIST1H1C | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2183 | HIST1H1D | RNA | Others | Others | Others |
2184 | HIST1H2AC | RNA | Others | Others | Others |
2185 | HIST1H2AE | RNA | Others | Others | Others |
2186 | HIST1H2BD | RNA | Others | Others | Others |
2187 | HIST1H2BF | RNA | Others | Others | Others |
2188 | HIST1H2BH | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2189 | HIST1H2BK | RNA | Others | Others | Others |
2190 | HIST1H3B | RNA | Others | Others | Others |
2191 | HIST1H3G | RNA | Others | Others | Others |
2192 | HIST1H3H | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
2193 | HIST1H4E | RNA | Others | Others | Others |
2194 | HIST1H4H | RNA | Others | Others | Others |
2195 | HIST3H2BB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2196 | HJURP | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2197 | HK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2198 | HK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2199 | HK3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2200 | HKDC1 | RNA | Others | Others | Others |
2201 | HLA-A | RNA | Antigen Processing | Others | Immuno-Oncology |
2202 | HLA-B | RNA | Antigen Processing | Others | Immuno-Oncology |
2203 | HLA-C | RNA | Antigen Processing | Others | Immuno-Oncology |
2204 | HLA-DMA | RNA | Antigen Processing | Others | Immuno-Oncology |
2205 | HLA-DMB | RNA | Antigen Processing | Others | Immuno-Oncology |
2206 | HLA-DOA | RNA | Others | Others | Others |
2207 | HLA-DOB | RNA | Antigen Processing | Lymphoid Compartment | Immuno-Oncology |
2208 | HLA-DPA1 | RNA | Antigen Processing | Others | Immuno-Oncology |
2209 | HLA-DPB1 | RNA | Antigen Processing | Others | Immuno-Oncology |
2210 | HLA-DQA | RNA | Others | Others | Others |
2211 | HLA-DQA1 | RNA | Antigen Processing | Others | Immuno-Oncology |
2212 | HLA-DQA2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2213 | HLA-DQB1 | RNA | Antigen Processing | Others | Immuno-Oncology |
2214 | HLA-DQB2 | RNA | Others | Others | Others |
2215 | HLA-DRA | RNA | Antigen Processing | Others | Immuno-Oncology |
2216 | HLA-DRB | RNA | Others | Others | Others |
2217 | HLA-DRB1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2218 | HLA-DRB1/3 | RNA | Others | Others | Others |
2219 | HLA-DRB3 | RNA | Antigen Processing | Others | Immuno-Oncology |
2220 | HLA-DRB3/4 | RNA | Others | Others | Others |
2221 | HLA-DRB4 | RNA | Antigen Processing | Others | Immuno-Oncology |
2222 | HLA-DRB5 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2223 | HLA-E | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2224 | HLA-F | RNA | Interferon Signaling | Others | Immuno-Oncology |
2225 | HLA-G | RNA | Others | Others | Others |
2226 | HLX | RNA | Others | Others | Others |
2227 | HMGA1 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2228 | HMGA2 | RNA | Others | Others | Others |
2229 | HMGB1 | RNA | Apoptosis | Others | Oncology |
2230 | HMGB2 | RNA | Others | Others | Others |
2231 | HMGCR | RNA | Others | Others | Others |
2232 | HMGCS2 | RNA | Others | Others | Others |
2233 | HMGN1 | RNA | Others | Others | Others |
2234 | HMGN5 | RNA | Others | Others | Others |
2235 | HMOX1 | RNA | Angiogenesis | Others | Cardiovascular |
2236 | HNF1A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2237 | HNF4A | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2238 | HNRNPM | RNA | Others | Others | Others |
2239 | HOMER1 | RNA | Others | Neural Connectivity | CNS |
2240 | HOXA10 | RNA | Others | Others | Others |
2241 | HOXA11 | RNA | Others | Others | Others |
2242 | HOXA5 | RNA | Cell Proliferation | Others | CNS |
2243 | HOXA7 | RNA | Angiogenesis | Others | Cardiovascular |
2244 | HOXA9 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
2245 | HOXB13 | RNA | Angiogenesis | Others | Cardiovascular |
2246 | HOXB3 | RNA | Angiogenesis | Others | Cardiovascular |
2247 | HPD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2248 | HPGD | RNA | Others | Others | Others |
2249 | HPGDS | RNA | Lipid Metabolism | Others | Metabolic Diseases |
2250 | HPRT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2251 | HPS4 | RNA | Others | Others | Others |
2252 | HPSE | RNA | Cellular Differentiation | Others | Oncology |
2253 | HRAS | RNA | Autophagy | Transmitter Release | Cardiovascular |
2254 | HRAS | RNA | Autophagy | Transmitter Release | CNS |
2255 | HRK | RNA | Others | Others | Others |
2256 | HSBP1 | RNA | Others | Others | Others |
2257 | HSD11B1 | RNA | Others | Others | Others |
2258 | HSD17B12 | RNA | Others | Others | Others |
2259 | HSD17B4 | RNA | Others | Others | Others |
2260 | HSD17B8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2261 | HSF1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2262 | HSF2 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2263 | HSH2D | RNA | Others | Others | Others |
2264 | HSP90AA1 | RNA | Others | Others | Others |
2265 | HSP90AB1 | RNA | Others | Others | Others |
2266 | HSP90B1 | RNA | Cellular Differentiation | Others | Oncology |
2267 | HSPA1A | RNA | Others | Others | Others |
2268 | HSPA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2269 | HSPA4 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2270 | HSPA6 | RNA | Others | Others | Others |
2271 | HSPA9 | RNA | Others | Others | Others |
2272 | HSPB1 | RNA | Cellular Differentiation | Others | Oncology |
2273 | HSPB2 | RNA | Others | Others | Others |
2274 | HSPE1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2275 | HSPG2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2276 | HTR1A | RNA | Transmitter Synthesis | Transmitter Release | CNS |
2277 | HTR5A | RNA | Others | Transmitter Release | CNS |
2278 | HTRA2 | RNA | Oxydative Stress | Others | Inflammation |
2279 | HTT | RNA | Others | Neural Connectivity | CNS |
2280 | HUNK | RNA | Cellular Differentiation | Others | Oncology |
2281 | HUS1 | RNA | Others | Others | Others |
2282 | HUWE1 | RNA | Others | Inflammation | Inflammation |
2283 | HVCN1 | RNA | Others | Others | Others |
2284 | IBSP | RNA | PI3K-AKT | Others | Oncology |
2285 | ICAM1 | RNA | Interferon Signaling | Others | Immuno-Oncology |
2286 | ICAM2 | RNA | Matrix Remodeling and Metastases | Others | CNS |
2287 | ICAM3 | RNA | Matrix Remodeling and Metastases | Others | CNS |
2288 | ICAM4 | RNA | Others | Others | Others |
2289 | ICAM5 | RNA | Others | Others | Others |
2290 | ICOS | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
2291 | ICOSLG | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
2292 | ID1 | RNA | Angiogenesis | Others | Cardiovascular |
2293 | ID2 | RNA | Cell Proliferation | Others | CNS |
2294 | ID4 | RNA | Cell Proliferation | Others | CNS |
2295 | IDE | RNA | Amyloid Processing | Others | CNS |
2296 | IDH1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2297 | IDH2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2298 | IDH3A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2299 | IDH3B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2300 | IDH3G | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2301 | IDNK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2302 | IDO1 | RNA | Biosynthesis and Anabolic Pathways | Lymphoid Compartment | CNS |
2303 | IDO1 | RNA | Biosynthesis and Anabolic Pathways | Lymphoid Compartment | Immuno-Oncology |
2304 | IDO2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2305 | IER3 | RNA | Others | Myeloid Compartment | CNS |
2306 | IFI16 | RNA | Cytotoxicity | Others | Oncology |
2307 | IFI27 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2308 | IFI27 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2309 | IFI30 | RNA | Others | Others | Others |
2310 | IFI35 | RNA | Cytotoxicity | Others | Oncology |
2311 | IFI44 | RNA | Others | Others | Others |
2312 | IFI44L | RNA | Others | Others | Others |
2313 | IFI6 | RNA | Cytotoxicity | Others | Oncology |
2314 | IFIH1 | RNA | Cytotoxicity | Others | Oncology |
2315 | IFIT1 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2316 | IFIT1 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2317 | IFIT2 | RNA | Cytotoxicity | Others | Oncology |
2318 | IFIT3 | RNA | Cytotoxicity | Others | Oncology |
2319 | IFITM1 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2320 | IFITM1 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2321 | IFITM2 | RNA | Cytotoxicity | Others | Oncology |
2322 | IFITM3 | RNA | Others | Others | Others |
2323 | IFNA1 | RNA | Interferon Signaling | Interleukins | Immuno-Oncology |
2324 | IFNA1 | RNA | Interferon Signaling | Interleukins | Inflammation |
2325 | IFNA1/13 | RNA | Others | Others | Others |
2326 | IFNA14/16 | RNA | Others | Others | Others |
2327 | IFNA17 | RNA | Others | Interleukins | Inflammation |
2328 | IFNA2 | RNA | Others | Interleukins | Inflammation |
2329 | IFNA4/7/10/17/21 | RNA | Others | Others | Others |
2330 | IFNA5 | RNA | Others | Others | Others |
2331 | IFNA6 | RNA | Others | Others | Others |
2332 | IFNA7 | RNA | Others | Interleukins | Inflammation |
2333 | IFNA7/17 | RNA | Others | Others | Others |
2334 | IFNA8 | RNA | Others | Interleukins | Inflammation |
2335 | IFNAR1 | RNA | Interferon Signaling | Others | Immuno-Oncology |
2336 | IFNAR2 | RNA | Others | Others | Others |
2337 | IFNB1 | RNA | Others | Others | Others |
2338 | IFNG | RNA | Cell Proliferation | Interleukins | CNS |
2339 | IFNG | RNA | Cell Proliferation | Interleukins | Inflammation |
2340 | IFNGR1 | RNA | Hypoxia | M1 Activation | Cardiovascular |
2341 | IFNGR1 | RNA | Hypoxia | M1 Activation | CNS |
2342 | IFNGR2 | RNA | Hypoxia | Others | Cardiovascular |
2343 | IFNK | RNA | Others | Others | Others |
2344 | IFNL1 | RNA | Others | Interleukins | Inflammation |
2345 | IFNL2 | RNA | Others | Others | Others |
2346 | IFNL2/3 | RNA | Others | Others | Others |
2347 | IFNL4 | RNA | Others | Others | Others |
2348 | IFNLR1 | RNA | Others | Others | Others |
2349 | IFNW1 | RNA | Others | Others | Others |
2350 | IFT140 | RNA | ER Signaling | Others | Oncology |
2351 | IGF1 | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake | CNS |
2352 | IGF1R | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake | CNS |
2353 | IGF2R | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2354 | IGF2R | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2355 | IGFBP3 | RNA | HIF1 Signaling | Others | Inflammation |
2356 | IGFBP4 | RNA | Cell Proliferation | Others | CNS |
2357 | IGFBP7 | RNA | Cell Proliferation | Others | CNS |
2358 | IGHA1 | RNA | Others | Others | Others |
2359 | IGHD | RNA | Others | Others | Others |
2360 | IGHG1 | RNA | Others | Others | Others |
2361 | IGHG2 | RNA | Others | Others | Others |
2362 | IGHG3 | RNA | Others | Others | Others |
2363 | IGHG4 | RNA | Others | Others | Others |
2364 | IGHM | RNA | Others | Others | Others |
2365 | IGHV4-59 | RNA | Others | Others | Others |
2366 | IGKC | RNA | Others | Others | Others |
2367 | IGLC1 | RNA | Others | Others | Others |
2368 | IGLL1 | RNA | Others | Others | Others |
2369 | IGSF10 | RNA | Others | Others | Others |
2370 | IGSF6 | RNA | Others | Others | Others |
2371 | IHH | RNA | Hedgehog | Others | CNS |
2372 | IKBKAP | RNA | Others | Others | Others |
2373 | IKBKB | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2374 | IKBKE | RNA | Others | Others | Others |
2375 | IKBKG | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2376 | IKZF1 | RNA | Others | Others | Others |
2377 | IKZF2 | RNA | Others | Others | Others |
2378 | IKZF3 | RNA | Angiogenesis | Others | Cardiovascular |
2379 | IKZF4 | RNA | Others | Others | Others |
2380 | IL10 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
2381 | IL10 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
2382 | IL10RA | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2383 | IL10RB | RNA | Others | Others | Others |
2384 | IL11 | RNA | Cell Proliferation | Interleukins | CNS |
2385 | IL11 | RNA | Cell Proliferation | Interleukins | Inflammation |
2386 | IL11RA | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2387 | IL12A | RNA | Others | Interleukins | Inflammation |
2388 | IL12B | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
2389 | IL12B | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
2390 | IL12RB1 | RNA | Interleukin Signaling | NK Cell Function | Immuno-Oncology |
2391 | IL12RB2 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
2392 | IL13 | RNA | Others | Interleukins | Inflammation |
2393 | IL13RA1 | RNA | Others | Others | Others |
2394 | IL13RA2 | RNA | Others | Others | Others |
2395 | IL15 | RNA | Cell Proliferation | Interleukins | CNS |
2396 | IL15 | RNA | Cell Proliferation | Interleukins | Inflammation |
2397 | IL15RA | RNA | Interleukin Signaling | Others | Immuno-Oncology |
2398 | IL16 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
2399 | IL16 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
2400 | IL17A | RNA | Costimulatory Signaling | Interleukins | Immuno-Oncology |
2401 | IL17A | RNA | Costimulatory Signaling | Interleukins | Inflammation |
2402 | IL17B | RNA | Others | Interleukins | Inflammation |
2403 | IL17C | RNA | Others | Others | Others |
2404 | IL17D | RNA | Others | Others | Others |
2405 | IL17F | RNA | Others | Interleukins | Inflammation |
2406 | IL17RA | RNA | Others | Others | Others |
2407 | IL17RB | RNA | Others | Others | Others |
2408 | IL17RC | RNA | Others | Others | Others |
2409 | IL17RD | RNA | Others | Others | Others |
2410 | IL17RE | RNA | Others | Others | Others |
2411 | IL18 | RNA | Angiogenesis | Interleukins | Cardiovascular |
2412 | IL18 | RNA | Angiogenesis | Interleukins | Inflammation |
2413 | IL18BP | RNA | Others | Others | Others |
2414 | IL18R1 | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
2415 | IL18RAP | RNA | Others | NK Cell Function | Immuno-Oncology |
2416 | IL19 | RNA | Others | Interleukins | Inflammation |
2417 | IL1A | RNA | Cell Proliferation | Interleukins | CNS |
2418 | IL1A | RNA | Cell Proliferation | Interleukins | Inflammation |
2419 | IL1B | RNA | Cell Proliferation | Interleukins | CNS |
2420 | IL1B | RNA | Cell Proliferation | Interleukins | Inflammation |
2421 | IL1F10 | RNA | Others | Others | Others |
2422 | IL1R1 | RNA | Oxydative Stress | Neural Connectivity | Inflammation |
2423 | IL1R1 | RNA | Oxydative Stress | Neural Connectivity | CNS |
2424 | IL1R2 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2425 | IL1RAP | RNA | Others | Others | Others |
2426 | IL1RAPL1 | RNA | Others | Others | Others |
2427 | IL1RAPL2 | RNA | Others | Others | Others |
2428 | IL1RL1 | RNA | Others | Others | Others |
2429 | IL1RL2 | RNA | Others | Others | Others |
2430 | IL1RN | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
2431 | IL1RN | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
2432 | IL2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2433 | IL20 | RNA | Others | Others | Others |
2434 | IL20RA | RNA | JAK-STAT | Others | CNS |
2435 | IL20RB | RNA | JAK-STAT | Others | CNS |
2436 | IL21 | RNA | Others | Interleukins | Inflammation |
2437 | IL21R | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2438 | IL22 | RNA | Others | Others | Others |
2439 | IL22RA1 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2440 | IL22RA2 | RNA | Interleukin Signaling | Others | Immuno-Oncology |
2441 | IL23A | RNA | Others | Interleukins | Inflammation |
2442 | IL23R | RNA | Others | Others | Others |
2443 | IL24 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
2444 | IL24 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
2445 | IL25 | RNA | Others | Interleukins | Inflammation |
2446 | IL26 | RNA | Others | Interleukins | Inflammation |
2447 | IL27 | RNA | Others | Interleukins | Inflammation |
2448 | IL27RA | RNA | Interleukin Signaling | Others | Immuno-Oncology |
2449 | IL28A | RNA | Others | Others | Others |
2450 | IL28A/B | RNA | Others | Others | Others |
2451 | IL29 | RNA | Others | Others | Others |
2452 | IL2RA | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2453 | IL2RB | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2454 | IL2RG | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
2455 | IL3 | RNA | Others | Others | Others |
2456 | IL31 | RNA | Others | Others | Others |
2457 | IL31RA | RNA | Others | Others | Others |
2458 | IL32 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
2459 | IL32 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
2460 | IL33 | RNA | Cytokine and Chemokine Signaling | M2 Activation | Immuno-Oncology |
2461 | IL33 | RNA | Cytokine and Chemokine Signaling | M2 Activation | CNS |
2462 | IL34 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
2463 | IL34 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
2464 | IL36A | RNA | Others | Others | Others |
2465 | IL36B | RNA | Others | Others | Others |
2466 | IL36G | RNA | Others | Others | Others |
2467 | IL36RN | RNA | Others | Others | Others |
2468 | IL37 | RNA | Others | Others | Others |
2469 | IL3RA | RNA | Interleukin Signaling | Others | Immuno-Oncology |
2470 | IL4 | RNA | Costimulatory Signaling | M2 Activation | Immuno-Oncology |
2471 | IL4 | RNA | Costimulatory Signaling | M2 Activation | CNS |
2472 | IL4I1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2473 | IL4R | RNA | Interleukin Signaling | Others | Immuno-Oncology |
2474 | IL5 | RNA | TCR Signaling | Others | Immuno-Oncology |
2475 | IL5RA | RNA | Others | Others | Others |
2476 | IL6 | RNA | Cell Proliferation | M2 Activation | CNS |
2477 | IL6R | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2478 | IL6ST | RNA | Interleukin Signaling | Others | Immuno-Oncology |
2479 | IL7 | RNA | Interleukin Signaling | Others | Immuno-Oncology |
2480 | IL7R | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2481 | IL8 | RNA | Others | Others | Others |
2482 | IL9 | RNA | Others | Others | Others |
2483 | IL9R | RNA | Interleukin Signaling | Others | Immuno-Oncology |
2484 | ILF3 | RNA | Others | Others | Others |
2485 | ILK | RNA | Cell Proliferation | Others | CNS |
2486 | IMPDH1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2487 | IMPDH2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2488 | INA | RNA | Others | Neuronal Cytoskeleton | CNS |
2489 | INHBA | RNA | Cell Proliferation | Others | CNS |
2490 | INHBB | RNA | TGF Beta Signaling | Others | Oncology |
2491 | INHBE | RNA | Others | Others | Others |
2492 | INMT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2493 | INPP4A | RNA | Others | Others | Others |
2494 | INPP5D | RNA | Others | Others | Others |
2495 | INPP5F | RNA | Others | Others | Others |
2496 | INPPL1 | RNA | Others | Others | Others |
2497 | INS | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake | CNS |
2498 | INSR | RNA | Carbohydrate Metabolism | Neural Connectivity | CNS |
2499 | IPCEF1 | RNA | Oxydative Stress | Others | Inflammation |
2500 | IQGAP1 | RNA | Others | Others | Others |
2501 | IQSEC1 | RNA | Others | Others | Others |
2502 | IRAK1 | RNA | Others | Others | Others |
2503 | IRAK2 | RNA | Others | Others | Others |
2504 | IRAK3 | RNA | Others | Others | Others |
2505 | IRAK4 | RNA | Others | Others | Others |
2506 | IRF1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
2507 | IRF1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
2508 | IRF2 | RNA | Interferon Signaling | Others | Immuno-Oncology |
2509 | IRF3 | RNA | Interferon Signaling | Others | Immuno-Oncology |
2510 | IRF4 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2511 | IRF4 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2512 | IRF5 | RNA | Others | Others | Others |
2513 | IRF6 | RNA | Cell Proliferation | Others | CNS |
2514 | IRF7 | RNA | Others | Others | Others |
2515 | IRF8 | RNA | Others | Others | Others |
2516 | IRF9 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2517 | IRF9 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2518 | IRGM | RNA | Others | Others | Others |
2519 | IRS1 | RNA | Others | Others | Others |
2520 | IRX1 | RNA | Others | Others | Others |
2521 | ISG15 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
2522 | ISG15 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
2523 | ISG20 | RNA | Others | Others | Others |
2524 | ISL1 | RNA | Cell Proliferation | Others | CNS |
2525 | ISLR | RNA | Others | Others | Others |
2526 | ISLR2 | RNA | Others | Others | Others |
2527 | ISM1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2528 | ITCH | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
2529 | ITGA1 | RNA | ECM Remodeling | Lymphoid Compartment | Metabolic Diseases |
2530 | ITGA1 | RNA | ECM Remodeling | Lymphoid Compartment | Immuno-Oncology |
2531 | ITGA10 | RNA | Others | Others | Others |
2532 | ITGA11 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2533 | ITGA2 | RNA | Cellular Differentiation | Others | Oncology |
2534 | ITGA2B | RNA | Others | Others | Others |
2535 | ITGA3 | RNA | Others | Others | Others |
2536 | ITGA4 | RNA | Matrix Remodeling and Metastases | Others | CNS |
2537 | ITGA5 | RNA | Angiogenesis | Neural Connectivity | Cardiovascular |
2538 | ITGA5 | RNA | Angiogenesis | Neural Connectivity | CNS |
2539 | ITGA6 | RNA | Matrix Remodeling and Metastases | Others | CNS |
2540 | ITGA7 | RNA | Others | Others | Others |
2541 | ITGA8 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2542 | ITGA9 | RNA | Others | Others | Others |
2543 | ITGAE | RNA | Matrix Remodeling and Metastases | Others | CNS |
2544 | ITGAL | RNA | Matrix Remodeling and Metastases | Others | CNS |
2545 | ITGAM | RNA | Matrix Remodeling and Metastases | Myeloid Compartment | CNS |
2546 | ITGAV | RNA | Androgen Signaling | Others | Oncology |
2547 | ITGAX | RNA | ECM Remodeling | Myeloid Compartment | Metabolic Diseases |
2548 | ITGAX | RNA | ECM Remodeling | Myeloid Compartment | CNS |
2549 | ITGB1 | RNA | Cell Proliferation | Others | CNS |
2550 | ITGB1BP1 | RNA | Others | Others | Others |
2551 | ITGB2 | RNA | Cellular Differentiation | Others | Oncology |
2552 | ITGB3 | RNA | Angiogenesis | Others | Cardiovascular |
2553 | ITGB4 | RNA | Others | Others | Others |
2554 | ITGB5 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2555 | ITGB6 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2556 | ITGB7 | RNA | Others | Others | Others |
2557 | ITGB8 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2558 | ITK | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2559 | ITLN1 | RNA | Others | Others | Others |
2560 | ITLN2 | RNA | Others | Others | Others |
2561 | ITM2A | RNA | Others | Others | Others |
2562 | ITPK1 | RNA | Angiogenesis | Others | Cardiovascular |
2563 | ITPR1 | RNA | ER Signaling | Neural Connectivity | Oncology |
2564 | ITPR1 | RNA | ER Signaling | Neural Connectivity | CNS |
2565 | ITPR2 | RNA | Adenosine Pathway | Transmitter Release | Immuno-Oncology |
2566 | ITPR2 | RNA | Adenosine Pathway | Transmitter Release | CNS |
2567 | ITPR3 | RNA | Others | Transmitter Release | CNS |
2568 | JADE1 | RNA | Others | Others | Others |
2569 | JAG1 | RNA | Angiogenesis | Others | Cardiovascular |
2570 | JAG2 | RNA | Notch | Others | Immuno-Oncology |
2571 | JAK1 | RNA | Cytotoxicity | Others | Oncology |
2572 | JAK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2573 | JAK3 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
2574 | JAM2 | RNA | EMT | Others | Oncology |
2575 | JAM3 | RNA | Angiogenesis | Others | Cardiovascular |
2576 | JAML | RNA | Others | Others | Others |
2577 | JARID2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2578 | JCAD | RNA | EMT | Others | Oncology |
2579 | JMJD1C | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2580 | JMJD4 | RNA | Others | Others | Others |
2581 | JUN | RNA | Angiogenesis | Transmitter Response and Reuptake | Cardiovascular |
2582 | JUN | RNA | Angiogenesis | Transmitter Response and Reuptake | CNS |
2583 | JUNB | RNA | AP1 Signaling | Others | Cardiovascular |
2584 | JUND | RNA | AP1 Signaling | Others | Cardiovascular |
2585 | JUP | RNA | Others | Others | Others |
2586 | KANSL1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2587 | KAT2A | RNA | Others | Others | Others |
2588 | KAT2B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2589 | KAT6A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2590 | KAT6B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2591 | KATNA1 | RNA | Others | Neuronal Cytoskeleton | CNS |
2592 | KBTBD8 | RNA | Others | Others | Others |
2593 | KCNA1 | RNA | Others | Neural Connectivity | CNS |
2594 | KCNB1 | RNA | DNA Damage Repair | Neural Connectivity | Epigenic and Nuclear Signaling |
2595 | KCNB1 | RNA | DNA Damage Repair | Neural Connectivity | CNS |
2596 | KCND1 | RNA | Others | Others | Others |
2597 | KCNJ10 | RNA | Myelination | Neural Connectivity | CNS |
2598 | KCNJ2 | RNA | Others | Others | Others |
2599 | KCNJ8 | RNA | Others | Others | Others |
2600 | KCNK13 | RNA | Others | Others | Others |
2601 | KCNK2 | RNA | Others | Others | Others |
2602 | KDM1A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2603 | KDM1B | RNA | Others | Others | Others |
2604 | KDM2A | RNA | Others | Others | Others |
2605 | KDM2B | RNA | Others | Others | Others |
2606 | KDM3A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2607 | KDM3B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2608 | KDM4A | RNA | Others | Others | Others |
2609 | KDM4B | RNA | Others | Others | Others |
2610 | KDM4C | RNA | Others | Others | Others |
2611 | KDM4D | RNA | Others | Others | Others |
2612 | KDM5A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2613 | KDM5B | RNA | Others | Others | Others |
2614 | KDM5C | RNA | Others | Others | Others |
2615 | KDM5D | RNA | Others | Others | Others |
2616 | KDM6A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2617 | KDM6B | RNA | Others | Others | Others |
2618 | KDR | RNA | Angiogenesis | Others | Cardiovascular |
2619 | KEAP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2620 | KEL | RNA | Myelination | Others | CNS |
2621 | KIAA0040 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2622 | KIAA1161 | RNA | Others | Others | Others |
2623 | KIAA1462 | RNA | Others | Others | Others |
2624 | KIF11 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2625 | KIF14 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2626 | KIF20A | RNA | Cell Cycle | Others | Oncology |
2627 | KIF22 | RNA | Others | Others | Others |
2628 | KIF23 | RNA | Cell Cycle | Others | Oncology |
2629 | KIF2C | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2630 | KIF3A | RNA | Others | Neural Connectivity | CNS |
2631 | KIFC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2632 | KIR Family | RNA | Others | Others | Others |
2633 | KIR_Activating_Subgroup_1 | RNA | Others | NK Cell Function | Immuno-Oncology |
2634 | KIR_Activating_Subgroup_2 | RNA | Others | NK Cell Function | Immuno-Oncology |
2635 | KIR_Inhibiting_Subgroup_1 | RNA | Others | NK Cell Function | Immuno-Oncology |
2636 | KIR_Inhibiting_Subgroup_2 | RNA | Others | NK Cell Function | Immuno-Oncology |
2637 | KIR2DL1 | RNA | Others | Others | Others |
2638 | KIR2DL1/2 | RNA | Others | Others | Others |
2639 | KIR2DL3 | RNA | Cytotoxicity | Others | Oncology |
2640 | KIR2DL3/4 | RNA | Others | Others | Others |
2641 | KIR2DL4 | RNA | Others | Others | Others |
2642 | KIR2DL5A/B | RNA | Others | Others | Others |
2643 | KIR2DS1/4 | RNA | Others | Others | Others |
2644 | KIR2DS4 | RNA | Others | Others | Others |
2645 | KIR3DL1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
2646 | KIR3DL1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
2647 | KIR3DL1/2 | RNA | Others | Others | Others |
2648 | KIR3DL1/3 | RNA | Others | Others | Others |
2649 | KIR3DL2 | RNA | Cytotoxicity | NK Cell Function | Oncology |
2650 | KIR3DL2 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
2651 | KIR3DL3 | RNA | Others | NK Cell Function | Immuno-Oncology |
2652 | KISS1 | RNA | Cell Proliferation | Others | CNS |
2653 | KIT | RNA | MAPK | Others | Cardiovascular |
2654 | KITLG | RNA | RAS | Others | Oncology |
2655 | KLC1 | RNA | Others | Others | Others |
2656 | KLF2 | RNA | Others | Others | Others |
2657 | KLF4 | RNA | Others | Others | Others |
2658 | KLF5 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2659 | KLK2 | RNA | Androgen Signaling | Others | Oncology |
2660 | KLK3 | RNA | Androgen Signaling | Others | Oncology |
2661 | KLK4 | RNA | Androgen Signaling | Others | Oncology |
2662 | KLK6 | RNA | Myelination | Others | CNS |
2663 | KLKB1 | RNA | Others | Others | Others |
2664 | KLRAP1 | RNA | Others | Others | Others |
2665 | KLRB1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
2666 | KLRB1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
2667 | KLRC1 | RNA | Others | NK Cell Function | Immuno-Oncology |
2668 | KLRC1/2 | RNA | Others | Others | Others |
2669 | KLRC2 | RNA | Others | NK Cell Function | Immuno-Oncology |
2670 | KLRC2/3 | RNA | Others | Others | Others |
2671 | KLRC3 | RNA | Others | Others | Others |
2672 | KLRC4 | RNA | Others | Others | Others |
2673 | KLRD1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
2674 | KLRD1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
2675 | KLRF1 | RNA | Others | NK Cell Function | Immuno-Oncology |
2676 | KLRF2 | RNA | Others | Others | Others |
2677 | KLRG1 | RNA | Others | NK Cell Function | Immuno-Oncology |
2678 | KLRG2 | RNA | Others | Others | Others |
2679 | KLRK1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
2680 | KLRK1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
2681 | KMO | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2682 | KMT2A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2683 | KMT2C | RNA | Others | Others | Others |
2684 | KMT2D | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2685 | KMT2E | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2686 | KNG1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2687 | KPNA2 | RNA | Cell Stress | Others | CNS |
2688 | KPNB1 | RNA | Others | Others | Others |
2689 | KRAS | RNA | Autophagy | Transmitter Release | Cardiovascular |
2690 | KRAS | RNA | Autophagy | Transmitter Release | CNS |
2691 | KRIT1 | RNA | Angiogenesis | Others | Cardiovascular |
2692 | KRT1 | RNA | Cell Stress | Others | CNS |
2693 | KRT10 | RNA | Others | Others | Others |
2694 | KRT14 | RNA | Cellular Differentiation | Others | Oncology |
2695 | KRT16 | RNA | Others | Others | Others |
2696 | KRT17 | RNA | Others | Others | Others |
2697 | KRT18 | RNA | Others | Others | Others |
2698 | KRT19 | RNA | Others | Others | Others |
2699 | KRT5 | RNA | Others | Others | Others |
2700 | KRT6A/B/C | RNA | Others | Others | Others |
2701 | KRT6B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2702 | KRT7 | RNA | EMT | Others | Oncology |
2703 | KYAT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2704 | KYAT3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2705 | KYNU | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2706 | L1CAM | RNA | Others | Others | Others |
2707 | L2HGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2708 | LACC1 | RNA | Others | Others | Others |
2709 | LAD1 | RNA | EMT | Others | Oncology |
2710 | LAG3 | RNA | Costimulatory Signaling | T Cell Activation | Immuno-Oncology |
2711 | LAIR1 | RNA | Others | Others | Others |
2712 | LAIR2 | RNA | Others | Others | Others |
2713 | LAMA1 | RNA | Matrix Remodeling and Metastases | Others | CNS |
2714 | LAMA2 | RNA | ECM Remodeling | Neural Connectivity | Metabolic Diseases |
2715 | LAMA2 | RNA | ECM Remodeling | Neural Connectivity | CNS |
2716 | LAMA3 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
2717 | LAMA4 | RNA | Cellular Differentiation | Others | Oncology |
2718 | LAMA5 | RNA | Angiogenesis | Others | Cardiovascular |
2719 | LAMB1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2720 | LAMB2 | RNA | Others | Neural Connectivity | CNS |
2721 | LAMB3 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2722 | LAMB4 | RNA | Others | Others | Others |
2723 | LAMC1 | RNA | Cell Proliferation | Others | CNS |
2724 | LAMC2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2725 | LAMC3 | RNA | Others | Others | Others |
2726 | LAMP1 | RNA | Others | Neural Connectivity | CNS |
2727 | LAMP2 | RNA | Others | Others | Others |
2728 | LAMP3 | RNA | Others | Others | Others |
2729 | LAMTOR1 | RNA | mTOR Signaling | Others | Oncology |
2730 | LAMTOR2 | RNA | mTOR Signaling | Others | Oncology |
2731 | LAMTOR3 | RNA | Others | Others | Others |
2732 | LAMTOR4 | RNA | mTOR Signaling | Others | Oncology |
2733 | LAMTOR5 | RNA | mTOR Signaling | Others | Oncology |
2734 | LANCL1 | RNA | Others | Others | Others |
2735 | LAT | RNA | RAS | Others | Oncology |
2736 | LAT2 | RNA | Others | Others | Others |
2737 | LATS1 | RNA | Hippo Signaling | Others | CNS |
2738 | LATS2 | RNA | Others | Others | Others |
2739 | LBP | RNA | Others | Others | Others |
2740 | LCK | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2741 | LCLAT1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
2742 | LCN2 | RNA | Others | Others | Others |
2743 | LCOR | RNA | Others | Others | Others |
2744 | LCP1 | RNA | Others | Others | Others |
2745 | LCP2 | RNA | TCR Signaling | Others | Immuno-Oncology |
2746 | LDHA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2747 | LDHAL6A | RNA | Others | Others | Others |
2748 | LDHB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2749 | LDHC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2750 | LDLRAD3 | RNA | Others | Others | Others |
2751 | LDLRAP1 | RNA | Others | Others | Others |
2752 | LEF1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2753 | LEFTY1 | RNA | Others | Others | Others |
2754 | LEFTY1/2 | RNA | Others | Others | Others |
2755 | LEFTY2 | RNA | TGF Beta Signaling | Others | Oncology |
2756 | LEMD1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2757 | LEP | RNA | JAK-STAT | Others | CNS |
2758 | LEPR | RNA | JAK-STAT | Others | CNS |
2759 | LFNG | RNA | Notch | Others | Immuno-Oncology |
2760 | LGALS1 | RNA | Others | Others | Others |
2761 | LGALS3 | RNA | Others | Others | Others |
2762 | LGALS9 | RNA | Others | Others | Others |
2763 | LGMN | RNA | Others | Others | Others |
2764 | LGR5 | RNA | Others | Others | Others |
2765 | LHFP | RNA | Others | Others | Others |
2766 | LIF | RNA | Cytotoxicity | Others | Oncology |
2767 | LIFR | RNA | Cell Proliferation | Others | CNS |
2768 | LIG1 | RNA | Cell Cycle | Others | Oncology |
2769 | LIG4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2770 | LILRA1 | RNA | Others | Others | Others |
2771 | LILRA2 | RNA | Others | Others | Others |
2772 | LILRA3 | RNA | Others | Others | Others |
2773 | LILRA4 | RNA | Others | Others | Others |
2774 | LILRA5 | RNA | Others | Others | Others |
2775 | LILRA6 | RNA | Others | Others | Others |
2776 | LILRB1 | RNA | Others | NK Cell Function | Immuno-Oncology |
2777 | LILRB2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2778 | LILRB3 | RNA | Others | Others | Others |
2779 | LILRB4 | RNA | Others | Others | Others |
2780 | LILRB5 | RNA | Others | Others | Others |
2781 | LIMK1 | RNA | Others | Others | Others |
2782 | LIMK2 | RNA | Others | Others | Others |
2783 | LIN9 | RNA | Cell Cycle | Others | Oncology |
2784 | LINC02381 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2785 | LINGO1 | RNA | Others | Others | Others |
2786 | LIPA | RNA | Others | Others | Others |
2787 | LIPC | RNA | Others | Others | Others |
2788 | LIPG | RNA | Others | Others | Others |
2789 | LITAF | RNA | Others | Others | Others |
2790 | LLGL2 | RNA | Others | Others | Others |
2791 | LMNA | RNA | Others | Others | Others |
2792 | LMNB1 | RNA | Others | Others | Others |
2793 | LNX1 | RNA | Others | Others | Others |
2794 | LOX | RNA | Collagen Biosynthesis & Modification | Others | CNS |
2795 | LOXL1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
2796 | LOXL2 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
2797 | LOXL4 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
2798 | LPA | RNA | Others | Others | Others |
2799 | LPAR1 | RNA | Myelination | Neural Connectivity | CNS |
2800 | LPAR5 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2801 | LPAR6 | RNA | Others | Others | Others |
2802 | LPCAT1 | RNA | Others | Others | Others |
2803 | LPIN1 | RNA | Others | Others | Others |
2804 | LPL | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2805 | LPO | RNA | Oxydative Stress | Others | Inflammation |
2806 | LRG1 | RNA | Others | Others | Others |
2807 | LRP1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2808 | LRP2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
2809 | LRP5 | RNA | Others | Others | Others |
2810 | LRP6 | RNA | Others | Others | Others |
2811 | LRR1 | RNA | Others | Others | Others |
2812 | LRRC25 | RNA | Others | Others | Others |
2813 | LRRC3 | RNA | Others | Others | Others |
2814 | LRRC32 | RNA | Others | Others | Others |
2815 | LRRC4 | RNA | Others | Neural Connectivity | CNS |
2816 | LRRC41 | RNA | Others | Others | Others |
2817 | LRRK2 | RNA | Epigenic and Transcriptional Regulation | Neural Connectivity | Epigenic and Nuclear Signaling |
2818 | LRRK2 | RNA | Epigenic and Transcriptional Regulation | Neural Connectivity | CNS |
2819 | LRRN3 | RNA | Others | Others | Others |
2820 | LSM2 | RNA | Others | Others | Others |
2821 | LSM7 | RNA | Others | Others | Others |
2822 | LSR | RNA | Lipid Metabolism | Others | Metabolic Diseases |
2823 | LST1 | RNA | Others | Others | Others |
2824 | LTA | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2825 | LTA4H | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2826 | LTB | RNA | NF-kappaB Signaling | Others | CNS |
2827 | LTB4R | RNA | Others | Others | Others |
2828 | LTB4R2 | RNA | Others | Others | Others |
2829 | LTBP1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
2830 | LTBP4 | RNA | Cellular Differentiation | Others | Oncology |
2831 | LTBR | RNA | HIF1 Signaling | Others | Inflammation |
2832 | LTC4S | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2833 | LTF | RNA | Others | Others | Others |
2834 | LTK | RNA | Others | Others | Others |
2835 | LUM | RNA | Others | Others | Others |
2836 | LY6E | RNA | Others | Others | Others |
2837 | LY86 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2838 | LY9 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2839 | LY96 | RNA | Apoptosis | Others | Oncology |
2840 | LYN | RNA | Others | Others | Others |
2841 | LYPLA1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
2842 | LYZ | RNA | Others | Others | Others |
2843 | MAD2L1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2844 | MAD2L2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2845 | MAF | RNA | EMT | Others | Oncology |
2846 | MAFB | RNA | Others | Others | Others |
2847 | MAFF | RNA | Others | Others | Others |
2848 | MAFG | RNA | Others | Others | Others |
2849 | MAFK | RNA | Others | Others | Others |
2850 | MAG | RNA | Myelination | Others | CNS |
2851 | MAGEA1 | RNA | Others | Others | Others |
2852 | MAGEA12 | RNA | Others | Others | Others |
2853 | MAGEA3 | RNA | Others | Others | Others |
2854 | MAGEA3/A6 | RNA | Others | Others | Others |
2855 | MAGEA4 | RNA | Others | Others | Others |
2856 | MAGEB2 | RNA | Others | Others | Others |
2857 | MAGEC1 | RNA | Others | Others | Others |
2858 | MAGEC2 | RNA | Others | Others | Others |
2859 | MAGED1 | RNA | Others | Others | Others |
2860 | MAGEE1 | RNA | Others | Others | Others |
2861 | MAGI2 | RNA | Others | Others | Others |
2862 | MAL | RNA | Myelination | Others | CNS |
2863 | MALL | RNA | Others | Others | Others |
2864 | MALT1 | RNA | TCR Signaling | Others | Immuno-Oncology |
2865 | MAML1 | RNA | Others | Others | Others |
2866 | MAML2 | RNA | Notch | Others | Immuno-Oncology |
2867 | MAML3 | RNA | Others | Others | Others |
2868 | MAN2B1 | RNA | Others | Others | Others |
2869 | MAP1LC3A | RNA | Others | Others | Others |
2870 | MAP1LC3B | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
2871 | MAP2 | RNA | Others | Others | Others |
2872 | MAP2K1 | RNA | Nutrient Capture and Catabolic Pathways | Transmitter Release | Metabolic Diseases |
2873 | MAP2K1 | RNA | Nutrient Capture and Catabolic Pathways | Transmitter Release | CNS |
2874 | MAP2K2 | RNA | Nutrient Capture and Catabolic Pathways | Transmitter Response and Reuptake | Metabolic Diseases |
2875 | MAP2K2 | RNA | Nutrient Capture and Catabolic Pathways | Transmitter Response and Reuptake | CNS |
2876 | MAP2K3 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2877 | MAP2K4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2878 | MAP2K6 | RNA | Others | Others | Others |
2879 | MAP2K7 | RNA | Others | Others | Others |
2880 | MAP3K1 | RNA | Others | Others | Others |
2881 | MAP3K12 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
2882 | MAP3K13 | RNA | Others | Others | Others |
2883 | MAP3K14 | RNA | Others | Others | Others |
2884 | MAP3K20 | RNA | Others | Others | Others |
2885 | MAP3K3 | RNA | Others | Others | Others |
2886 | MAP3K5 | RNA | MAPK | Others | Cardiovascular |
2887 | MAP3K7 | RNA | Angiogenesis | Others | Cardiovascular |
2888 | MAP3K8 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
2889 | MAP3K9 | RNA | Others | Others | Others |
2890 | MAP4K1 | RNA | Others | Others | Others |
2891 | MAP4K2 | RNA | Others | Others | Others |
2892 | MAP4K4 | RNA | Others | Others | Others |
2893 | MAPK1 | RNA | Biosynthesis and Anabolic Pathways | Transmitter Release | CNS |
2894 | MAPK10 | RNA | AP1 Signaling | Transmitter Release | Cardiovascular |
2895 | MAPK10 | RNA | AP1 Signaling | Transmitter Release | CNS |
2896 | MAPK11 | RNA | AP1 Signaling | Others | Cardiovascular |
2897 | MAPK12 | RNA | Others | Others | Others |
2898 | MAPK13 | RNA | VEGFR Signaling | Others | Cardiovascular |
2899 | MAPK14 | RNA | AP1 Signaling | Others | Cardiovascular |
2900 | MAPK15 | RNA | Others | Others | Others |
2901 | MAPK3 | RNA | Cellular Differentiation | Transmitter Release | Oncology |
2902 | MAPK3 | RNA | Cellular Differentiation | Transmitter Release | CNS |
2903 | MAPK7 | RNA | Others | Others | Others |
2904 | MAPK8 | RNA | AP1 Signaling | Transmitter Release | Cardiovascular |
2905 | MAPK8 | RNA | AP1 Signaling | Transmitter Release | CNS |
2906 | MAPK8IP1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2907 | MAPK8IP2 | RNA | MAPK | Others | Cardiovascular |
2908 | MAPK9 | RNA | AP1 Signaling | Transmitter Release | Cardiovascular |
2909 | MAPK9 | RNA | AP1 Signaling | Transmitter Release | CNS |
2910 | MAPKAP1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2911 | MAPKAPK2 | RNA | Others | Others | Others |
2912 | MAPKAPK3 | RNA | Others | Others | Others |
2913 | MAPKAPK5 | RNA | Others | Others | Others |
2914 | MAPT | RNA | ER Signaling | Neuronal Cytoskeleton | Oncology |
2915 | MAPT | RNA | ER Signaling | Neuronal Cytoskeleton | CNS |
2916 | MARCKS | RNA | Others | Others | Others |
2917 | MARCO | RNA | Others | Others | Others |
2918 | MASP1 | RNA | Others | Others | Others |
2919 | MASP2 | RNA | Others | Others | Others |
2920 | MAT1A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2921 | MAT2A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2922 | MAVS | RNA | Others | Others | Others |
2923 | MAX | RNA | Others | Others | Others |
2924 | MB21D1 | RNA | Others | Others | Others |
2925 | MBD2 | RNA | Others | Others | Others |
2926 | MBD3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
2927 | MBL2 | RNA | Others | Others | Others |
2928 | MBNL1 | RNA | Others | Others | Others |
2929 | MBNL3 | RNA | Others | Others | Others |
2930 | MBP | RNA | Myelination | Vesicle Trafficking | CNS |
2931 | MBTPS2 | RNA | Others | Others | Others |
2932 | MCAM | RNA | Angiogenesis | Others | Cardiovascular |
2933 | MCAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2934 | MCL1 | RNA | Others | Others | Others |
2935 | MCM2 | RNA | Cell Cycle | Others | Oncology |
2936 | MCM3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2937 | MCM4 | RNA | Cell Cycle | Others | Oncology |
2938 | MCM5 | RNA | Others | Others | Others |
2939 | MCM6 | RNA | Others | Others | Others |
2940 | MCM7 | RNA | Others | Others | Others |
2941 | MDC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2942 | MDFIC | RNA | Others | Others | Others |
2943 | MDH2 | RNA | Others | Others | Others |
2944 | MDM2 | RNA | Cell Cycle | Others | Oncology |
2945 | MDM4 | RNA | Others | Others | Others |
2946 | ME2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2947 | MEAF6 | RNA | Others | Others | Others |
2948 | MECOM | RNA | Others | Others | Others |
2949 | MECP2 | RNA | Others | Vesicle Trafficking | CNS |
2950 | MED1 | RNA | Angiogenesis | Others | Cardiovascular |
2951 | MED12 | RNA | Others | Others | Others |
2952 | MED23 | RNA | Others | Others | Others |
2953 | MEF2A | RNA | Others | Others | Others |
2954 | MEF2BNB-MEF2B | RNA | Others | Others | Others |
2955 | MEF2C | RNA | Others | Others | Others |
2956 | MEF2D | RNA | Others | Others | Others |
2957 | MEFV | RNA | Others | Others | Others |
2958 | MEG3 | RNA | Cell Proliferation | Others | CNS |
2959 | MELK | RNA | Proliferation | Others | Oncology |
2960 | MEN1 | RNA | Others | Others | Others |
2961 | MEOX2 | RNA | Angiogenesis | Others | Cardiovascular |
2962 | MERTK | RNA | Others | Others | Others |
2963 | MET | RNA | Cell Proliferation | Others | CNS |
2964 | MFAP3 | RNA | Others | Others | Others |
2965 | MFAP4 | RNA | Others | Others | Others |
2966 | MFGE8 | RNA | Others | Others | Others |
2967 | MFN2 | RNA | Others | Others | Others |
2968 | MFNG | RNA | Notch | Others | Immuno-Oncology |
2969 | MGA | RNA | Myc | Others | Oncology |
2970 | MGAM | RNA | Others | Others | Others |
2971 | MGAT5 | RNA | Others | Others | Others |
2972 | MGMT | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2973 | MGP | RNA | Others | Others | Others |
2974 | MGST3 | RNA | Cell Stress | Others | CNS |
2975 | MIA | RNA | Others | Others | Others |
2976 | MIB1 | RNA | Others | Others | Others |
2977 | MICA | RNA | Others | Others | Others |
2978 | MICB | RNA | Others | Others | Others |
2979 | MID1IP1 | RNA | Others | Others | Others |
2980 | MIF | RNA | Others | Others | Others |
2981 | MINOS1 | RNA | Others | Others | Others |
2982 | MIS18A | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2983 | MISP | RNA | Others | Others | Others |
2984 | MKI67 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
2985 | MKNK1 | RNA | Others | Others | Others |
2986 | MLANA | RNA | Others | Others | Others |
2987 | MLF1 | RNA | Others | Others | Others |
2988 | MLH1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2989 | MLKL | RNA | Others | Others | Others |
2990 | MLLT3 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
2991 | MLLT4 | RNA | RAS | Others | Oncology |
2992 | MLPH | RNA | Others | Others | Others |
2993 | MLST8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
2994 | MLXIPL | RNA | Others | Others | Others |
2995 | MLYCD | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
2996 | MME | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
2997 | MMP1 | RNA | Cellular Differentiation | Others | Oncology |
2998 | MMP10 | RNA | Matrix Remodeling and Metastases | Others | CNS |
2999 | MMP11 | RNA | Others | Others | Others |
3000 | MMP12 | RNA | Cell Proliferation | Others | CNS |
3001 | MMP13 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
3002 | MMP14 | RNA | Angiogenesis | Others | Cardiovascular |
3003 | MMP16 | RNA | Others | Others | Others |
3004 | MMP17 | RNA | Matrix Remodeling and Metastases | Others | CNS |
3005 | MMP19 | RNA | Others | Others | Others |
3006 | MMP2 | RNA | Angiogenesis | Others | Cardiovascular |
3007 | MMP24 | RNA | Cellular Differentiation | Others | Oncology |
3008 | MMP3 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3009 | MMP7 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
3010 | MMP8 | RNA | Others | Others | Others |
3011 | MMP9 | RNA | Angiogenesis | Others | Cardiovascular |
3012 | MMRN1 | RNA | Others | Others | Others |
3013 | MMRN2 | RNA | Angiogenesis | Others | Cardiovascular |
3014 | MMUT | RNA | Others | Others | Others |
3015 | MNAT1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3016 | MNDA | RNA | Others | Others | Others |
3017 | MNX1 | RNA | Others | Others | Others |
3018 | MOB1B | RNA | Others | Others | Others |
3019 | MOBP | RNA | Others | Others | Others |
3020 | MOG | RNA | Myelination | Others | CNS |
3021 | MPC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3022 | MPC2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3023 | MPDZ | RNA | Others | Others | Others |
3024 | MPEG1 | RNA | Others | Others | Others |
3025 | MPG | RNA | Others | Others | Others |
3026 | MPL | RNA | Others | Others | Others |
3027 | MPO | RNA | Cell Stress | Others | CNS |
3028 | MPPED1 | RNA | Others | Others | Others |
3029 | MPV17 | RNA | Others | Others | Others |
3030 | MPZ | RNA | Others | Vesicle Trafficking | CNS |
3031 | MPZL1 | RNA | Others | Others | Others |
3032 | MR1 | RNA | Antigen Processing | Others | Immuno-Oncology |
3033 | MRAS | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3034 | MRC1 | RNA | Others | Others | Others |
3035 | MRE11 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3036 | MRM2 | RNA | Others | Others | Others |
3037 | MRPL19 | RNA | Others | Others | Others |
3038 | MRPS5 | RNA | Others | Others | Others |
3039 | MRPS7 | RNA | Others | Others | Others |
3040 | MS4A1 | RNA | Others | Others | Others |
3041 | MS4A2 | RNA | Others | Others | Others |
3042 | MS4A4A | RNA | Others | Others | Others |
3043 | MS4A6A | RNA | Others | Others | Others |
3044 | MS4A7 | RNA | Others | Others | Others |
3045 | MSH2 | RNA | Cell Stress | Others | CNS |
3046 | MSH6 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3047 | MSLN | RNA | Others | Others | Others |
3048 | MSN | RNA | Others | Others | Others |
3049 | MSR1 | RNA | Others | Others | Others |
3050 | MSRA | RNA | Others | Others | Others |
3051 | MSRB2 | RNA | Cell Stress | Others | CNS |
3052 | MST1R | RNA | Others | Others | Others |
3053 | MT1G | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3054 | MT2A | RNA | Others | Others | Others |
3055 | MT3 | RNA | Cell Proliferation | Others | CNS |
3056 | MTA1 | RNA | Others | Others | Others |
3057 | MTA2 | RNA | Others | Others | Others |
3058 | MTBP | RNA | Cell Proliferation | Others | CNS |
3059 | MTCP1 | RNA | Others | Others | Others |
3060 | MTDH | RNA | Others | Others | Others |
3061 | MTF1 | RNA | Cell Stress | Others | CNS |
3062 | MTF2 | RNA | Others | Others | Others |
3063 | MTHFD1 | RNA | Others | Others | Others |
3064 | MTHFD1L | RNA | Others | Others | Others |
3065 | MTHFD2 | RNA | mTOR Signaling | Others | Oncology |
3066 | MTHFR | RNA | Others | Others | Others |
3067 | MTHFS | RNA | Others | Others | Others |
3068 | MTMR14 | RNA | Others | Others | Others |
3069 | MTMR3 | RNA | Others | Others | Others |
3070 | MTMR4 | RNA | Others | Others | Others |
3071 | MTOR | RNA | Autophagy | Others | Cardiovascular |
3072 | MTR | RNA | Others | Others | Others |
3073 | MUC1 | RNA | EMT | Others | Oncology |
3074 | MUC16 | RNA | Others | Others | Others |
3075 | MUC4 | RNA | Others | Others | Others |
3076 | MUC5B | RNA | Others | Others | Others |
3077 | MUS81 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3078 | MUTYH | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3079 | MVP | RNA | Others | Others | Others |
3080 | MX1 | RNA | Cytotoxicity | Others | Oncology |
3081 | MX2 | RNA | Others | Others | Others |
3082 | MXI1 | RNA | Others | Others | Others |
3083 | MYB | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3084 | MYBL1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3085 | MYBL2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3086 | MYC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3087 | MYCL | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3088 | MYCN | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3089 | MYCT1 | RNA | Angiogenesis | Others | Cardiovascular |
3090 | MYD88 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3091 | MYH10 | RNA | Others | Others | Others |
3092 | MYH11 | RNA | Others | Others | Others |
3093 | MYL2 | RNA | Others | Others | Others |
3094 | MYL9 | RNA | Others | Others | Others |
3095 | MYLK | RNA | Others | Others | Others |
3096 | MYO1D | RNA | Others | Others | Others |
3097 | MYO5C | RNA | Others | Others | Others |
3098 | MYORG | RNA | Others | Others | Others |
3099 | MYRF | RNA | Myelination | Others | CNS |
3100 | MYSM1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3101 | MZB1 | RNA | Others | Others | Others |
3102 | NAA15 | RNA | Angiogenesis | Others | Cardiovascular |
3103 | NAA20 | RNA | Others | Others | Others |
3104 | NAA50 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3105 | NAALAD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3106 | NADK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3107 | NADK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3108 | NAE1 | RNA | Others | Others | Others |
3109 | NAGLU | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3110 | NAMPT | RNA | Others | Others | Others |
3111 | NANOG | RNA | Others | Others | Others |
3112 | NAP1L3 | RNA | Others | Others | Others |
3113 | NAPSA | RNA | Others | Others | Others |
3114 | NASP | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
3115 | NAT1 | RNA | ER Signaling | Others | Oncology |
3116 | NAT8L | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3117 | NBL1 | RNA | Others | Others | Others |
3118 | NBN | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3119 | NCAM1 | RNA | Matrix Remodeling and Metastases | Vesicle Trafficking | CNS |
3120 | NCAPD2 | RNA | Others | Others | Others |
3121 | NCAPG | RNA | Cell Cycle | Others | Oncology |
3122 | NCAPG2 | RNA | Others | Others | Others |
3123 | NCAPH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3124 | NCAPH2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3125 | NCEH1 | RNA | Others | Others | Others |
3126 | NCF1 | RNA | Oxydative Stress | Others | Inflammation |
3127 | NCF2 | RNA | Others | Others | Others |
3128 | NCF4 | RNA | Others | Others | Others |
3129 | NCK1 | RNA | PDGF Signaling | Others | Oncology |
3130 | NCK2 | RNA | Others | Others | Others |
3131 | NCKAP1L | RNA | Others | Others | Others |
3132 | NCL | RNA | Angiogenesis | Others | Cardiovascular |
3133 | NCOA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3134 | NCOR1 | RNA | Androgen Signaling | Others | Oncology |
3135 | NCOR2 | RNA | Others | Others | Others |
3136 | NCR1 | RNA | Others | Others | Others |
3137 | NCR2 | RNA | Others | Others | Others |
3138 | NCR3 | RNA | Others | Others | Others |
3139 | NCSTN | RNA | Others | Others | Others |
3140 | NDC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3141 | NDC80 | RNA | Others | Others | Others |
3142 | NDNF | RNA | Others | Others | Others |
3143 | NDP | RNA | Cell Proliferation | Others | CNS |
3144 | NDRG1 | RNA | Others | Others | Others |
3145 | NDUFA1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3146 | NDUFA11 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3147 | NDUFA12 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3148 | NDUFA13 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3149 | NDUFA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3150 | NDUFA3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3151 | NDUFA4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3152 | NDUFA4L2 | RNA | Others | Others | Others |
3153 | NDUFA6 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3154 | NDUFA7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3155 | NDUFAB1 | RNA | Others | Others | Others |
3156 | NDUFB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3157 | NDUFB10 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3158 | NDUFB11 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3159 | NDUFB2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3160 | NDUFB4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3161 | NDUFB5 | RNA | Others | Others | Others |
3162 | NDUFB6 | RNA | Others | Others | Others |
3163 | NDUFB7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3164 | NDUFB8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3165 | NDUFB9 | RNA | Others | Others | Others |
3166 | NDUFC1 | RNA | Others | Others | Others |
3167 | NDUFS3 | RNA | Others | Others | Others |
3168 | NDUFS5 | RNA | Others | Others | Others |
3169 | NDUFS7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3170 | NDUFS8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3171 | NECTIN1 | RNA | Others | Others | Others |
3172 | NECTIN2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3173 | NEDD8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3174 | NEFH | RNA | Oxydative Stress | Others | Inflammation |
3175 | NEFL | RNA | Others | Others | Others |
3176 | NEGR1 | RNA | Others | Others | Others |
3177 | NEIL1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3178 | NEIL2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3179 | NEIL3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3180 | NEK2 | RNA | Cell Cycle | Others | Oncology |
3181 | NELFA | RNA | Others | Others | Others |
3182 | NELL2 | RNA | Others | Others | Others |
3183 | NEO1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3184 | NES | RNA | Others | Others | Others |
3185 | NETO2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3186 | NEU1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3187 | NF1 | RNA | Apoptosis | Transmitter Response and Reuptake | Oncology |
3188 | NF1 | RNA | Apoptosis | Transmitter Response and Reuptake | CNS |
3189 | NF2 | RNA | Cell Proliferation | Others | CNS |
3190 | NFAM1 | RNA | Others | Others | Others |
3191 | NFAT5 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3192 | NFATC1 | RNA | MAPK | Others | Cardiovascular |
3193 | NFATC2 | RNA | Cell Proliferation | Others | CNS |
3194 | NFATC2IP | RNA | Others | Others | Others |
3195 | NFATC3 | RNA | TCR Signaling | Others | Immuno-Oncology |
3196 | NFATC4 | RNA | Others | Others | Others |
3197 | NFE2L1 | RNA | Others | Others | Others |
3198 | NFE2L2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3199 | NFIL3 | RNA | Angiogenesis | Others | Cardiovascular |
3200 | NFKB1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3201 | NFKB2 | RNA | MAPK | Others | Cardiovascular |
3202 | NFKBIA | RNA | Costimulatory Signaling | Transmitter Response and Reuptake | Immuno-Oncology |
3203 | NFKBIA | RNA | Costimulatory Signaling | Transmitter Response and Reuptake | CNS |
3204 | NFKBIB | RNA | Others | Others | Others |
3205 | NFKBIE | RNA | NF-kappaB Signaling | Others | CNS |
3206 | NFKBIZ | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3207 | NFS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3208 | NGF | RNA | RAS | Others | Oncology |
3209 | NGFR | RNA | MAPK | Vesicle Trafficking | Cardiovascular |
3210 | NGFR | RNA | MAPK | Vesicle Trafficking | CNS |
3211 | NGLY1 | RNA | Others | Others | Others |
3212 | NID1 | RNA | Others | Others | Others |
3213 | NID2 | RNA | Cellular Differentiation | Others | Oncology |
3214 | NINJ2 | RNA | Others | Others | Others |
3215 | NKD1 | RNA | Others | Others | Others |
3216 | NKG7 | RNA | Cytotoxicity | Others | Oncology |
3217 | NKIRAS2 | RNA | Others | Others | Others |
3218 | NKX2-1 | RNA | Others | Others | Others |
3219 | NKX3-1 | RNA | Androgen Signaling | Others | Oncology |
3220 | NKX6-2 | RNA | Myelination | Others | CNS |
3221 | NLGN1 | RNA | Others | Others | Others |
3222 | NLGN2 | RNA | Others | Others | Others |
3223 | NLGN4X | RNA | Others | Vesicle Trafficking | CNS |
3224 | NLRC4 | RNA | Others | Others | Others |
3225 | NLRC5 | RNA | Others | Others | Others |
3226 | NLRP1 | RNA | Others | Others | Others |
3227 | NLRP3 | RNA | Others | Others | Others |
3228 | NMB | RNA | Others | Others | Others |
3229 | NME1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3230 | NME2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3231 | NME4 | RNA | Others | Others | Others |
3232 | NME5 | RNA | Oxydative Stress | Others | Inflammation |
3233 | NMNAT2 | RNA | Others | Others | Others |
3234 | NMT1 | RNA | Others | Others | Others |
3235 | NOD1 | RNA | Others | Others | Others |
3236 | NOD2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3237 | NODAL | RNA | Cell Proliferation | Others | CNS |
3238 | NOG | RNA | Others | Others | Others |
3239 | NOL3 | RNA | Oxydative Stress | Others | Inflammation |
3240 | NOL7 | RNA | Others | Others | Others |
3241 | NOS1 | RNA | Biosynthesis and Anabolic Pathways | Transmitter Response and Reuptake | CNS |
3242 | NOS2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3243 | NOS2A | RNA | Others | Others | Others |
3244 | NOS3 | RNA | Angiogenesis | Transmitter Response and Reuptake | Cardiovascular |
3245 | NOS3 | RNA | Angiogenesis | Transmitter Response and Reuptake | CNS |
3246 | NOSTRIN | RNA | Others | Others | Others |
3247 | NOTCH1 | RNA | Cellular Differentiation | Others | Oncology |
3248 | NOTCH2 | RNA | Notch | Others | Immuno-Oncology |
3249 | NOTCH3 | RNA | Notch | Others | Immuno-Oncology |
3250 | NOTCH4 | RNA | Others | Others | Others |
3251 | NOVA1 | RNA | Others | Vesicle Trafficking | CNS |
3252 | NOX1 | RNA | Cell Stress | Others | CNS |
3253 | NOX3 | RNA | Cell Stress | Others | CNS |
3254 | NOX4 | RNA | Cell Stress | Others | CNS |
3255 | NOX5 | RNA | Angiogenesis | Others | Cardiovascular |
3256 | NPAS4 | RNA | Others | Vesicle Trafficking | CNS |
3257 | NPC1 | RNA | Others | Others | Others |
3258 | NPC2 | RNA | Others | Others | Others |
3259 | NPEPPS | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3260 | NPHP4 | RNA | Others | Others | Others |
3261 | NPL | RNA | Others | Others | Others |
3262 | NPM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3263 | NPM2 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
3264 | NPNT | RNA | Others | Others | Others |
3265 | NPR1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3266 | NPR2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3267 | NPRL2 | RNA | Others | Others | Others |
3268 | NPRL3 | RNA | Others | Others | Others |
3269 | NPTN | RNA | Others | Transmitter Response and Reuptake | CNS |
3270 | NPTX1 | RNA | Others | Others | Others |
3271 | NPY | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake | CNS |
3272 | NQO1 | RNA | Cell Stress | Vesicle Trafficking | CNS |
3273 | NR1H2 | RNA | Others | Others | Others |
3274 | NR1H3 | RNA | Others | Others | Others |
3275 | NR1H4 | RNA | Others | Others | Others |
3276 | NR2F1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3277 | NR3C1 | RNA | Cell Proliferation | Others | CNS |
3278 | NR4A1 | RNA | Cell Proliferation | Others | CNS |
3279 | NR4A2 | RNA | Oxydative Stress | Others | Inflammation |
3280 | NR4A3 | RNA | Cell Proliferation | Others | CNS |
3281 | NRAS | RNA | Autophagy | Others | Cardiovascular |
3282 | NRBF2 | RNA | Others | Others | Others |
3283 | NRCAM | RNA | Angiogenesis | Others | Cardiovascular |
3284 | NRDE2 | RNA | Others | Others | Others |
3285 | NRF1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3286 | NRG1 | RNA | Myelination | Others | CNS |
3287 | NRGN | RNA | Others | Others | Others |
3288 | NRIP3 | RNA | Others | Others | Others |
3289 | NRL | RNA | AP1 Signaling | Others | Cardiovascular |
3290 | NRM | RNA | Others | Others | Others |
3291 | NRP1 | RNA | Angiogenesis | Others | Cardiovascular |
3292 | NRP2 | RNA | Angiogenesis | Others | Cardiovascular |
3293 | NRXN1 | RNA | Angiogenesis | Vesicle Trafficking | Cardiovascular |
3294 | NRXN1 | RNA | Angiogenesis | Vesicle Trafficking | CNS |
3295 | NRXN3 | RNA | Angiogenesis | Others | Cardiovascular |
3296 | NSD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3297 | NSD2 | RNA | Others | Others | Others |
3298 | NSD3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3299 | NSF | RNA | Transmitter Synthesis | Vesicle Trafficking | CNS |
3300 | NT5E | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3301 | NTF3 | RNA | Myelination | Vesicle Trafficking | CNS |
3302 | NTHL1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3303 | NTNG1 | RNA | Others | Others | Others |
3304 | NTNG2 | RNA | Others | Others | Others |
3305 | NTRK1 | RNA | Cell Proliferation | Vesicle Trafficking | CNS |
3306 | NTRK2 | RNA | MAPK | Others | Cardiovascular |
3307 | NTS | RNA | Others | Others | Others |
3308 | NUBP1 | RNA | Others | Others | Others |
3309 | NUDT1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3310 | NUDT2 | RNA | Others | Others | Others |
3311 | NUF2 | RNA | Cell Cycle | Others | Oncology |
3312 | NUMB | RNA | Others | Others | Others |
3313 | NUMBL | RNA | Notch | Others | Immuno-Oncology |
3314 | NUP107 | RNA | Others | Others | Others |
3315 | NUP205 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3316 | NUP54 | RNA | Others | Others | Others |
3317 | NUP62 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3318 | NUPR1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3319 | NWD1 | RNA | Others | Others | Others |
3320 | OAS1 | RNA | Cytotoxicity | Others | Oncology |
3321 | OAS2 | RNA | Cytotoxicity | Others | Oncology |
3322 | OAS3 | RNA | Cytotoxicity | Others | Oncology |
3323 | OASL | RNA | Others | Others | Others |
3324 | OAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3325 | OAZ1 | RNA | Others | Others | Others |
3326 | OCIAD2 | RNA | Others | Others | Others |
3327 | OCLN | RNA | EMT | Others | Oncology |
3328 | ODC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3329 | OGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3330 | OGDHL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3331 | OGG1 | RNA | Others | Others | Others |
3332 | OGN | RNA | Cell Proliferation | Others | CNS |
3333 | OGT | RNA | Others | Others | Others |
3334 | OLFM3 | RNA | Others | Others | Others |
3335 | OLFML2B | RNA | EMT | Others | Oncology |
3336 | OLFML3 | RNA | Others | Others | Others |
3337 | OLIG2 | RNA | Myelination | Others | CNS |
3338 | OLR1 | RNA | Others | Others | Others |
3339 | OMA1 | RNA | Others | Others | Others |
3340 | OPA1 | RNA | Others | Others | Others |
3341 | OPALIN | RNA | Others | Others | Others |
3342 | OPN3 | RNA | Others | Others | Others |
3343 | OPTN | RNA | Others | Others | Others |
3344 | ORAI1 | RNA | Others | Others | Others |
3345 | ORC2 | RNA | Others | Others | Others |
3346 | ORC4 | RNA | Others | Others | Others |
3347 | ORC6 | RNA | Others | Others | Others |
3348 | OS9 | RNA | Others | Others | Others |
3349 | OSBPL5 | RNA | Others | Others | Others |
3350 | OSGIN1 | RNA | Others | Others | Others |
3351 | OSM | RNA | Others | Others | Others |
3352 | OSMR | RNA | Others | Others | Others |
3353 | OTC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3354 | OTOA | RNA | Others | Others | Others |
3355 | OTUD7B | RNA | Others | Others | Others |
3356 | OTULIN | RNA | Others | Others | Others |
3357 | OVOL2 | RNA | Angiogenesis | Others | Cardiovascular |
3358 | OXER1 | RNA | Others | Others | Others |
3359 | OXR1 | RNA | Oxydative Stress | Others | Inflammation |
3360 | OXSM | RNA | Others | Others | Others |
3361 | P2RX4 | RNA | Others | Others | Others |
3362 | P2RX7 | RNA | Others | Vesicle Trafficking | CNS |
3363 | P2RY12 | RNA | Others | Others | Others |
3364 | P2RY13 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3365 | P3H1 | RNA | Others | Others | Others |
3366 | P3H2 | RNA | Cellular Differentiation | Others | Oncology |
3367 | P3H3 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
3368 | P4HA1 | RNA | Others | Others | Others |
3369 | P4HA2 | RNA | HIF1 Signaling | Others | Inflammation |
3370 | P4HB | RNA | Collagen Biosynthesis & Modification | Others | CNS |
3371 | PA2G4 | RNA | Myc | Others | Oncology |
3372 | PACSIN1 | RNA | Others | Others | Others |
3373 | PADI2 | RNA | Others | Others | Others |
3374 | PADI4 | RNA | Others | Others | Others |
3375 | PAH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3376 | PAK1 | RNA | Others | Others | Others |
3377 | PAK2 | RNA | TCR Signaling | Others | Immuno-Oncology |
3378 | PAK3 | RNA | RAS | Others | Oncology |
3379 | PAK5 | RNA | Others | Others | Others |
3380 | PAK7 | RNA | RAS | Others | Oncology |
3381 | PALB2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3382 | PALM | RNA | Others | Others | Others |
3383 | PALMD | RNA | Angiogenesis | Others | Cardiovascular |
3384 | PANX1 | RNA | Others | Others | Others |
3385 | PARD3 | RNA | Hippo Signaling | Others | CNS |
3386 | PARK2 | RNA | Others | Others | Others |
3387 | PARK7 | RNA | Oxydative Stress | Vesicle Trafficking | Inflammation |
3388 | PARK7 | RNA | Oxydative Stress | Vesicle Trafficking | CNS |
3389 | PARP1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3390 | PARP12 | RNA | Others | Others | Others |
3391 | PARP2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3392 | PARP3 | RNA | Others | Others | Others |
3393 | PARP4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3394 | PARP9 | RNA | Others | Others | Others |
3395 | PARVA | RNA | Others | Others | Others |
3396 | PASD1 | RNA | Others | Others | Others |
3397 | PAX3 | RNA | Others | Others | Others |
3398 | PAX5 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3399 | PAX8 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3400 | PBK | RNA | Others | Others | Others |
3401 | PBRM1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3402 | PBX1 | RNA | Others | Others | Others |
3403 | PBX3 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3404 | PC | RNA | Metabolism Stress | Others | Metabolic Diseases |
3405 | PCCA | RNA | Others | Others | Others |
3406 | PCCB | RNA | Others | Others | Others |
3407 | PCGF2 | RNA | Others | Others | Others |
3408 | PCK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3409 | PCK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3410 | PCLAF | RNA | Cell Stress | Others | CNS |
3411 | PCNA | RNA | Cell Cycle | Others | Oncology |
3412 | PCOLCE | RNA | Others | Others | Others |
3413 | PCSK2 | RNA | Others | Others | Others |
3414 | PCTP | RNA | Others | Others | Others |
3415 | PDCD1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3416 | PDCD10 | RNA | Angiogenesis | Others | Cardiovascular |
3417 | PDCD1LG2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3418 | PDCD2 | RNA | Others | Others | Others |
3419 | PDCL3 | RNA | Angiogenesis | Others | Cardiovascular |
3420 | PDE1B | RNA | Transmitter Synthesis | Others | CNS |
3421 | PDE2A | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3422 | PDE3B | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3423 | PDE4D | RNA | Others | Others | Others |
3424 | PDE9A | RNA | Others | Others | Others |
3425 | PDGFA | RNA | Angiogenesis | Others | Cardiovascular |
3426 | PDGFB | RNA | Angiogenesis | Others | Cardiovascular |
3427 | PDGFC | RNA | Cell Proliferation | Others | CNS |
3428 | PDGFD | RNA | RAS | Others | Oncology |
3429 | PDGFRA | RNA | MAPK | Others | Cardiovascular |
3430 | PDGFRB | RNA | Cell Proliferation | Others | CNS |
3431 | PDHA1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3432 | PDHB | RNA | Others | Others | Others |
3433 | PDK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3434 | PDK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3435 | PDK3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3436 | PDK4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3437 | PDLIM5 | RNA | Androgen Signaling | Others | Oncology |
3438 | PDP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3439 | PDPK1 | RNA | Carbohydrate Metabolism | Others | CNS |
3440 | PDPN | RNA | Cell Proliferation | Others | CNS |
3441 | PDZK1IP1 | RNA | Others | Others | Others |
3442 | PEBP1 | RNA | Cell Stress | Others | CNS |
3443 | PEBP4 | RNA | Others | Others | Others |
3444 | PECAM1 | RNA | Matrix Remodeling and Metastases | Others | CNS |
3445 | PELI1 | RNA | Others | Others | Others |
3446 | PELI2 | RNA | Others | Others | Others |
3447 | PEMT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3448 | PEX14 | RNA | Others | Others | Others |
3449 | PF4 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
3450 | PF4V1 | RNA | Others | Others | Others |
3451 | PFDN2 | RNA | ER Signaling | Others | Oncology |
3452 | PFKFB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3453 | PFKFB3 | RNA | HIF1 Signaling | Others | Inflammation |
3454 | PFKFB4 | RNA | Others | Others | Others |
3455 | PFKL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3456 | PFKM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3457 | PFKP | RNA | HIF1 Signaling | Others | Inflammation |
3458 | PFN1 | RNA | Others | Others | Others |
3459 | PGAM1 | RNA | Carbohydrate Metabolism | Others | CNS |
3460 | PGAM2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3461 | PGD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3462 | PGF | RNA | RAS | Others | Oncology |
3463 | PGK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3464 | PGLYRP2 | RNA | Others | Others | Others |
3465 | PGLYRP3 | RNA | Others | Others | Others |
3466 | PGM1 | RNA | Others | Others | Others |
3467 | PGM2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3468 | PGPEP1 | RNA | Angiogenesis | Others | Cardiovascular |
3469 | PGR | RNA | ER Signaling | Others | Oncology |
3470 | PHB | RNA | Androgen Signaling | Others | Oncology |
3471 | PHC3 | RNA | Others | Others | Others |
3472 | PHF19 | RNA | Others | Others | Others |
3473 | PHF2 | RNA | Others | Others | Others |
3474 | PHF21A | RNA | Others | Others | Others |
3475 | PHF6 | RNA | Others | Others | Others |
3476 | PHGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3477 | PHLPP1 | RNA | Others | Others | Others |
3478 | PHYKPL | RNA | Others | Others | Others |
3479 | PIAS1 | RNA | Others | Others | Others |
3480 | PIAS2 | RNA | Others | Others | Others |
3481 | PIAS4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3482 | PIDD1 | RNA | Others | Others | Others |
3483 | PIGR | RNA | Others | Others | Others |
3484 | PIK3AP1 | RNA | Others | Others | Others |
3485 | PIK3C2A | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3486 | PIK3C2G | RNA | Others | Others | Others |
3487 | PIK3C3 | RNA | Others | Others | Others |
3488 | PIK3CA | RNA | Angiogenesis | Others | Cardiovascular |
3489 | PIK3CB | RNA | Carbohydrate Metabolism | Others | CNS |
3490 | PIK3CD | RNA | Autophagy | Others | Cardiovascular |
3491 | PIK3CG | RNA | Angiogenesis | Others | Cardiovascular |
3492 | PIK3R1 | RNA | Autophagy | Others | Cardiovascular |
3493 | PIK3R2 | RNA | Autophagy | Others | Cardiovascular |
3494 | PIK3R3 | RNA | JAK-STAT | Others | CNS |
3495 | PIK3R4 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3496 | PIK3R5 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
3497 | PIK3R6 | RNA | Angiogenesis | Others | Cardiovascular |
3498 | PILRA | RNA | Others | Others | Others |
3499 | PILRB | RNA | Others | Others | Others |
3500 | PIM1 | RNA | JAK-STAT | Others | CNS |
3501 | PIN1 | RNA | Others | Others | Others |
3502 | PINK1 | RNA | Oxydative Stress | Others | Inflammation |
3503 | PIP | RNA | Others | Others | Others |
3504 | PITX2 | RNA | Others | Others | Others |
3505 | PKHD1 | RNA | Others | Others | Others |
3506 | PKLR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3507 | PKM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3508 | PKMYT1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3509 | PKN1 | RNA | Cellular Differentiation | Others | Oncology |
3510 | PKN2 | RNA | Others | Others | Others |
3511 | PKNOX1 | RNA | Angiogenesis | Others | Cardiovascular |
3512 | PKP3 | RNA | Others | Others | Others |
3513 | PLA1A | RNA | MAPK | Others | Cardiovascular |
3514 | PLA2G10 | RNA | RAS | Others | Oncology |
3515 | PLA2G15 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3516 | PLA2G16 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3517 | PLA2G1B | RNA | Others | Others | Others |
3518 | PLA2G2A | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3519 | PLA2G2D | RNA | Others | Others | Others |
3520 | PLA2G2E | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3521 | PLA2G2F | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3522 | PLA2G3 | RNA | MAPK | Others | Cardiovascular |
3523 | PLA2G4A | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3524 | PLA2G4B | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3525 | PLA2G4C | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3526 | PLA2G4D | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3527 | PLA2G4E | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3528 | PLA2G4F | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3529 | PLA2G5 | RNA | RAS | Others | Oncology |
3530 | PLA2G6 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3531 | PLAT | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3532 | PLAU | RNA | Cell Proliferation | Others | CNS |
3533 | PLAUR | RNA | Cell Proliferation | Others | CNS |
3534 | PLCB1 | RNA | Wnt Signaling | Others | CNS |
3535 | PLCB2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3536 | PLCB3 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3537 | PLCB4 | RNA | Wnt Signaling | Others | CNS |
3538 | PLCE1 | RNA | MAPK | Others | Cardiovascular |
3539 | PLCG1 | RNA | PI3K-AKT | Others | Oncology |
3540 | PLCG2 | RNA | RAS | Others | Oncology |
3541 | PLCL2 | RNA | Others | Others | Others |
3542 | PLD1 | RNA | MAPK | Others | Cardiovascular |
3543 | PLD2 | RNA | Others | Others | Others |
3544 | PLD3 | RNA | Others | Others | Others |
3545 | PLEK | RNA | Others | Others | Others |
3546 | PLEK2 | RNA | Others | Others | Others |
3547 | PLEKHA1 | RNA | Others | Others | Others |
3548 | PLEKHB1 | RNA | Others | Others | Others |
3549 | PLEKHB2 | RNA | Others | Others | Others |
3550 | PLEKHM1 | RNA | Others | Others | Others |
3551 | PLEKHO1 | RNA | Others | Others | Others |
3552 | PLEKHO2 | RNA | Others | Others | Others |
3553 | PLG | RNA | Others | Others | Others |
3554 | PLIN4 | RNA | Others | Others | Others |
3555 | PLK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3556 | PLLP | RNA | Myelination | Others | CNS |
3557 | PLOD2 | RNA | Matrix Remodeling and Metastases | Others | CNS |
3558 | PLP1 | RNA | Others | Others | Others |
3559 | PLPP4 | RNA | Others | Others | Others |
3560 | PLS1 | RNA | Others | Others | Others |
3561 | PLSCR1 | RNA | Others | Others | Others |
3562 | PLTP | RNA | Others | Others | Others |
3563 | PLXDC1 | RNA | Angiogenesis | Others | Cardiovascular |
3564 | PLXDC2 | RNA | Others | Others | Others |
3565 | PLXNB3 | RNA | Others | Others | Others |
3566 | PLXNC1 | RNA | Others | Others | Others |
3567 | PLXND1 | RNA | Angiogenesis | Others | Cardiovascular |
3568 | PMAIP1 | RNA | p53 Signaling | Others | Oncology |
3569 | PMCH | RNA | Others | Others | Others |
3570 | PMEL | RNA | Others | Others | Others |
3571 | PML | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3572 | PMP22 | RNA | Cell Proliferation | Others | CNS |
3573 | PMS2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3574 | PNKD | RNA | Transmitter Synthesis | Others | CNS |
3575 | PNMA1 | RNA | Others | Others | Others |
3576 | PNOC | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3577 | PNP | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3578 | PNPLA3 | RNA | Others | Others | Others |
3579 | PNPLA6 | RNA | Angiogenesis | Others | Cardiovascular |
3580 | POLB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3581 | POLD1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3582 | POLD4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3583 | POLE | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3584 | POLE2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3585 | POLQ | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3586 | POLR1C | RNA | Others | Others | Others |
3587 | POLR1D | RNA | Others | Others | Others |
3588 | POLR2A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3589 | POLR2B | RNA | Others | Others | Others |
3590 | POLR2D | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3591 | POLR2H | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3592 | POLR2J | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3593 | POLR2K | RNA | Others | Others | Others |
3594 | POLR2L | RNA | Others | Others | Others |
3595 | POLR3D | RNA | Others | Others | Others |
3596 | POLR3H | RNA | Others | Others | Others |
3597 | POMC | RNA | Others | Others | Others |
3598 | POPDC3 | RNA | EMT | Others | Oncology |
3599 | POSTN | RNA | Others | Others | Others |
3600 | POU2AF1 | RNA | Others | Others | Others |
3601 | POU2F2 | RNA | Others | Others | Others |
3602 | POU5F1 | RNA | Others | Others | Others |
3603 | PPAN | RNA | Myc | Others | Oncology |
3604 | PPARA | RNA | Others | Others | Others |
3605 | PPARD | RNA | Others | Others | Others |
3606 | PPARG | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3607 | PPARGC1A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3608 | PPARGC1B | RNA | Others | Others | Others |
3609 | PPAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3610 | PPBP | RNA | Others | Others | Others |
3611 | PPFIA4 | RNA | Others | Others | Others |
3612 | PPFIBP2 | RNA | Others | Others | Others |
3613 | PPIA | RNA | Others | Others | Others |
3614 | PPL | RNA | Others | Others | Others |
3615 | PPM1A | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3616 | PPM1F | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3617 | PPM1L | RNA | Others | Others | Others |
3618 | PPP1CB | RNA | Others | Others | Others |
3619 | PPP1R12B | RNA | Others | Others | Others |
3620 | PPP1R16B | RNA | Others | Others | Others |
3621 | PPP2CA | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3622 | PPP2CB | RNA | PI3K-AKT | Others | Oncology |
3623 | PPP2R1A | RNA | PI3K-AKT | Others | Oncology |
3624 | PPP2R1B | RNA | Others | Others | Others |
3625 | PPP2R2B | RNA | Others | Others | Others |
3626 | PPP2R2C | RNA | PI3K-AKT | Others | Oncology |
3627 | PPP2R3A | RNA | Others | Others | Others |
3628 | PPP2R5A | RNA | Others | Others | Others |
3629 | PPP2R5B | RNA | Others | Others | Others |
3630 | PPP2R5C | RNA | Carbohydrate Metabolism | Others | CNS |
3631 | PPP2R5D | RNA | Others | Others | Others |
3632 | PPP2R5E | RNA | Carbohydrate Metabolism | Others | CNS |
3633 | PPP3CA | RNA | Others | Others | Others |
3634 | PPP3CB | RNA | Others | Others | Others |
3635 | PPP3CC | RNA | Others | Others | Others |
3636 | PPP3R1 | RNA | Others | Others | Others |
3637 | PPP3R2 | RNA | Others | Others | Others |
3638 | PPT1 | RNA | Others | Others | Others |
3639 | PPT2 | RNA | Others | Others | Others |
3640 | PQBP1 | RNA | Others | Others | Others |
3641 | PRAME | RNA | Others | Others | Others |
3642 | PRAP1 | RNA | Others | Others | Others |
3643 | PRC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3644 | PRCP | RNA | Others | Others | Others |
3645 | PRDM1 | RNA | Others | Others | Others |
3646 | PRDM16 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3647 | PRDX1 | RNA | Cell Stress | Others | CNS |
3648 | PRDX2 | RNA | Others | Others | Others |
3649 | PRDX5 | RNA | Cell Stress | Others | CNS |
3650 | PRDX6 | RNA | Others | Others | Others |
3651 | PRELP | RNA | Cellular Differentiation | Others | Oncology |
3652 | PREP | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3653 | PREX1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3654 | PRF1 | RNA | Cytotoxicity | Others | Oncology |
3655 | PRG2 | RNA | Others | Others | Others |
3656 | PRICKLE3 | RNA | Others | Others | Others |
3657 | PRIM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3658 | PRIM2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3659 | PRKAA1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3660 | PRKAA2 | RNA | Autophagy | Others | Cardiovascular |
3661 | PRKAB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3662 | PRKAB2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3663 | PRKACA | RNA | Hedgehog | Others | CNS |
3664 | PRKACB | RNA | Autophagy | Others | Cardiovascular |
3665 | PRKACG | RNA | RAS | Others | Oncology |
3666 | PRKAG1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3667 | PRKAG2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3668 | PRKAG3 | RNA | Others | Others | Others |
3669 | PRKAR1A | RNA | Others | Others | Others |
3670 | PRKAR1B | RNA | Others | Others | Others |
3671 | PRKAR2A | RNA | Others | Others | Others |
3672 | PRKAR2B | RNA | Others | Others | Others |
3673 | PRKCA | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3674 | PRKCB | RNA | Cellular Differentiation | Others | Oncology |
3675 | PRKCD | RNA | Others | Others | Others |
3676 | PRKCE | RNA | Others | Others | Others |
3677 | PRKCG | RNA | Cellular Differentiation | Others | Oncology |
3678 | PRKCQ | RNA | Others | Others | Others |
3679 | PRKCSH | RNA | Others | Others | Others |
3680 | PRKCZ | RNA | Others | Others | Others |
3681 | PRKDC | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3682 | PRKN | RNA | Cell Stress | Others | CNS |
3683 | PRKX | RNA | Hedgehog | Others | CNS |
3684 | PRL | RNA | Others | Others | Others |
3685 | PRLR | RNA | Cytotoxicity | Others | Oncology |
3686 | PRM1 | RNA | Others | Others | Others |
3687 | PRMT5 | RNA | Others | Others | Others |
3688 | PRMT8 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
3689 | PRNP | RNA | Oxydative Stress | Others | Inflammation |
3690 | PROCR | RNA | Others | Others | Others |
3691 | PRODH2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3692 | PROK2 | RNA | Angiogenesis | Others | Cardiovascular |
3693 | PROM1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3694 | PROS1 | RNA | Others | Others | Others |
3695 | PRPF3 | RNA | Others | Others | Others |
3696 | PRPF31 | RNA | Others | Others | Others |
3697 | PRPF38A | RNA | Others | Others | Others |
3698 | PRPS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3699 | PRR15L | RNA | Others | Others | Others |
3700 | PRR5 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3701 | PRSS22 | RNA | Matrix Remodeling and Metastases | Others | CNS |
3702 | PRSS8 | RNA | Matrix Remodeling and Metastases | Others | CNS |
3703 | PRUNE1 | RNA | Others | Others | Others |
3704 | PSAP | RNA | Others | Others | Others |
3705 | PSAT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3706 | PSEN1 | RNA | Amyloid Processing | Others | CNS |
3707 | PSEN2 | RNA | Others | Others | Others |
3708 | PSENEN | RNA | Others | Others | Others |
3709 | PSIP1 | RNA | Others | Others | Others |
3710 | PSMA1 | RNA | Others | Others | Others |
3711 | PSMA2 | RNA | Others | Others | Others |
3712 | PSMA3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3713 | PSMA6 | RNA | Others | Others | Others |
3714 | PSMA7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3715 | PSMB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3716 | PSMB10 | RNA | Apoptosis | Others | Oncology |
3717 | PSMB3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3718 | PSMB5 | RNA | Apoptosis | Others | Oncology |
3719 | PSMB7 | RNA | Antigen Processing | Others | Immuno-Oncology |
3720 | PSMB8 | RNA | Apoptosis | Others | Oncology |
3721 | PSMB9 | RNA | Antigen Processing | Others | Immuno-Oncology |
3722 | PSMC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3723 | PSMC2 | RNA | TCR Signaling | Others | Immuno-Oncology |
3724 | PSMC3 | RNA | Others | Others | Others |
3725 | PSMC4 | RNA | Apoptosis | Others | Oncology |
3726 | PSMC6 | RNA | Others | Others | Others |
3727 | PSMD13 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3728 | PSMD6 | RNA | Others | Others | Others |
3729 | PSMD7 | RNA | TCR Signaling | Others | Immuno-Oncology |
3730 | PSME2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3731 | PSPH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3732 | PSTPIP1 | RNA | Others | Others | Others |
3733 | PTAFR | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3734 | PTCD1 | RNA | Others | Others | Others |
3735 | PTCD2 | RNA | Others | Others | Others |
3736 | PTCH1 | RNA | Hedgehog | Others | CNS |
3737 | PTCH2 | RNA | Others | Others | Others |
3738 | PTCRA | RNA | Others | Others | Others |
3739 | PTDSS1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3740 | PTDSS2 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
3741 | PTEN | RNA | Angiogenesis | Others | Cardiovascular |
3742 | PTGDR2 | RNA | Others | Others | Others |
3743 | PTGDS | RNA | EMT | Others | Oncology |
3744 | PTGER1 | RNA | Others | Others | Others |
3745 | PTGER2 | RNA | Others | Others | Others |
3746 | PTGER3 | RNA | ER Signaling | Others | Oncology |
3747 | PTGER4 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3748 | PTGES | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3749 | PTGFR | RNA | Others | Others | Others |
3750 | PTGIR | RNA | Others | Others | Others |
3751 | PTGIS | RNA | Others | Others | Others |
3752 | PTGR1 | RNA | Others | Others | Others |
3753 | PTGS1 | RNA | Cell Stress | Others | CNS |
3754 | PTGS2 | RNA | Angiogenesis | Others | Cardiovascular |
3755 | PTK2 | RNA | Angiogenesis | Others | Cardiovascular |
3756 | PTK2B | RNA | Angiogenesis | Others | Cardiovascular |
3757 | PTK6 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3758 | PTMS | RNA | Others | Others | Others |
3759 | PTPA | RNA | Others | Others | Others |
3760 | PTPN1 | RNA | Others | Others | Others |
3761 | PTPN11 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3762 | PTPN12 | RNA | Others | Others | Others |
3763 | PTPN18 | RNA | Others | Others | Others |
3764 | PTPN2 | RNA | Others | Others | Others |
3765 | PTPN22 | RNA | TCR Signaling | Others | Immuno-Oncology |
3766 | PTPN4 | RNA | Others | Others | Others |
3767 | PTPN5 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3768 | PTPN6 | RNA | TCR Signaling | Others | Immuno-Oncology |
3769 | PTPN7 | RNA | Others | Others | Others |
3770 | PTPRB | RNA | Angiogenesis | Others | Cardiovascular |
3771 | PTPRC | RNA | Cell Proliferation | Others | CNS |
3772 | PTPRC_all (common probe) | RNA | TCR Signaling | Others | Immuno-Oncology |
3773 | PTPRJ | RNA | Others | Others | Others |
3774 | PTPRK | RNA | Others | Others | Others |
3775 | PTPRM | RNA | Cell Proliferation | Others | CNS |
3776 | PTPRN2 | RNA | Others | Others | Others |
3777 | PTPRR | RNA | Others | Others | Others |
3778 | PTPRS | RNA | Others | Others | Others |
3779 | PTRF | RNA | Others | Others | Others |
3780 | PTTG1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3781 | PTTG2 | RNA | Others | Others | Others |
3782 | PTX3 | RNA | Others | Others | Others |
3783 | PUDP | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3784 | PUM1 | RNA | Others | Others | Others |
3785 | PURA | RNA | Others | Others | Others |
3786 | PVALB | RNA | Others | Others | Others |
3787 | PVR | RNA | Others | Others | Others |
3788 | PVRIG | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3789 | PXDN | RNA | Others | Others | Others |
3790 | PXN | RNA | Others | Others | Others |
3791 | PYCARD | RNA | EMT | Others | Oncology |
3792 | PYCR1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3793 | PYCR2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3794 | PYCR3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3795 | PYGM | RNA | Others | Others | Others |
3796 | QKI | RNA | Vasculogenesis | Others | Cardiovascular |
3797 | RAB25 | RNA | Cell Proliferation | Others | CNS |
3798 | RAB2A | RNA | Carbohydrate Metabolism | Others | CNS |
3799 | RAB31 | RNA | Others | Others | Others |
3800 | RAB3A | RNA | Transmitter Synthesis | Others | CNS |
3801 | RAB3C | RNA | Others | Others | Others |
3802 | RAB5C | RNA | Others | Others | Others |
3803 | RAB6B | RNA | Others | Others | Others |
3804 | RAB7A | RNA | Others | Others | Others |
3805 | RAB7B | RNA | Others | Others | Others |
3806 | RAC1 | RNA | Cellular Differentiation | Others | Oncology |
3807 | RAC2 | RNA | Cell Proliferation | Others | CNS |
3808 | RAC3 | RNA | MAPK | Others | Cardiovascular |
3809 | RACK1 | RNA | Others | Others | Others |
3810 | RAD1 | RNA | Others | Others | Others |
3811 | RAD17 | RNA | Others | Others | Others |
3812 | RAD21 | RNA | Others | Others | Others |
3813 | RAD23B | RNA | Others | Others | Others |
3814 | RAD50 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3815 | RAD51 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3816 | RAD51AP1 | RNA | Cell Stress | Others | CNS |
3817 | RAD51B | RNA | Others | Others | Others |
3818 | RAD51C | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3819 | RAD52 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3820 | RAD54B | RNA | Others | Others | Others |
3821 | RAD54L | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3822 | RAD9A | RNA | Others | Others | Others |
3823 | RAE1 | RNA | Others | Others | Others |
3824 | RAF1 | RNA | Cell Proliferation | Others | CNS |
3825 | RAG1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3826 | RAG2 | RNA | Others | Others | Others |
3827 | RAI1 | RNA | Others | Others | Others |
3828 | RALA | RNA | Others | Others | Others |
3829 | RALB | RNA | Others | Others | Others |
3830 | RAMP1 | RNA | Angiogenesis | Others | Cardiovascular |
3831 | RAMP2 | RNA | Angiogenesis | Others | Cardiovascular |
3832 | RAN | RNA | Others | Others | Others |
3833 | RANBP2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3834 | RAP1A | RNA | Others | Others | Others |
3835 | RAP1B | RNA | Others | Others | Others |
3836 | RAPGEF1 | RNA | Others | Others | Others |
3837 | RAPGEF2 | RNA | Others | Others | Others |
3838 | RAPGEF3 | RNA | Others | Others | Others |
3839 | RARA | RNA | Others | Others | Others |
3840 | RARB | RNA | Others | Others | Others |
3841 | RARG | RNA | Others | Others | Others |
3842 | RARRES3 | RNA | Others | Others | Others |
3843 | RASA1 | RNA | PDGF Signaling | Others | Oncology |
3844 | RASA4 | RNA | RAS | Others | Oncology |
3845 | RASAL1 | RNA | MAPK | Others | Cardiovascular |
3846 | RASGRF1 | RNA | MAPK | Others | Cardiovascular |
3847 | RASGRF2 | RNA | MAPK | Others | Cardiovascular |
3848 | RASGRP1 | RNA | MAPK | Others | Cardiovascular |
3849 | RASGRP2 | RNA | RAS | Others | Oncology |
3850 | RASGRP3 | RNA | Others | Others | Others |
3851 | RASGRP4 | RNA | Others | Others | Others |
3852 | RASSF5 | RNA | Others | Others | Others |
3853 | RB1 | RNA | Androgen Signaling | Others | Oncology |
3854 | RB1CC1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3855 | RBBP5 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3856 | RBCK1 | RNA | Others | Others | Others |
3857 | RBFOX3 | RNA | Others | Others | Others |
3858 | RBKS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3859 | RBL1 | RNA | Cell Cycle | Others | Oncology |
3860 | RBL2 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
3861 | RBM45 | RNA | Others | Others | Others |
3862 | RBM47 | RNA | Others | Others | Others |
3863 | RBP4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3864 | RBPJ | RNA | Angiogenesis | Others | Cardiovascular |
3865 | RBX1 | RNA | Cell Cycle | Others | Oncology |
3866 | RDH10 | RNA | Others | Others | Others |
3867 | RDH14 | RNA | Others | Others | Others |
3868 | RDH5 | RNA | Others | Others | Others |
3869 | RDX | RNA | Others | Others | Others |
3870 | REL | RNA | Others | Others | Others |
3871 | RELA | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3872 | RELB | RNA | MAPK | Others | Cardiovascular |
3873 | RELN | RNA | Cellular Differentiation | Others | Oncology |
3874 | REN | RNA | Others | Others | Others |
3875 | REPS1 | RNA | Others | Others | Others |
3876 | REST | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3877 | RET | RNA | Others | Others | Others |
3878 | RETN | RNA | Others | Others | Others |
3879 | RFC2 | RNA | Cell Cycle | Others | Oncology |
3880 | RFC3 | RNA | Cell Cycle | Others | Oncology |
3881 | RFC4 | RNA | Cell Cycle | Others | Oncology |
3882 | RGCC | RNA | Others | Others | Others |
3883 | RGL1 | RNA | Others | Others | Others |
3884 | RGMA | RNA | Others | Others | Others |
3885 | RGMB | RNA | Others | Others | Others |
3886 | RGN | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3887 | RGS16 | RNA | Others | Others | Others |
3888 | RGS2 | RNA | Others | Others | Others |
3889 | RGS7 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3890 | RHEB | RNA | Others | Others | Others |
3891 | RHO | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3892 | RHOA | RNA | Cellular Differentiation | Others | Oncology |
3893 | RHOB | RNA | Others | Others | Others |
3894 | RHOG | RNA | Others | Others | Others |
3895 | RICTOR | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3896 | RIMKLA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3897 | RIMKLB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3898 | RIMS1 | RNA | Transmitter Synthesis | Others | CNS |
3899 | RIN1 | RNA | RAS | Others | Oncology |
3900 | RING1 | RNA | Others | Others | Others |
3901 | RIPK1 | RNA | Apoptosis | Others | Oncology |
3902 | RIPK2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
3903 | RIPK3 | RNA | Apoptosis | Others | Oncology |
3904 | RIT2 | RNA | Others | Others | Others |
3905 | RNA | RNA | Others | Others | Others |
3906 | RNASE2 | RNA | Angiogenesis | Others | Cardiovascular |
3907 | RNASEH2A | RNA | Others | Others | Others |
3908 | RNASEL | RNA | Others | Others | Others |
3909 | RNF103 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
3910 | RNF111 | RNA | Others | Others | Others |
3911 | RNF114 | RNA | Others | Others | Others |
3912 | RNF126 | RNA | Others | Others | Others |
3913 | RNF135 | RNA | Others | Others | Others |
3914 | RNF152 | RNA | Others | Others | Others |
3915 | RNF31 | RNA | Others | Others | Others |
3916 | RNF43 | RNA | Others | Others | Others |
3917 | RNF8 | RNA | Others | Others | Others |
3918 | RNH1 | RNA | Others | Others | Others |
3919 | RNLS | RNA | Others | Others | Others |
3920 | ROBO4 | RNA | Angiogenesis | Others | Cardiovascular |
3921 | ROCK1 | RNA | Apoptosis | Others | Oncology |
3922 | ROCK2 | RNA | TGF Beta Signaling | Others | Oncology |
3923 | ROPN1 | RNA | Others | Others | Others |
3924 | ROR2 | RNA | Others | Others | Others |
3925 | RORA | RNA | Angiogenesis | Others | Cardiovascular |
3926 | RORB | RNA | Cell Proliferation | Others | CNS |
3927 | RORC | RNA | Others | Others | Others |
3928 | RORg | RNA | Others | Others | Others |
3929 | RORgt | RNA | Others | Others | Others |
3930 | RPA1 | RNA | Others | Others | Others |
3931 | RPA3 | RNA | Cell Cycle | Others | Oncology |
3932 | RPIA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3933 | RPL23 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3934 | RPL28 | RNA | Others | Others | Others |
3935 | RPL29 | RNA | Others | Others | Others |
3936 | RPL3 | RNA | Others | Others | Others |
3937 | RPL36AL | RNA | Others | Others | Others |
3938 | RPL4 | RNA | Others | Others | Others |
3939 | RPL7A | RNA | Angiogenesis | Others | Cardiovascular |
3940 | RPL9 | RNA | Others | Others | Others |
3941 | RPLP0 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3942 | RPS10 | RNA | Others | Others | Others |
3943 | RPS2 | RNA | Others | Others | Others |
3944 | RPS21 | RNA | Others | Others | Others |
3945 | RPS27A | RNA | Cellular Differentiation | Others | Oncology |
3946 | RPS3 | RNA | Others | Others | Others |
3947 | RPS6 | RNA | Others | Others | Others |
3948 | RPS6KA1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3949 | RPS6KA2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3950 | RPS6KA3 | RNA | Others | Others | Others |
3951 | RPS6KA5 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
3952 | RPS6KA6 | RNA | Others | Others | Others |
3953 | RPS6KB1 | RNA | Autophagy | Others | Cardiovascular |
3954 | RPS6KB2 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
3955 | RPS9 | RNA | Others | Others | Others |
3956 | RPTOR | RNA | Autophagy | Others | Cardiovascular |
3957 | RRAD | RNA | Others | Others | Others |
3958 | RRAGC | RNA | mTOR Signaling | Others | Oncology |
3959 | RRAS | RNA | Others | Others | Others |
3960 | RRAS2 | RNA | RAS | Others | Oncology |
3961 | RRM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3962 | RRM2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
3963 | RSAD2 | RNA | Others | Others | Others |
3964 | RTN4 | RNA | Angiogenesis | Others | Cardiovascular |
3965 | RTN4RL1 | RNA | Others | Others | Others |
3966 | RUNX1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3967 | RUNX1T1 | RNA | Others | Others | Others |
3968 | RUNX2 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3969 | RUNX3 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
3970 | RUVBL1 | RNA | Cell Cycle | Others | Oncology |
3971 | RXRG | RNA | Others | Others | Others |
3972 | RYBP | RNA | Others | Others | Others |
3973 | RYR1 | RNA | Others | Others | Others |
3974 | RYR2 | RNA | Others | Others | Others |
3975 | RYR3 | RNA | Others | Others | Others |
3976 | S100A1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3977 | S100A10 | RNA | Others | Others | Others |
3978 | S100A12 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
3979 | S100A14 | RNA | EMT | Others | Oncology |
3980 | S100A4 | RNA | Others | Others | Others |
3981 | S100A7 | RNA | Angiogenesis | Others | Cardiovascular |
3982 | S100A8 | RNA | Others | Others | Others |
3983 | S100A9 | RNA | Others | Others | Others |
3984 | S100B | RNA | Others | Others | Others |
3985 | S1PR1 | RNA | Angiogenesis | Others | Cardiovascular |
3986 | S1PR3 | RNA | Others | Others | Others |
3987 | S1PR4 | RNA | Others | Others | Others |
3988 | S1PR5 | RNA | Others | Others | Others |
3989 | SAA1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
3990 | SACS | RNA | Others | Others | Others |
3991 | SALL1 | RNA | Others | Others | Others |
3992 | SAMD9 | RNA | Others | Others | Others |
3993 | SAMHD1 | RNA | Others | Others | Others |
3994 | SAMSN1 | RNA | Others | Others | Others |
3995 | SAP130 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
3996 | SAR1B | RNA | Others | Others | Others |
3997 | SART1 | RNA | Others | Others | Others |
3998 | SAV1 | RNA | Hippo Signaling | Others | CNS |
3999 | SBNO2 | RNA | Others | Others | Others |
4000 | SCAMP2 | RNA | Others | Others | Others |
4001 | SCARA5 | RNA | Others | Others | Others |
4002 | SCARB2 | RNA | Others | Others | Others |
4003 | SCD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4004 | SCG2 | RNA | Angiogenesis | Others | Cardiovascular |
4005 | SCIN | RNA | Others | Others | Others |
4006 | SCN1A | RNA | Others | Others | Others |
4007 | SCN2A | RNA | Myelination | Others | CNS |
4008 | SCNN1A | RNA | Others | Others | Others |
4009 | SCP2 | RNA | Others | Others | Others |
4010 | sCTLA4 (soluble form) | RNA | TCR Signaling | Others | Immuno-Oncology |
4011 | SCUBE2 | RNA | ER Signaling | Others | Oncology |
4012 | SDC1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
4013 | SDC3 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
4014 | SDC4 | RNA | Others | Others | Others |
4015 | SDHA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4016 | SDHB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4017 | SDHC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4018 | SDS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4019 | SDSL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4020 | SEC13 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4021 | SEC22B | RNA | Others | Others | Others |
4022 | SEC23A | RNA | Others | Others | Others |
4023 | SEC24C | RNA | Others | Others | Others |
4024 | SEC61B | RNA | Others | Others | Others |
4025 | SEH1L | RNA | Others | Others | Others |
4026 | SEL1L | RNA | Others | Others | Others |
4027 | SELE | RNA | Others | Others | Others |
4028 | SELENBP1 | RNA | Others | Others | Others |
4029 | SELENOK | RNA | Cell Stress | Others | CNS |
4030 | SELENOS | RNA | Others | Others | Others |
4031 | SELL | RNA | Others | Others | Others |
4032 | SELP | RNA | Others | Others | Others |
4033 | SELPLG | RNA | Others | Others | Others |
4034 | SEM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4035 | SEMA3E | RNA | Others | Others | Others |
4036 | SEMA4D | RNA | Others | Others | Others |
4037 | SEMG1 | RNA | Others | Others | Others |
4038 | SERBP1 | RNA | ER Signaling | Others | Oncology |
4039 | SERINC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4040 | SERINC2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4041 | SERINC3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4042 | SERINC4 | RNA | Others | Others | Others |
4043 | SERINC5 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4044 | SERPINA1 | RNA | Matrix Remodeling and Metastases | Others | CNS |
4045 | SERPINA3 | RNA | Others | Others | Others |
4046 | SERPINB2 | RNA | Others | Others | Others |
4047 | SERPINB5 | RNA | Angiogenesis | Others | Cardiovascular |
4048 | SERPINB6 | RNA | Others | Others | Others |
4049 | SERPINB9 | RNA | Others | Others | Others |
4050 | SERPINE1 | RNA | Angiogenesis | Others | Cardiovascular |
4051 | SERPINF1 | RNA | Cell Proliferation | Others | CNS |
4052 | SERPINF2 | RNA | Others | Others | Others |
4053 | SERPING1 | RNA | Others | Others | Others |
4054 | SERPINH1 | RNA | Angiogenesis | Others | Cardiovascular |
4055 | SESN1 | RNA | Others | Others | Others |
4056 | SESN2 | RNA | Others | Others | Others |
4057 | SESN3 | RNA | Others | Others | Others |
4058 | SET | RNA | Cell Proliferation | Others | CNS |
4059 | SETBP1 | RNA | Others | Others | Others |
4060 | SETD1A | RNA | Others | Others | Others |
4061 | SETD1B | RNA | Others | Others | Others |
4062 | SETD2 | RNA | Angiogenesis | Others | Cardiovascular |
4063 | SETD7 | RNA | Others | Others | Others |
4064 | SETDB1 | RNA | Others | Others | Others |
4065 | SF3A1 | RNA | Others | Others | Others |
4066 | SF3A2 | RNA | Others | Others | Others |
4067 | SF3A3 | RNA | Others | Others | Others |
4068 | SF3B1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4069 | SF3B2 | RNA | Others | Others | Others |
4070 | SF3B4 | RNA | Others | Others | Others |
4071 | SFN | RNA | Cell Cycle | Others | Oncology |
4072 | SFRP1 | RNA | Cell Proliferation | Others | CNS |
4073 | SFRP2 | RNA | Cell Proliferation | Others | CNS |
4074 | SFRP4 | RNA | Wnt Signaling | Others | CNS |
4075 | SFTPA1 | RNA | Others | Others | Others |
4076 | SFTPD | RNA | Others | Others | Others |
4077 | SFXN1 | RNA | Others | Others | Others |
4078 | SGK1 | RNA | Metabolism Stress | Others | Metabolic Diseases |
4079 | SGK2 | RNA | Others | Others | Others |
4080 | SGK3 | RNA | Others | Others | Others |
4081 | SGO2 | RNA | Others | Others | Others |
4082 | SGPL1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
4083 | SH2B2 | RNA | Others | Others | Others |
4084 | SH2B3 | RNA | Others | Others | Others |
4085 | SH2D1A | RNA | Others | Others | Others |
4086 | SH2D1B | RNA | Others | Others | Others |
4087 | SH2D3A | RNA | Others | Others | Others |
4088 | SH3BP2 | RNA | Others | Others | Others |
4089 | SH3PXD2A | RNA | Others | Others | Others |
4090 | SH3TC2 | RNA | Myelination | Others | CNS |
4091 | SH3YL1 | RNA | Others | Others | Others |
4092 | SHANK2 | RNA | Others | Others | Others |
4093 | SHANK3 | RNA | Others | Others | Others |
4094 | SHB | RNA | Angiogenesis | Others | Cardiovascular |
4095 | SHC1 | RNA | RAS | Others | Oncology |
4096 | SHC2 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
4097 | SHC3 | RNA | RAS | Others | Oncology |
4098 | SHC4 | RNA | MAPK | Others | Cardiovascular |
4099 | SHE | RNA | Angiogenesis | Others | Cardiovascular |
4100 | SHH | RNA | Others | Others | Others |
4101 | SHMT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4102 | SHMT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4103 | SIDT1 | RNA | Others | Others | Others |
4104 | SIGIRR | RNA | Others | Others | Others |
4105 | SIGLEC1 | RNA | Others | Others | Others |
4106 | SIGLEC5 | RNA | Others | Others | Others |
4107 | SIGLEC6 | RNA | Others | Others | Others |
4108 | SIGLEC8 | RNA | Others | Others | Others |
4109 | SIGLEC9 | RNA | Others | Others | Others |
4110 | SIK1 | RNA | Others | Others | Others |
4111 | SIL1 | RNA | Others | Others | Others |
4112 | SIN3A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4113 | SIPA1 | RNA | Others | Others | Others |
4114 | SIRPA | RNA | Cytotoxicity | Others | Oncology |
4115 | SIRPB2 | RNA | Others | Others | Others |
4116 | SIRT1 | RNA | Angiogenesis | Others | Cardiovascular |
4117 | SIRT2 | RNA | Myelination | Others | CNS |
4118 | SIRT4 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
4119 | SIRT7 | RNA | Others | Others | Others |
4120 | SIX1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
4121 | SKA1 | RNA | Cell Cycle | Others | Oncology |
4122 | SKA3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4123 | SKI | RNA | Others | Others | Others |
4124 | SKIL | RNA | Others | Others | Others |
4125 | SKP1 | RNA | Proliferation | Others | Oncology |
4126 | SKP2 | RNA | Cell Cycle | Others | Oncology |
4127 | SLA | RNA | Others | Others | Others |
4128 | SLAMF1 | RNA | Others | Others | Others |
4129 | SLAMF6 | RNA | Others | Others | Others |
4130 | SLAMF7 | RNA | Others | Others | Others |
4131 | SLAMF8 | RNA | Others | Others | Others |
4132 | SLAMF9 | RNA | Others | Others | Others |
4133 | SLC10A6 | RNA | Others | Others | Others |
4134 | SLC11A1 | RNA | Others | Others | Others |
4135 | SLC12A5 | RNA | Others | Others | Others |
4136 | SLC12A6 | RNA | Angiogenesis | Others | Cardiovascular |
4137 | SLC16A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4138 | SLC16A11 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4139 | SLC16A13 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4140 | SLC16A2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4141 | SLC16A3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4142 | SLC16A6 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4143 | SLC16A7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4144 | SLC16A8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4145 | SLC17A6 | RNA | Transmitter Synthesis | Others | CNS |
4146 | SLC17A7 | RNA | Others | Others | Others |
4147 | SLC18A2 | RNA | Transmitter Synthesis | Others | CNS |
4148 | SLC18A3 | RNA | Transmitter Synthesis | Others | CNS |
4149 | SLC1A1 | RNA | Carbohydrate Metabolism | Others | CNS |
4150 | SLC1A2 | RNA | Carbohydrate Metabolism | Others | CNS |
4151 | SLC1A3 | RNA | Others | Others | Others |
4152 | SLC1A5 | RNA | Metabolism Stress | Others | Metabolic Diseases |
4153 | SLC25A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4154 | SLC25A10 | RNA | Others | Others | Others |
4155 | SLC25A13 | RNA | Others | Others | Others |
4156 | SLC25A20 | RNA | Others | Others | Others |
4157 | SLC25A6 | RNA | Others | Others | Others |
4158 | SLC27A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4159 | SLC27A3 | RNA | Others | Others | Others |
4160 | SLC2A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4161 | SLC2A11 | RNA | Others | Others | Others |
4162 | SLC2A12 | RNA | Others | Others | Others |
4163 | SLC2A14 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4164 | SLC2A2 | RNA | Others | Others | Others |
4165 | SLC2A3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4166 | SLC2A3/14 | RNA | Others | Others | Others |
4167 | SLC2A5 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4168 | SLC2A6 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4169 | SLC2A8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4170 | SLC32A1 | RNA | Transmitter Synthesis | Others | CNS |
4171 | SLC35A3 | RNA | Others | Others | Others |
4172 | SLC37A1 | RNA | Others | Others | Others |
4173 | SLC37A4 | RNA | Others | Others | Others |
4174 | SLC39A6 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4175 | SLC3A1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4176 | SLC3A2 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4177 | SLC44A1 | RNA | Others | Others | Others |
4178 | SLC44A4 | RNA | EMT | Others | Oncology |
4179 | SLC4A10 | RNA | Others | Others | Others |
4180 | SLC4A1AP | RNA | Others | Others | Others |
4181 | SLC6A1 | RNA | Others | Others | Others |
4182 | SLC6A12 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4183 | SLC6A18 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4184 | SLC6A19 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4185 | SLC6A3 | RNA | Transmitter Synthesis | Others | CNS |
4186 | SLC6A4 | RNA | Transmitter Synthesis | Others | CNS |
4187 | SLC7A11 | RNA | Cell Stress | Others | CNS |
4188 | SLC7A5 | RNA | Metabolism Stress | Others | Metabolic Diseases |
4189 | SLC7A9 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4190 | SLC8A1 | RNA | Oxydative Stress | Others | Inflammation |
4191 | SLC9A6 | RNA | Others | Others | Others |
4192 | SLCO2B1 | RNA | Others | Others | Others |
4193 | SLFN11 | RNA | Others | Others | Others |
4194 | SLIT2 | RNA | Hippo Signaling | Others | CNS |
4195 | SLPI | RNA | EMT | Others | Oncology |
4196 | SLU7 | RNA | Others | Others | Others |
4197 | SMAD1 | RNA | Cell Proliferation | Others | CNS |
4198 | SMAD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4199 | SMAD3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4200 | SMAD4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4201 | SMAD5 | RNA | Proliferation | Others | Oncology |
4202 | SMAD6 | RNA | Others | Others | Others |
4203 | SMAD7 | RNA | Hippo Signaling | Others | CNS |
4204 | SMAD9 | RNA | Others | Others | Others |
4205 | SMAP1 | RNA | Others | Others | Others |
4206 | SMARCA4 | RNA | Others | Others | Others |
4207 | SMARCA5 | RNA | Others | Others | Others |
4208 | SMARCB1 | RNA | Others | Others | Others |
4209 | SMARCC2 | RNA | Others | Others | Others |
4210 | SMARCD1 | RNA | Others | Others | Others |
4211 | SMC1A | RNA | Others | Others | Others |
4212 | SMC1B | RNA | Proliferation | Others | Oncology |
4213 | SMC2 | RNA | Others | Others | Others |
4214 | SMC3 | RNA | Cell Cycle | Others | Oncology |
4215 | SMN1 | RNA | Others | Others | Others |
4216 | SMO | RNA | Hedgehog | Others | CNS |
4217 | SMOC1 | RNA | Others | Others | Others |
4218 | SMPD3 | RNA | Others | Others | Others |
4219 | SMPD4 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
4220 | SMS | RNA | Androgen Signaling | Others | Oncology |
4221 | SMURF1 | RNA | Others | Others | Others |
4222 | SMURF2 | RNA | Proliferation | Others | Oncology |
4223 | SMYD1 | RNA | Others | Others | Others |
4224 | SNAI1 | RNA | Cellular Differentiation | Others | Oncology |
4225 | SNAI2 | RNA | Cellular Differentiation | Others | Oncology |
4226 | SNAI3 | RNA | Others | Others | Others |
4227 | SNAP91 | RNA | Others | Others | Others |
4228 | SNCA | RNA | Oxydative Stress | Others | Inflammation |
4229 | SNCAIP | RNA | Transmitter Synthesis | Others | CNS |
4230 | SNCB | RNA | Transmitter Synthesis | Others | CNS |
4231 | SNF8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4232 | SNRPA | RNA | Others | Others | Others |
4233 | SNRPF | RNA | Others | Others | Others |
4234 | SOCS1 | RNA | JAK-STAT | Others | CNS |
4235 | SOCS2 | RNA | JAK-STAT | Others | CNS |
4236 | SOCS3 | RNA | JAK-STAT | Others | CNS |
4237 | SOCS4 | RNA | Others | Others | Others |
4238 | SOCS5 | RNA | Others | Others | Others |
4239 | SOD1 | RNA | Carbohydrate Metabolism | Others | CNS |
4240 | SOD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4241 | SOD3 | RNA | Cell Stress | Others | CNS |
4242 | SORBS1 | RNA | Others | Others | Others |
4243 | SORCS3 | RNA | Others | Others | Others |
4244 | SORD | RNA | Androgen Signaling | Others | Oncology |
4245 | SORL1 | RNA | Others | Others | Others |
4246 | SORT1 | RNA | Others | Others | Others |
4247 | SOS1 | RNA | EGFR Signaling | Others | Oncology |
4248 | SOS2 | RNA | RAS | Others | Oncology |
4249 | SOST | RNA | Others | Others | Others |
4250 | SOX10 | RNA | Others | Others | Others |
4251 | SOX11 | RNA | Wnt Signaling | Others | CNS |
4252 | SOX17 | RNA | Angiogenesis | Others | Cardiovascular |
4253 | SOX2 | RNA | Hippo Signaling | Others | CNS |
4254 | SOX4 | RNA | Others | Others | Others |
4255 | SOX7 | RNA | Others | Others | Others |
4256 | SOX9 | RNA | Cell Proliferation | Others | CNS |
4257 | SP1 | RNA | TGF Beta Signaling | Others | Oncology |
4258 | SP100 | RNA | Others | Others | Others |
4259 | SP3 | RNA | Others | Others | Others |
4260 | SPA17 | RNA | Others | Others | Others |
4261 | SPACA3 | RNA | Others | Others | Others |
4262 | SPAG9 | RNA | AP1 Signaling | Others | Cardiovascular |
4263 | SPANXB1 | RNA | Others | Others | Others |
4264 | SPARC | RNA | Cell Proliferation | Others | CNS |
4265 | SPARCL1 | RNA | Others | Others | Others |
4266 | SPAST | RNA | Others | Others | Others |
4267 | SPC25 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4268 | SPDEF | RNA | Androgen Signaling | Others | Oncology |
4269 | SPHK1 | RNA | Others | Others | Others |
4270 | SPHK2 | RNA | Cell Proliferation | Others | CNS |
4271 | SPI1 | RNA | Others | Others | Others |
4272 | SPIB | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4273 | SPINK1 | RNA | Others | Others | Others |
4274 | SPINK5 | RNA | Others | Others | Others |
4275 | SPINT1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4276 | SPINT2 | RNA | Met Signaling | Others | Oncology |
4277 | SPN | RNA | Others | Others | Others |
4278 | SPO11 | RNA | Others | Others | Others |
4279 | SPOCK3 | RNA | Others | Others | Others |
4280 | SPOP | RNA | Others | Others | Others |
4281 | SPOPL | RNA | Others | Others | Others |
4282 | SPP1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4283 | SPPL2B | RNA | Others | Others | Others |
4284 | SPRED1 | RNA | Others | Others | Others |
4285 | SPRY1 | RNA | JAK-STAT | Others | CNS |
4286 | SPRY2 | RNA | JAK-STAT | Others | CNS |
4287 | SPRY4 | RNA | Cytotoxicity | Others | Oncology |
4288 | SPTAN1 | RNA | Others | Others | Others |
4289 | SPTBN2 | RNA | Others | Others | Others |
4290 | SQLE | RNA | mTOR Signaling | Others | Oncology |
4291 | SQSTM1 | RNA | mTOR Signaling | Others | Oncology |
4292 | SRC | RNA | Cell Proliferation | Others | CNS |
4293 | SRD5A2 | RNA | Others | Others | Others |
4294 | SREBF1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
4295 | SREBF2 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4296 | SRF | RNA | Angiogenesis | Others | Cardiovascular |
4297 | SRGN | RNA | Others | Others | Others |
4298 | SRI | RNA | Others | Others | Others |
4299 | SRM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4300 | SRP54 | RNA | Others | Others | Others |
4301 | SRPK2 | RNA | Angiogenesis | Others | Cardiovascular |
4302 | SRPX | RNA | Others | Others | Others |
4303 | SRPX2 | RNA | Angiogenesis | Others | Cardiovascular |
4304 | SRR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4305 | SRSF2 | RNA | Others | Others | Others |
4306 | SRSF4 | RNA | Others | Others | Others |
4307 | SRXN1 | RNA | Others | Others | Others |
4308 | SSR1 | RNA | Others | Others | Others |
4309 | SSR2 | RNA | Others | Others | Others |
4310 | SSR4 | RNA | Others | Others | Others |
4311 | SSRP1 | RNA | p53 Signaling | Others | Oncology |
4312 | SSTR2 | RNA | Cell Proliferation | Others | CNS |
4313 | SSX1 | RNA | Others | Others | Others |
4314 | SSX4 | RNA | Others | Others | Others |
4315 | ST14 | RNA | Others | Others | Others |
4316 | ST3GAL6 | RNA | Others | Others | Others |
4317 | ST6GAL1 | RNA | Others | Others | Others |
4318 | ST6GALNAC2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4319 | ST8SIA6 | RNA | Others | Others | Others |
4320 | STAB1 | RNA | Others | Others | Others |
4321 | STAB2 | RNA | Angiogenesis | Others | Cardiovascular |
4322 | STAG2 | RNA | Cell Cycle | Others | Oncology |
4323 | STAM | RNA | Others | Others | Others |
4324 | STAM2 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4325 | STAMBPL1 | RNA | Others | Others | Others |
4326 | STAT1 | RNA | Cell Proliferation | Others | CNS |
4327 | STAT2 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
4328 | STAT3 | RNA | Cell Proliferation | Others | CNS |
4329 | STAT4 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4330 | STAT5A | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4331 | STAT5B | RNA | Others | Others | Others |
4332 | STAT6 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4333 | STC1 | RNA | Angiogenesis | Others | Cardiovascular |
4334 | STC2 | RNA | Others | Others | Others |
4335 | STEAP4 | RNA | Others | Others | Others |
4336 | STIM1 | RNA | Others | Others | Others |
4337 | STING1 | RNA | Others | Others | Others |
4338 | STIP1 | RNA | mTOR Signaling | Others | Oncology |
4339 | STK11 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4340 | STK11IP | RNA | Others | Others | Others |
4341 | STK26 | RNA | Others | Others | Others |
4342 | STK3 | RNA | Hippo Signaling | Others | CNS |
4343 | STK4 | RNA | Hippo Signaling | Others | CNS |
4344 | STMN1 | RNA | Others | Others | Others |
4345 | STRADB | RNA | Others | Others | Others |
4346 | STRAP | RNA | Others | Others | Others |
4347 | STT3B | RNA | Others | Others | Others |
4348 | STX18 | RNA | Others | Others | Others |
4349 | STX1A | RNA | Transmitter Synthesis | Others | CNS |
4350 | STX1B | RNA | Transmitter Synthesis | Others | CNS |
4351 | STX2 | RNA | Oxydative Stress | Others | Inflammation |
4352 | SUCLA2 | RNA | Carbohydrate Metabolism | Others | CNS |
4353 | SUFU | RNA | Others | Others | Others |
4354 | SUGT1 | RNA | Others | Others | Others |
4355 | SULF1 | RNA | Cell Proliferation | Others | CNS |
4356 | SUMO1 | RNA | Others | Others | Others |
4357 | SUPT16H | RNA | p53 Signaling | Others | Oncology |
4358 | SUV39H1 | RNA | Others | Others | Others |
4359 | SUV39H2 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
4360 | SUZ12 | RNA | Others | Others | Others |
4361 | SV2B | RNA | Cellular Differentiation | Others | Oncology |
4362 | SYCP1 | RNA | Others | Others | Others |
4363 | SYK | RNA | Angiogenesis | Others | Cardiovascular |
4364 | SYN2 | RNA | Others | Others | Others |
4365 | SYNE1 | RNA | Others | Others | Others |
4366 | SYNJ1 | RNA | Others | Others | Others |
4367 | SYP | RNA | Others | Others | Others |
4368 | SYT1 | RNA | Transmitter Synthesis | Others | CNS |
4369 | SYT13 | RNA | Others | Others | Others |
4370 | SYT17 | RNA | Others | Others | Others |
4371 | SYT4 | RNA | Others | Others | Others |
4372 | SYT7 | RNA | Others | Others | Others |
4373 | SYTL4 | RNA | ER Signaling | Others | Oncology |
4374 | TAB1 | RNA | Others | Others | Others |
4375 | TAB2 | RNA | Others | Others | Others |
4376 | TAB3 | RNA | Others | Others | Others |
4377 | TACSTD2 | RNA | Cell Proliferation | Others | CNS |
4378 | TAF10 | RNA | Others | Others | Others |
4379 | TAF3 | RNA | Others | Others | Others |
4380 | TAF4 | RNA | Others | Others | Others |
4381 | TAF4B | RNA | Others | Others | Others |
4382 | TAF6L | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4383 | TAF9 | RNA | Others | Others | Others |
4384 | TAGAP | RNA | Others | Others | Others |
4385 | TAL1 | RNA | Angiogenesis | Others | Cardiovascular |
4386 | TALDO1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4387 | TANK | RNA | Others | Others | Others |
4388 | TAOK2 | RNA | Others | Others | Others |
4389 | TAP1 | RNA | Antigen Processing | Others | Immuno-Oncology |
4390 | TAP2 | RNA | Antigen Processing | Others | Immuno-Oncology |
4391 | TAPBP | RNA | Antigen Processing | Others | Immuno-Oncology |
4392 | TAPBPL | RNA | Others | Others | Others |
4393 | TARBP2 | RNA | Others | Others | Others |
4394 | TARDBP | RNA | Others | Others | Others |
4395 | TARP | RNA | Others | Others | Others |
4396 | TARP/TRGC1/2 | RNA | Others | Others | Others |
4397 | TATDN1 | RNA | Others | Others | Others |
4398 | TAX1BP1 | RNA | Others | Others | Others |
4399 | TAZ | RNA | Hippo Signaling | Others | CNS |
4400 | TBC1D10B | RNA | Others | Others | Others |
4401 | TBC1D4 | RNA | Others | Others | Others |
4402 | TBC1D9 | RNA | ER Signaling | Others | Oncology |
4403 | TBK1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4404 | TBL1XR1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4405 | TBP | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4406 | TBPL1 | RNA | Others | Others | Others |
4407 | TBR1 | RNA | Others | Others | Others |
4408 | TBRG4 | RNA | Myc | Others | Oncology |
4409 | TBX1 | RNA | Angiogenesis | Others | Cardiovascular |
4410 | TBX21 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4411 | TBX4 | RNA | Angiogenesis | Others | Cardiovascular |
4412 | TBXA2R | RNA | Others | Others | Others |
4413 | TBXAS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4414 | TCEAL1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4415 | TCEB1 | RNA | Others | Others | Others |
4416 | TCEB2 | RNA | Others | Others | Others |
4417 | TCERG1 | RNA | Others | Others | Others |
4418 | TCF20 | RNA | Others | Others | Others |
4419 | TCF3 | RNA | Others | Others | Others |
4420 | TCF4 | RNA | EMT | Others | Oncology |
4421 | TCF7 | RNA | Others | Others | Others |
4422 | TCF7L1 | RNA | Wnt Signaling | Others | CNS |
4423 | TCF7L2 | RNA | Others | Others | Others |
4424 | TCIRG1 | RNA | Transmitter Synthesis | Others | CNS |
4425 | TCL1A | RNA | PI3K-AKT | Others | Oncology |
4426 | TCL1B | RNA | Others | Others | Others |
4427 | TCN2 | RNA | Others | Others | Others |
4428 | TCOF1 | RNA | Myc | Others | Oncology |
4429 | TDGF1 | RNA | Cell Proliferation | Others | CNS |
4430 | TDO2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4431 | TDRD1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4432 | TEAD1 | RNA | Hippo Signaling | Others | CNS |
4433 | TEAD2 | RNA | Hippo Signaling | Others | CNS |
4434 | TECR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4435 | TEK | RNA | Angiogenesis | Others | Cardiovascular |
4436 | TELO2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4437 | TENM2 | RNA | Others | Others | Others |
4438 | TERF2IP | RNA | Others | Others | Others |
4439 | TERT | RNA | Myc | Others | Oncology |
4440 | TET1 | RNA | Others | Others | Others |
4441 | TET2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4442 | TF | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4443 | TFAM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4444 | TFB2M | RNA | Others | Others | Others |
4445 | TFDP1 | RNA | Cell Cycle | Others | Oncology |
4446 | TFE3 | RNA | Others | Others | Others |
4447 | TFEB | RNA | Autophagy | Others | Cardiovascular |
4448 | TFF1 | RNA | ER Signaling | Others | Oncology |
4449 | TFF3 | RNA | Others | Others | Others |
4450 | TFG | RNA | Others | Others | Others |
4451 | TFPI2 | RNA | Others | Others | Others |
4452 | TFRC | RNA | Hypoxia | Others | Cardiovascular |
4453 | TG | RNA | Others | Others | Others |
4454 | TGFA | RNA | Others | Others | Others |
4455 | TGFB1 | RNA | Cell Proliferation | Others | CNS |
4456 | TGFB1I1 | RNA | Others | Others | Others |
4457 | TGFB2 | RNA | Angiogenesis | Others | Cardiovascular |
4458 | TGFB3 | RNA | ECM Remodeling | Others | Metabolic Diseases |
4459 | TGFBI | RNA | Angiogenesis | Others | Cardiovascular |
4460 | TGFBR1 | RNA | MAPK | Others | Cardiovascular |
4461 | TGFBR2 | RNA | Cell Proliferation | Others | CNS |
4462 | TGIF2 | RNA | Others | Others | Others |
4463 | TGM1 | RNA | Others | Others | Others |
4464 | TGM2 | RNA | Hippo Signaling | Others | CNS |
4465 | TH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4466 | THBD | RNA | Others | Others | Others |
4467 | THBS1 | RNA | Angiogenesis | Others | Cardiovascular |
4468 | THBS2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
4469 | THBS3 | RNA | Others | Others | Others |
4470 | THBS4 | RNA | Cell Proliferation | Others | CNS |
4471 | THEM4 | RNA | Others | Others | Others |
4472 | THOP1 | RNA | Others | Others | Others |
4473 | THY1 | RNA | Angiogenesis | Others | Cardiovascular |
4474 | TIAM1 | RNA | RAS | Others | Oncology |
4475 | TICAM1 | RNA | Apoptosis | Others | Oncology |
4476 | TICAM2 | RNA | Others | Others | Others |
4477 | TIE1 | RNA | Angiogenesis | Others | Cardiovascular |
4478 | TIFA | RNA | Others | Others | Others |
4479 | TIGAR | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4480 | TIGIT | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4481 | TIMELESS | RNA | Cell Stress | Others | CNS |
4482 | TIMM17A | RNA | Others | Others | Others |
4483 | TIMM23 | RNA | Others | Others | Others |
4484 | TIMP1 | RNA | Cell Proliferation | Others | CNS |
4485 | TIMP2 | RNA | Cell Proliferation | Others | CNS |
4486 | TIMP4 | RNA | Matrix Remodeling and Metastases | Others | CNS |
4487 | TIRAP | RNA | Others | Others | Others |
4488 | TJP1 | RNA | Hippo Signaling | Others | CNS |
4489 | TJP2 | RNA | Others | Others | Others |
4490 | TJP3 | RNA | Others | Others | Others |
4491 | TK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4492 | TK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4493 | TKT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4494 | TLE3 | RNA | ER Signaling | Others | Oncology |
4495 | TLE4 | RNA | Others | Others | Others |
4496 | TLK2 | RNA | Others | Others | Others |
4497 | TLN1 | RNA | Others | Others | Others |
4498 | TLR1 | RNA | Others | Others | Others |
4499 | TLR10 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4500 | TLR2 | RNA | PI3K-AKT | Others | Oncology |
4501 | TLR3 | RNA | Apoptosis | Others | Oncology |
4502 | TLR4 | RNA | Apoptosis | Others | Oncology |
4503 | TLR5 | RNA | Others | Others | Others |
4504 | TLR6 | RNA | Others | Others | Others |
4505 | TLR7 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4506 | TLR8 | RNA | Others | Others | Others |
4507 | TLR9 | RNA | Others | Others | Others |
4508 | TLX1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
4509 | TM4SF1 | RNA | Others | Others | Others |
4510 | TM6SF2 | RNA | Others | Others | Others |
4511 | TMC6 | RNA | Others | Others | Others |
4512 | TMC7 | RNA | Others | Others | Others |
4513 | TMCC3 | RNA | Others | Others | Others |
4514 | TMED2 | RNA | Others | Others | Others |
4515 | TMEFF2 | RNA | Others | Others | Others |
4516 | TMEM100 | RNA | Angiogenesis | Others | Cardiovascular |
4517 | TMEM119 | RNA | Others | Others | Others |
4518 | TMEM140 | RNA | Others | Others | Others |
4519 | TMEM144 | RNA | Others | Others | Others |
4520 | TMEM163 | RNA | Others | Others | Others |
4521 | TMEM173 | RNA | Others | Others | Others |
4522 | TMEM176A | RNA | Others | Others | Others |
4523 | TMEM204 | RNA | Others | Others | Others |
4524 | TMEM206 | RNA | Others | Others | Others |
4525 | TMEM30B | RNA | Cellular Differentiation | Others | Oncology |
4526 | TMEM37 | RNA | Others | Others | Others |
4527 | TMEM45B | RNA | Others | Others | Others |
4528 | TMEM64 | RNA | Others | Others | Others |
4529 | TMEM88B | RNA | Others | Others | Others |
4530 | TMPRSS2 | RNA | Androgen Signaling | Others | Oncology |
4531 | TMPRSS4 | RNA | EMT | Others | Oncology |
4532 | TMPRSS6 | RNA | Angiogenesis | Others | Cardiovascular |
4533 | TMUB2 | RNA | Others | Others | Others |
4534 | TNC | RNA | Cell Proliferation | Others | CNS |
4535 | TNF | RNA | Apoptosis | Others | Oncology |
4536 | TNFAIP3 | RNA | Others | Others | Others |
4537 | TNFAIP6 | RNA | Angiogenesis | Others | Cardiovascular |
4538 | TNFRSF10A | RNA | Others | Others | Others |
4539 | TNFRSF10B | RNA | Apoptosis | Others | Oncology |
4540 | TNFRSF10C | RNA | Others | Others | Others |
4541 | TNFRSF10D | RNA | Others | Others | Others |
4542 | TNFRSF11A | RNA | NF-kappaB Signaling | Others | CNS |
4543 | TNFRSF11B | RNA | NF-kappaB Signaling | Others | CNS |
4544 | TNFRSF12A | RNA | Angiogenesis | Others | Cardiovascular |
4545 | TNFRSF13B | RNA | Others | Others | Others |
4546 | TNFRSF13C | RNA | Others | Others | Others |
4547 | TNFRSF14 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4548 | TNFRSF17 | RNA | NF-kappaB Signaling | Others | CNS |
4549 | TNFRSF18 | RNA | NF-kappaB Signaling | Others | CNS |
4550 | TNFRSF1A | RNA | MAPK | Others | Cardiovascular |
4551 | TNFRSF1B | RNA | NF-kappaB Signaling | Others | CNS |
4552 | TNFRSF25 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4553 | TNFRSF4 | RNA | NF-kappaB Signaling | Others | CNS |
4554 | TNFRSF8 | RNA | Others | Others | Others |
4555 | TNFRSF9 | RNA | TNF Superfamily | Others | Oncology |
4556 | TNFSF10 | RNA | Apoptosis | Others | Oncology |
4557 | TNFSF11 | RNA | TNF Superfamily | Others | Oncology |
4558 | TNFSF12 | RNA | Angiogenesis | Others | Cardiovascular |
4559 | TNFSF13 | RNA | Cell Proliferation | Others | CNS |
4560 | TNFSF13B | RNA | NF-kappaB Signaling | Others | CNS |
4561 | TNFSF14 | RNA | TNF Superfamily | Others | Oncology |
4562 | TNFSF15 | RNA | Others | Others | Others |
4563 | TNFSF18 | RNA | NF-kappaB Signaling | Others | CNS |
4564 | TNFSF4 | RNA | NF-kappaB Signaling | Others | CNS |
4565 | TNFSF8 | RNA | TNF Superfamily | Others | Oncology |
4566 | TNFSF9 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4567 | TNKS | RNA | Apoptosis | Others | Oncology |
4568 | TNKS2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4569 | TNMD | RNA | Cell Proliferation | Others | CNS |
4570 | TNN | RNA | PI3K-AKT | Others | Oncology |
4571 | TNR | RNA | Others | Others | Others |
4572 | TNS1 | RNA | Hippo Signaling | Others | CNS |
4573 | TNS4 | RNA | Met Signaling | Others | Oncology |
4574 | TNXB | RNA | Cellular Differentiation | Others | Oncology |
4575 | TOLLIP | RNA | Others | Others | Others |
4576 | TOM1L1 | RNA | Others | Others | Others |
4577 | TOMM6 | RNA | Others | Others | Others |
4578 | TOP2A | RNA | Cell Cycle | Others | Oncology |
4579 | TOPBP1 | RNA | Others | Others | Others |
4580 | TOR1A | RNA | Oxydative Stress | Others | Inflammation |
4581 | TOX | RNA | Others | Others | Others |
4582 | TOX2 | RNA | Others | Others | Others |
4583 | TOX3 | RNA | Others | Others | Others |
4584 | TOX4 | RNA | Others | Others | Others |
4585 | TP53 | RNA | Apoptosis | Others | Oncology |
4586 | TP53BP2 | RNA | Others | Others | Others |
4587 | TP53INP2 | RNA | Others | Others | Others |
4588 | TP63 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4589 | TP73 | RNA | Hippo Signaling | Others | CNS |
4590 | TPD52 | RNA | Androgen Signaling | Others | Oncology |
4591 | TPH1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4592 | TPI1 | RNA | HIF1 Signaling | Others | Inflammation |
4593 | TPM1 | RNA | Angiogenesis | Others | Cardiovascular |
4594 | TPM2 | RNA | Others | Others | Others |
4595 | TPO | RNA | Others | Others | Others |
4596 | TPP1 | RNA | Others | Others | Others |
4597 | TPP2 | RNA | Others | Others | Others |
4598 | TPR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4599 | TPSAB1 | RNA | Others | Others | Others |
4600 | TPSAB1/B2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
4601 | TPSB2 | RNA | Matrix Remodeling and Metastases | Others | CNS |
4602 | TPSD1 | RNA | Matrix Remodeling and Metastases | Others | CNS |
4603 | TPTE | RNA | Others | Others | Others |
4604 | TPX2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4605 | TRAC | RNA | Others | Others | Others |
4606 | TRADD | RNA | Others | Others | Others |
4607 | TRAF1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4608 | TRAF2 | RNA | Others | Others | Others |
4609 | TRAF3 | RNA | Others | Others | Others |
4610 | TRAF4 | RNA | Others | Others | Others |
4611 | TRAF5 | RNA | Others | Others | Others |
4612 | TRAF6 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4613 | TRAF7 | RNA | Others | Others | Others |
4614 | TRAM1 | RNA | Others | Others | Others |
4615 | TRAT1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4616 | TRAV10 | RNA | Others | Others | Others |
4617 | TRAV11 | RNA | Others | Others | Others |
4618 | TRAV1-1 | RNA | Others | Others | Others |
4619 | TRAV1-2 | RNA | Others | Others | Others |
4620 | TRAV12-1 | RNA | Others | Others | Others |
4621 | TRAV12-2 | RNA | Others | Others | Others |
4622 | TRAV12-3 | RNA | Others | Others | Others |
4623 | TRAV13-1 | RNA | Others | Others | Others |
4624 | TRAV13-2 | RNA | Others | Others | Others |
4625 | TRAV14 | RNA | Others | Others | Others |
4626 | TRAV16 | RNA | Others | Others | Others |
4627 | TRAV17 | RNA | Others | Others | Others |
4628 | TRAV18 | RNA | Others | Others | Others |
4629 | TRAV19 | RNA | Others | Others | Others |
4630 | TRAV2 | RNA | Others | Others | Others |
4631 | TRAV20 | RNA | Others | Others | Others |
4632 | TRAV21 | RNA | Others | Others | Others |
4633 | TRAV22 | RNA | Others | Others | Others |
4634 | TRAV23 | RNA | Others | Others | Others |
4635 | TRAV24 | RNA | Others | Others | Others |
4636 | TRAV25 | RNA | Others | Others | Others |
4637 | TRAV26-1 | RNA | Others | Others | Others |
4638 | TRAV26-2 | RNA | Others | Others | Others |
4639 | TRAV27 | RNA | Others | Others | Others |
4640 | TRAV29 | RNA | Others | Others | Others |
4641 | TRAV3 | RNA | Others | Others | Others |
4642 | TRAV30 | RNA | Others | Others | Others |
4643 | TRAV34 | RNA | Others | Others | Others |
4644 | TRAV35 | RNA | Others | Others | Others |
4645 | TRAV36 | RNA | Others | Others | Others |
4646 | TRAV38-1 | RNA | Others | Others | Others |
4647 | TRAV38-2 | RNA | Others | Others | Others |
4648 | TRAV39 | RNA | Others | Others | Others |
4649 | TRAV4 | RNA | Others | Others | Others |
4650 | TRAV40 | RNA | Others | Others | Others |
4651 | TRAV41 | RNA | Others | Others | Others |
4652 | TRAV5 | RNA | Others | Others | Others |
4653 | TRAV6 | RNA | Others | Others | Others |
4654 | TRAV7 | RNA | Others | Others | Others |
4655 | TRAV8-1 | RNA | Others | Others | Others |
4656 | TRAV8-2 | RNA | Others | Others | Others |
4657 | TRAV8-3 | RNA | Others | Others | Others |
4658 | TRAV8-6 | RNA | Others | Others | Others |
4659 | TRAV9-1 | RNA | Others | Others | Others |
4660 | TRAV9-2 | RNA | Others | Others | Others |
4661 | TRBC1/2 | RNA | Others | Others | Others |
4662 | TRBV10-1 | RNA | Others | Others | Others |
4663 | TRBV10-2 | RNA | Others | Others | Others |
4664 | TRBV10-3 | RNA | Others | Others | Others |
4665 | TRBV11-1 | RNA | Others | Others | Others |
4666 | TRBV11-2 | RNA | Others | Others | Others |
4667 | TRBV11-3 | RNA | Others | Others | Others |
4668 | TRBV12-3 | RNA | Others | Others | Others |
4669 | TRBV12-5 | RNA | Others | Others | Others |
4670 | TRBV13 | RNA | Others | Others | Others |
4671 | TRBV14 | RNA | Others | Others | Others |
4672 | TRBV15 | RNA | Others | Others | Others |
4673 | TRBV16 | RNA | Others | Others | Others |
4674 | TRBV18 | RNA | Others | Others | Others |
4675 | TRBV19 | RNA | Others | Others | Others |
4676 | TRBV2 | RNA | Others | Others | Others |
4677 | TRBV20-1 | RNA | Others | Others | Others |
4678 | TRBV24-1 | RNA | Others | Others | Others |
4679 | TRBV25-1 | RNA | Others | Others | Others |
4680 | TRBV27 | RNA | Others | Others | Others |
4681 | TRBV28 | RNA | Others | Others | Others |
4682 | TRBV29-1 | RNA | Others | Others | Others |
4683 | TRBV30 | RNA | Others | Others | Others |
4684 | TRBV3-1 | RNA | Others | Others | Others |
4685 | TRBV4-1 | RNA | Others | Others | Others |
4686 | TRBV4-2 | RNA | Others | Others | Others |
4687 | TRBV4-3 | RNA | Others | Others | Others |
4688 | TRBV5-1 | RNA | Others | Others | Others |
4689 | TRBV5-4 | RNA | Others | Others | Others |
4690 | TRBV5-5 | RNA | Others | Others | Others |
4691 | TRBV5-6 | RNA | Others | Others | Others |
4692 | TRBV5-8 | RNA | Others | Others | Others |
4693 | TRBV6-1 | RNA | Others | Others | Others |
4694 | TRBV6-2 | RNA | Others | Others | Others |
4695 | TRBV6-4 | RNA | Others | Others | Others |
4696 | TRBV6-5 | RNA | Others | Others | Others |
4697 | TRBV6-6 | RNA | Others | Others | Others |
4698 | TRBV6-8 | RNA | Others | Others | Others |
4699 | TRBV6-9 | RNA | Others | Others | Others |
4700 | TRBV7-2 | RNA | Others | Others | Others |
4701 | TRBV7-3 | RNA | Others | Others | Others |
4702 | TRBV7-4 | RNA | Others | Others | Others |
4703 | TRBV7-6 | RNA | Others | Others | Others |
4704 | TRBV7-7 | RNA | Others | Others | Others |
4705 | TRBV7-8 | RNA | Others | Others | Others |
4706 | TRBV7-9 | RNA | Others | Others | Others |
4707 | TRBV9 | RNA | Others | Others | Others |
4708 | TRDC | RNA | Others | Others | Others |
4709 | TRDV1 | RNA | Others | Others | Others |
4710 | TRDV2 | RNA | Others | Others | Others |
4711 | TRDV3 | RNA | Others | Others | Others |
4712 | TREM1 | RNA | Others | Others | Others |
4713 | TREM2 | RNA | Others | Others | Others |
4714 | TREX1 | RNA | Others | Others | Others |
4715 | TRGC1 | RNA | Others | Others | Others |
4716 | TRGC2 | RNA | Others | Others | Others |
4717 | TRGV2 | RNA | Others | Others | Others |
4718 | TRGV3/5 | RNA | Others | Others | Others |
4719 | TRGV4 | RNA | Others | Others | Others |
4720 | TRGV8 | RNA | Others | Others | Others |
4721 | TRGV9 | RNA | Others | Others | Others |
4722 | TRIB3 | RNA | Others | Others | Others |
4723 | TRIM10 | RNA | Others | Others | Others |
4724 | TRIM14 | RNA | Others | Others | Others |
4725 | TRIM2 | RNA | Others | Others | Others |
4726 | TRIM21 | RNA | Others | Others | Others |
4727 | TRIM22 | RNA | Others | Others | Others |
4728 | TRIM25 | RNA | Others | Others | Others |
4729 | TRIM26 | RNA | Others | Others | Others |
4730 | TRIM28 | RNA | Others | Others | Others |
4731 | TRIM29 | RNA | Others | Others | Others |
4732 | TRIM31 | RNA | Others | Others | Others |
4733 | TRIM33 | RNA | Others | Others | Others |
4734 | TRIM34 | RNA | Others | Others | Others |
4735 | TRIM35 | RNA | Others | Others | Others |
4736 | TRIM36 | RNA | Others | Others | Others |
4737 | TRIM37 | RNA | Others | Others | Others |
4738 | TRIM39 | RNA | Others | Others | Others |
4739 | TRIM46 | RNA | Others | Others | Others |
4740 | TRIM47 | RNA | Others | Others | Others |
4741 | TRIM48 | RNA | Others | Others | Others |
4742 | TRIM5 | RNA | Others | Others | Others |
4743 | TRIM56 | RNA | Others | Others | Others |
4744 | TRIM6 | RNA | Others | Others | Others |
4745 | TRIM68 | RNA | Others | Others | Others |
4746 | TRIM8 | RNA | Others | Others | Others |
4747 | TRIM9 | RNA | Others | Others | Others |
4748 | TRIP13 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4749 | TROVE2 | RNA | Others | Others | Others |
4750 | TRPA1 | RNA | Others | Others | Others |
4751 | TRPC1 | RNA | Others | Others | Others |
4752 | TRPC6 | RNA | Others | Others | Others |
4753 | TRPM2 | RNA | Oxydative Stress | Others | Inflammation |
4754 | TRPM4 | RNA | Others | Others | Others |
4755 | TRPM7 | RNA | Others | Others | Others |
4756 | TRPV1 | RNA | Others | Others | Others |
4757 | TRRAP | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4758 | TSC1 | RNA | Others | Others | Others |
4759 | TSC2 | RNA | Others | Others | Others |
4760 | TSHR | RNA | Cell Proliferation | Others | CNS |
4761 | TSLP | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4762 | TSPAN1 | RNA | EMT | Others | Oncology |
4763 | TSPAN18 | RNA | Others | Others | Others |
4764 | TSPAN7 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
4765 | TSPO | RNA | Others | Others | Others |
4766 | TTC30A | RNA | Others | Others | Others |
4767 | TTC31 | RNA | Others | Others | Others |
4768 | TTK | RNA | Cell Cycle | Others | Oncology |
4769 | TTN | RNA | Others | Others | Others |
4770 | TTPA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4771 | TTR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4772 | TTYH1 | RNA | Others | Others | Others |
4773 | TUBA4A | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4774 | TUBB | RNA | Others | Others | Others |
4775 | TUBB3 | RNA | Others | Others | Others |
4776 | TUBB4A | RNA | Others | Others | Others |
4777 | TUBG1 | RNA | Cell Cycle | Others | Oncology |
4778 | TUSC2 | RNA | Others | Others | Others |
4779 | TWF1 | RNA | Others | Others | Others |
4780 | TWIST1 | RNA | Cellular Differentiation | Others | Oncology |
4781 | TWIST2 | RNA | Cell Proliferation | Others | CNS |
4782 | TWISTNB | RNA | Others | Others | Others |
4783 | TXK | RNA | Others | Others | Others |
4784 | TXN | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4785 | TXN2 | RNA | Cell Stress | Others | CNS |
4786 | TXNDC5 | RNA | Others | Others | Others |
4787 | TXNIP | RNA | Cell Proliferation | Others | CNS |
4788 | TXNL1 | RNA | Oxydative Stress | Others | Inflammation |
4789 | TXNRD1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4790 | TXNRD2 | RNA | Others | Others | Others |
4791 | TYK2 | RNA | Others | Others | Others |
4792 | TYMP | RNA | Angiogenesis | Others | Cardiovascular |
4793 | TYMS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4794 | TYROBP | RNA | Others | Others | Others |
4795 | U2AF1 | RNA | Others | Others | Others |
4796 | U2AF2 | RNA | Others | Others | Others |
4797 | UBA5 | RNA | Others | Others | Others |
4798 | UBA52 | RNA | Others | Others | Others |
4799 | UBA7 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4800 | UBB | RNA | Apoptosis | Others | Oncology |
4801 | UBC | RNA | Others | Others | Others |
4802 | UBE2C | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4803 | UBE2D1 | RNA | Others | Others | Others |
4804 | UBE2D2 | RNA | Others | Others | Others |
4805 | UBE2F | RNA | Others | Others | Others |
4806 | UBE2I | RNA | Others | Others | Others |
4807 | UBE2K | RNA | Others | Others | Others |
4808 | UBE2L3 | RNA | Others | Others | Others |
4809 | UBE2L6 | RNA | Others | Others | Others |
4810 | UBE2N | RNA | Others | Others | Others |
4811 | UBE2S | RNA | Others | Others | Others |
4812 | UBE2T | RNA | Cell Stress | Others | CNS |
4813 | UBE2V1 | RNA | Others | Others | Others |
4814 | UBE3A | RNA | Others | Others | Others |
4815 | UBE4B | RNA | Others | Others | Others |
4816 | UBQLN1 | RNA | Oxydative Stress | Others | Inflammation |
4817 | UCHL1 | RNA | Others | Others | Others |
4818 | UCHL5 | RNA | mTOR Signaling | Others | Oncology |
4819 | UCK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4820 | UCK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4821 | UCKL1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4822 | UCP1 | RNA | Others | Others | Others |
4823 | UGCG | RNA | Lipid Metabolism | Others | Metabolic Diseases |
4824 | UGDH | RNA | Androgen Signaling | Others | Oncology |
4825 | UGT8 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
4826 | UHRF1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4827 | ULBP2 | RNA | Others | Others | Others |
4828 | ULBP3 | RNA | Others | Others | Others |
4829 | ULK1 | RNA | Others | Others | Others |
4830 | ULK2 | RNA | Others | Others | Others |
4831 | UMPS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4832 | UNC13A | RNA | Transmitter Synthesis | Others | CNS |
4833 | UNC93B1 | RNA | Others | Others | Others |
4834 | UNG | RNA | Others | Others | Others |
4835 | UPP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4836 | UPP2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4837 | UQCR10 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4838 | UQCR11 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4839 | UQCRB | RNA | Others | Others | Others |
4840 | UQCRFS1 | RNA | Others | Others | Others |
4841 | UQCRH | RNA | Others | Others | Others |
4842 | UQCRQ | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4843 | USP15 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4844 | USP18 | RNA | Others | Others | Others |
4845 | USP21 | RNA | Others | Others | Others |
4846 | USP30 | RNA | Others | Others | Others |
4847 | USP39 | RNA | Others | Others | Others |
4848 | USP8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4849 | USP9Y | RNA | Others | Others | Others |
4850 | UTS2 | RNA | Others | Others | Others |
4851 | UTY | RNA | Others | Others | Others |
4852 | VAMP2 | RNA | Others | Others | Others |
4853 | VAMP3 | RNA | Others | Others | Others |
4854 | VAMP7 | RNA | Others | Others | Others |
4855 | VAMP8 | RNA | Others | Others | Others |
4856 | VASH1 | RNA | Angiogenesis | Others | Cardiovascular |
4857 | VAV1 | RNA | TCR Signaling | Others | Immuno-Oncology |
4858 | VAV2 | RNA | Angiogenesis | Others | Cardiovascular |
4859 | VAV3 | RNA | Angiogenesis | Others | Cardiovascular |
4860 | VCAM1 | RNA | Cell Proliferation | Others | CNS |
4861 | VCAN | RNA | Angiogenesis | Others | Cardiovascular |
4862 | VCL | RNA | Others | Others | Others |
4863 | VCP | RNA | Others | Others | Others |
4864 | VDAC1 | RNA | Others | Others | Others |
4865 | VEGFA | RNA | Angiogenesis | Others | Cardiovascular |
4866 | VEGFB | RNA | Angiogenesis | Others | Cardiovascular |
4867 | VEGFC | RNA | Angiogenesis | Others | Cardiovascular |
4868 | VEGFD | RNA | MAPK | Others | Cardiovascular |
4869 | VEZF1 | RNA | Angiogenesis | Others | Cardiovascular |
4870 | VHL | RNA | Cell Proliferation | Others | CNS |
4871 | VIM | RNA | EMT | Others | Oncology |
4872 | VIP | RNA | Carbohydrate Metabolism | Others | CNS |
4873 | VIT | RNA | EMT | Others | Oncology |
4874 | VPS13A | RNA | Others | Others | Others |
4875 | VPS28 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4876 | VPS33B | RNA | Others | Others | Others |
4877 | VPS4A | RNA | Others | Others | Others |
4878 | VPS4B | RNA | Others | Others | Others |
4879 | VRK3 | RNA | Others | Others | Others |
4880 | VSIG4 | RNA | Cell Proliferation | Others | CNS |
4881 | VSIR | RNA | Others | Others | Others |
4882 | VTCN1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4883 | VTN | RNA | Others | Others | Others |
4884 | VWA1 | RNA | Others | Others | Others |
4885 | VWA2 | RNA | Others | Others | Others |
4886 | VWF | RNA | ECM Remodeling | Others | Metabolic Diseases |
4887 | WARS | RNA | Angiogenesis | Others | Cardiovascular |
4888 | WAS | RNA | Others | Others | Others |
4889 | WASF2 | RNA | VEGFR Signaling | Others | Cardiovascular |
4890 | WASHC4 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4891 | WDR45 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
4892 | WDR5 | RNA | Others | Others | Others |
4893 | WDR76 | RNA | Others | Others | Others |
4894 | WDR77 | RNA | ER Signaling | Others | Oncology |
4895 | WEE1 | RNA | Cell Cycle | Others | Oncology |
4896 | WFS1 | RNA | Others | Others | Others |
4897 | WHSC1 | RNA | Others | Others | Others |
4898 | WHSC1L1 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
4899 | WIF1 | RNA | Wnt Signaling | Others | CNS |
4900 | WIPF1 | RNA | Cellular Differentiation | Others | Oncology |
4901 | WIPI1 | RNA | Others | Others | Others |
4902 | WNT1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
4903 | WNT10A | RNA | Hedgehog | Others | CNS |
4904 | WNT10B | RNA | Others | Others | Others |
4905 | WNT11 | RNA | Hedgehog | Others | CNS |
4906 | WNT16 | RNA | Others | Others | Others |
4907 | WNT2 | RNA | Hedgehog | Others | CNS |
4908 | WNT2B | RNA | Hedgehog | Others | CNS |
4909 | WNT3 | RNA | Others | Others | Others |
4910 | WNT3A | RNA | Hedgehog | Others | CNS |
4911 | WNT4 | RNA | Hedgehog | Others | CNS |
4912 | WNT5A | RNA | Cell Proliferation | Others | CNS |
4913 | WNT5B | RNA | Cellular Differentiation | Others | Oncology |
4914 | WNT6 | RNA | Hedgehog | Others | CNS |
4915 | WNT7A | RNA | Others | Others | Others |
4916 | WNT7B | RNA | Hedgehog | Others | CNS |
4917 | WRAP53 | RNA | Cell Cycle | Others | Oncology |
4918 | WRN | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4919 | WT1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
4920 | WWC1 | RNA | Hippo Signaling | Others | CNS |
4921 | WWTR1 | RNA | Hippo Signaling | Others | CNS |
4922 | XAB2 | RNA | Others | Others | Others |
4923 | XAF1 | RNA | Others | Others | Others |
4924 | XBP1 | RNA | mTOR Signaling | Others | Oncology |
4925 | XCL1 | RNA | Others | Others | Others |
4926 | XCL1/2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
4927 | XCL2 | RNA | Others | Others | Others |
4928 | XCR1 | RNA | Others | Others | Others |
4929 | XDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4930 | XIAP | RNA | Others | Others | Others |
4931 | XK | RNA | Myelination | Others | CNS |
4932 | XPA | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4933 | XRCC2 | RNA | Cell Stress | Others | CNS |
4934 | XRCC3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4935 | XRCC4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4936 | XRCC6 | RNA | Others | Others | Others |
4937 | YAP1 | RNA | Hippo Signaling | Others | CNS |
4938 | YES1 | RNA | Others | Others | Others |
4939 | YTHDF2 | RNA | Others | Others | Others |
4940 | YWHAB | RNA | Others | Others | Others |
4941 | YWHAE | RNA | Others | Others | Others |
4942 | YWHAG | RNA | Others | Others | Others |
4943 | YWHAQ | RNA | Others | Others | Others |
4944 | YWHAZ | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
4945 | YY1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4946 | ZAK | RNA | Others | Others | Others |
4947 | ZAP70 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
4948 | ZBP1 | RNA | Others | Others | Others |
4949 | ZBTB16 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
4950 | ZBTB20 | RNA | Others | Others | Others |
4951 | ZBTB32 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
4952 | ZC3H12A | RNA | Angiogenesis | Others | Cardiovascular |
4953 | ZC3H14 | RNA | Others | Others | Others |
4954 | ZCCHC24 | RNA | Others | Others | Others |
4955 | ZDHHC2 | RNA | Others | Others | Others |
4956 | ZEB1 | RNA | Cell Proliferation | Others | CNS |
4957 | ZEB2 | RNA | Cell Proliferation | Others | CNS |
4958 | ZFP36L2 | RNA | Others | Others | Others |
4959 | ZFPM2 | RNA | EMT | Others | Oncology |
4960 | ZFYVE16 | RNA | Others | Others | Others |
4961 | ZFYVE9 | RNA | Proliferation | Others | Oncology |
4962 | ZIC2 | RNA | Hedgehog | Others | CNS |
4963 | ZKSCAN5 | RNA | Others | Others | Others |
4964 | ZMYM2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4965 | ZNF100 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4966 | ZNF136 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4967 | ZNF143 | RNA | Others | Others | Others |
4968 | ZNF205 | RNA | Others | Others | Others |
4969 | ZNF24 | RNA | Myelination | Others | CNS |
4970 | ZNF253 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4971 | ZNF254 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4972 | ZNF346 | RNA | Others | Others | Others |
4973 | ZNF367 | RNA | Others | Others | Others |
4974 | ZNF384 | RNA | Others | Others | Others |
4975 | ZNF385A | RNA | Others | Others | Others |
4976 | ZNF43 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4977 | ZNF610 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4978 | ZNF675 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4979 | ZNF682 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4980 | ZNF683 | RNA | Others | Others | Others |
4981 | ZNF708 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4982 | ZNF85 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4983 | ZNF91 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4984 | ZNF93 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
4985 | Alanine | Amino-acid & Metabolites | Others | Others | Others |
4986 | 3-MT | Amino-acid & Metabolites | Others | Others | Others |
4987 | Adenosine | Amino-acid & Metabolites | Others | Others | Others |
4988 | ADP | Amino-acid & Metabolites | Others | Others | Others |
4989 | AMP | Amino-acid & Metabolites | Others | Others | Others |
4990 | AMPc | Amino-acid & Metabolites | Others | Others | Others |
4991 | Arginine | Amino-acid & Metabolites | Others | Others | Others |
4992 | Asparagine | Amino-acid & Metabolites | Others | Others | Others |
4993 | Aspartate | Amino-acid & Metabolites | Others | Others | Others |
4994 | ATP | Amino-acid & Metabolites | Others | Others | Others |
4995 | Citrate | Amino-acid & Metabolites | Others | Others | Others |
4996 | Dopamine | Amino-acid & Metabolites | Others | Others | Others |
4997 | Fructose 1 P | Amino-acid & Metabolites | Others | Others | Others |
4998 | Fumarate | Amino-acid & Metabolites | Others | Others | Others |
4999 | GDP | Amino-acid & Metabolites | Others | Others | Others |
5000 | Glucose | Amino-acid & Metabolites | Others | Others | Others |
5001 | Glucose 6P | Amino-acid & Metabolites | Others | Others | Others |
5002 | glutamate | Amino-acid & Metabolites | Others | Others | Others |
5003 | Glutamine | Amino-acid & Metabolites | Others | Others | Others |
5004 | Glycine | Amino-acid & Metabolites | Others | Others | Others |
5005 | GMP | Amino-acid & Metabolites | Others | Others | Others |
5006 | GTP | Amino-acid & Metabolites | Others | Others | Others |
5007 | Guanine | Amino-acid & Metabolites | Others | Others | Others |
5008 | guanosine | Amino-acid & Metabolites | Others | Others | Others |
5009 | HIAA (5-hydroxy-Indole-3-acetic acid) | Amino-acid & Metabolites | Others | Others | Others |
5010 | Hypoxanthine | Amino-acid & Metabolites | Others | Others | Others |
5011 | IMP | Amino-acid & Metabolites | Others | Others | Others |
5012 | Inosine | Amino-acid & Metabolites | Others | Others | Others |
5013 | kynurenic acid | Amino-acid & Metabolites | Others | Others | Others |
5014 | Lactate | Amino-acid & Metabolites | Others | Others | Others |
5015 | L-DOPA | Amino-acid & Metabolites | Others | Others | Others |
5016 | Leucine (Isoleucine) | Amino-acid & Metabolites | Others | Others | Others |
5017 | Lysine | Amino-acid & Metabolites | Others | Others | Others |
5018 | malate | Amino-acid & Metabolites | Others | Others | Others |
5019 | MTA adenosine | Amino-acid & Metabolites | Others | Others | Others |
5020 | ornithine | Amino-acid & Metabolites | Others | Others | Others |
5021 | Phenylalanine | Amino-acid & Metabolites | Others | Others | Others |
5022 | Proline | Amino-acid & Metabolites | Others | Others | Others |
5023 | Pyruvate | Amino-acid & Metabolites | Others | Others | Others |
5024 | Serine | Amino-acid & Metabolites | Others | Others | Others |
5025 | Serotonin | Amino-acid & Metabolites | Others | Others | Others |
5026 | Spermidine | Amino-acid & Metabolites | Others | Others | Others |
5027 | Taurine | Amino-acid & Metabolites | Others | Others | Others |
5028 | Theronine | Amino-acid & Metabolites | Others | Others | Others |
5029 | Tryptamine | Amino-acid & Metabolites | Others | Others | Others |
5030 | Tryptophan | Amino-acid & Metabolites | Others | Others | Others |
5031 | uric acid | Amino-acid & Metabolites | Others | Others | Others |
5032 | Valine | Amino-acid & Metabolites | Others | Others | Others |
5033 | xanthine | Amino-acid & Metabolites | Others | Others | Others |
5034 | PE(19:0/0:0) | Lipid | Others | Others | Others |
5035 | Apigenin 7-glucuronide-4′-(6 »-malonylglucoside) | Lipid | Others | Others | Others |
5036 | Anguvetin | Lipid | Others | Others | Others |
5037 | Anastatin A | Lipid | Others | Others | Others |
5038 | Anandamide (20:l, n-9) | Lipid | Others | Others | Others |
5039 | Amaronol B | Lipid | Others | Others | Others |
5040 | alhpa-tocopheronolactone | Lipid | Others | Others | Others |
5041 | algestone | Lipid | Others | Others | Others |
5042 | Agavegenin A | Lipid | Others | Others | Others |
5043 | Adrenic acid | Lipid | Others | Others | Others |
5044 | Acylcarnitine C18:0 | Lipid | Others | Others | Others |
5045 | 9Z,12Z,15Z,18Z-Tetracosatetraenoic acid | Lipid | Others | Others | Others |
5046 | 9Z,11E,13-Tetradecatrienal | Lipid | Others | Others | Others |
5047 | 9S,10S,11R-trihydroxy-12Z-octadecenoic acid | Lipid | Others | Others | Others |
5048 | 9-oxo-2E-decenoic acid | Lipid | Others | Others | Others |
5049 | 9-deoxy-9-methylene-16,16-dimethyl -PGE2 | Lipid | Others | Others | Others |
5050 | 9,11alpha-epoxypregn-4-ene-3,20-dione | Lipid | Others | Others | Others |
5051 | 9,11alpha-epoxy-6alpha-acetoxy-cholest-7-en-3beta,5alpha,19-triol | Lipid | Others | Others | Others |
5052 | 8′-apo-beta-carotenol | Lipid | Others | Others | Others |
5053 | 8,9,10,11-Tetrafluoro-8E,10E-dodecadien-1-ol | Lipid | Others | Others | Others |
5054 | 8,8-Dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b’]dipyran-4-one | Lipid | Others | Others | Others |
5055 | 8,11,14-Docosatriynoic acid | Lipid | Others | Others | Others |
5056 | 7-O-Methyllicoricidin | Lipid | Others | Others | Others |
5057 | 7-methyl-3-oxooctanoyl-CoA | Lipid | Others | Others | Others |
5058 | 6Z,9Z-Docosadiene | Lipid | Others | Others | Others |
5059 | 6-fluorovitamin D3 / 6-fluorocholecalciferol | Lipid | Others | Others | Others |
5060 | 6beta-Hydroxyasiatic acid | Lipid | Others | Others | Others |
5061 | 5-oxo-7-octenoic acid | Lipid | Others | Others | Others |
5062 | 5beta-scymnol sulfate | Lipid | Others | Others | Others |
5063 | 5alpha-Tetrahydrocorticosterone | Lipid | Others | Others | Others |
5064 | 4E,14Z-Sphingadiene | Lipid | Others | Others | Others |
5065 | 4,7-dioxo-octanoic acid | Lipid | Others | Others | Others |
5066 | 4,4′-Diaponeurosporene | Lipid | Others | Others | Others |
5067 | 4,2′,3′,4′,6′-Pentahydroxy-5′-neryldihydrochalcone | Lipid | Others | Others | Others |
5068 | 3-oxoglycyrrhetinic acid | Lipid | Others | Others | Others |
5069 | 3-O-Methylanhydrotuberosin | Lipid | Others | Others | Others |
5070 | 3-O-(2-O-(2E-decenoyl)-alpha-L-rhamnopyranosyl)-3-hydroxydecanoic acid | Lipid | Others | Others | Others |
5071 | 3-Deoxyvitamin D3 | Lipid | Others | Others | Others |
5072 | 38:5(23Z,26Z,29Z,32Z,35Z) | Lipid | Others | Others | Others |
5073 | 32,35-anhydrobacteriohopan-11-ene-tetrol | Lipid | Others | Others | Others |
5074 | 3,5-Di-O-methyl-8-prenylafzelechin-4beta-ol | Lipid | Others | Others | Others |
5075 | 3,5,7,9,11-dodecapentaenoic acid | Lipid | Others | Others | Others |
5076 | 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione | Lipid | Others | Others | Others |
5077 | 3,4,17-trihydroxy-9,10-seco-androsta-1,3,5(10)-triene-9-one | Lipid | Others | Others | Others |
5078 | 3,17-dioxoandrost-4-en-19-al | Lipid | Others | Others | Others |
5079 | 2S-aminoheptanoic acid | Lipid | Others | Others | Others |
5080 | 2-Methyldocosane | Lipid | Others | Others | Others |
5081 | 2-Methylacetophenone | Lipid | Others | Others | Others |
5082 | 2-demethylmenaquinone-8 | Lipid | Others | Others | Others |
5083 | 2-Amino-3-methylbutanoic acid | Lipid | Others | Others | Others |
5084 | 26,26,26-trifluoro-25-hydroxy-27-norvitamin D3 / 26,26,26-trifluoro-25-hydroxy-27-norcholecalciferol | Lipid | Others | Others | Others |
5085 | 24,24-difluoro-1alpha,25-dihydroxy-24a-homovitamin D3 / 24,24-difluoro-1alpha,25-dihydroxy-24a-homocholecalciferol | Lipid | Others | Others | Others |
5086 | 22:6 Cholesteryl ester | Lipid | Others | Others | Others |
5087 | 20-COOH-leukotriene E4 | Lipid | Others | Others | Others |
5088 | 20:1 Campesteryl ester | Lipid | Others | Others | Others |
5089 | 1-tetradecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | Others | Others | Others |
5090 | 1-Hexadecylglycerol | Lipid | Others | Others | Others |
5091 | 1-hexadecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | Others | Others | Others |
5092 | 1alpha,25-dihydroxy-2beta-(6-hydroxyhexyl)vitamin D3 / 1alpha,25-dihydroxy-2beta-(6-hydroxyhexyl)cholecalciferol | Lipid | Others | Others | Others |
5093 | 1alpha,25-dihydroxy-2beta-(3-hydroxypropyl)vitamin D3 / 1alpha,25-dihydroxy-2beta-(3-hydroxypropyl)cholecalciferol | Lipid | Others | Others | Others |
5094 | 1alpha,22-dihydroxy-23,24,25,26,27-pentanorvitamin D3 / 1alpha,22-dihydroxy-23,24,25,26,27-pentanorcholecalciferol | Lipid | Others | Others | Others |
5095 | 18-Oxocortisol | Lipid | Others | Others | Others |
5096 | 18:3-Glc-Stigmasterol | Lipid | Others | Others | Others |
5097 | 18:0-Glc-Campesterol | Lipid | Others | Others | Others |
5098 | 17,18-dehydro-clavulone I | Lipid | Others | Others | Others |
5099 | 16:0-Glc-Campesterol | Lipid | Others | Others | Others |
5100 | 16,17-epoxy-DHA | Lipid | Others | Others | Others |
5101 | 15-methyl-15R-PGF2alpha | Lipid | Others | Others | Others |
5102 | 12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid | Lipid | Others | Others | Others |
5103 | 12-hydroxyjasmonic acid 12-O-beta-D-glucoside | Lipid | Others | Others | Others |
5104 | 11,12-dihydroxy arachidic acid | Lipid | Others | Others | Others |
5105 | 10-[5]-ladderane-decanoic acid | Lipid | Others | Others | Others |
5106 | 1,2-Dihydro-5-hydroxy-2-(1-hydroxy-1-methylethyl)-4-(isobutyryl)-6-phenylfurano[2,3-h][1]benzopyran-8-one | Lipid | Others | Others | Others |
5107 | 1-(8-[5]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | Others | Others | Others |
5108 | 1-(8-[5]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | Others | Others | Others |
5109 | 1-(8-[3]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | Others | Others | Others |
5110 | 1-(8-[3]-ladderane-octanoyl-2-(8-[3]-ladderane-octanyl)-sn-glycerol | Lipid | Others | Others | Others |
5111 | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | Others | Others | Others |
5112 | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | Others | Others | Others |
5113 | 1-(2E,6E-phytadienyl)-2-(2E,6E-phytadienyl)-sn-glycero-3-phosphocholine | Lipid | Others | Others | Others |
5114 | (E,E)-2,4-Decadienoic isobutylamide | Lipid | Others | Others | Others |
5115 | (7Z,10Z,13Z,16Z,19Z)-docosapentaenoylcarnitine | Lipid | Others | Others | Others |
5116 | (6S)-vitamin D2 6,19-sulfur dioxide adduct / (6S)-ergocalciferol 6,19-sulfur dioxide adduct | Lipid | Others | Others | Others |
5117 | (6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3 / (6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrocholecalciferol | Lipid | Others | Others | Others |
5118 | (5E,10Z)-19-fluoro-1alpha-hydroxyvitamin-D3 / (5E,10Z)-19-fluoro-1alpha-hydroxycholecalciferol | Lipid | Others | Others | Others |
5119 | (5E,10E)-19-fluoro-1alpha,25-dihydroxyvitamin D3 / (5E,10E)-19-fluoro-1alpha,25-dihydroxycholecalciferol | Lipid | Others | Others | Others |
5120 | (3′-sulfo)Galbeta-Cer(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
5121 | (3′-sulfo)Galbeta-Cer(d18:1/24:1(15Z)(2OH)) | Lipid | Others | Others | Others |
5122 | (3′-sulfo)Galbeta-Cer(d18:1/24:0) | Lipid | Others | Others | Others |
5123 | (3′-sulfo)Galbeta-Cer(d18:1/24:0(2OH)) | Lipid | Others | Others | Others |
5124 | (3′-sulfo)Galbeta-Cer(d18:1/22:0) | Lipid | Others | Others | Others |
5125 | (3′-sulfo)Galbeta-Cer(d18:1/22:0(2OH)) | Lipid | Others | Others | Others |
5126 | (3′-sulfo)Galbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
5127 | (3′-sulfo)Galbeta-Cer(d18:1/20:0(2OH)) | Lipid | Others | Others | Others |
5128 | (3′-sulfo)Galbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
5129 | (3′-sulfo)Galbeta-Cer(d18:1/18:0(2OH)) | Lipid | Others | Others | Others |
5130 | (3′-sulfo)Galbeta-Cer(d18:1/16:0) | Lipid | Others | Others | Others |
5131 | (24R)-1alpha,24-dihydroxy-22-oxa-20-epivitamin D3 / (24R)-1alpha,24-dihydroxy-22-oxa-20-epicholecalciferol | Lipid | Others | Others | Others |
5132 | (23R,25S)-1alpha,25-dihydroxyvitamin D3 26,23-lactone / (23R,25S)-1alpha,25-dihydroxycholecalciferol 26,23-lactone | Lipid | Others | Others | Others |
5133 | (-)N-(2R-hydroxy-propyl) alpha,alpha-dimethylarachidonoyl amine | Lipid | Others | Others | Others |
5134 | (-)-Fusidic acid | Lipid | Others | Others | Others |
5135 | (-)-Asbestinine 2 | Lipid | Others | Others | Others |
5136 | Butyl 4′-O-butanoyl-6-O-hexadecanoyl-neohesperidoside | Lipid | Others | Others | Others |
5137 | C17 Sphinganine | Lipid | Others | Others | Others |
5138 | Cauliflorin A | Lipid | Others | Others | Others |
5139 | Cer(d14:1(4E)/26:0(2OH)) | Lipid | Others | Others | Others |
5140 | Cer(d14:2(4E,6E)/22:0) | Lipid | Others | Others | Others |
5141 | Cer(d16:1(4E)/22:0(2OH)) | Lipid | Others | Others | Others |
5142 | Cer(d18:0/18:1(9Z)) | Lipid | Others | Others | Others |
5143 | Cer(d18:1/20:0) | Lipid | Others | Others | Others |
5144 | Cer(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
5145 | Cer(d18:2/22:0) | Lipid | Others | Others | Others |
5146 | Cer(m18:0/22:0) | Lipid | Others | Others | Others |
5147 | CerP(d18:1/16:0) | Lipid | Others | Others | Others |
5148 | CerP(d18:1/18:0) | Lipid | Others | Others | Others |
5149 | CerP(d18:1/22:0) | Lipid | Others | Others | Others |
5150 | CerP(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
5151 | CerP(d18:1/8:0) | Lipid | Others | Others | Others |
5152 | Cholestanyl glucoside | Lipid | Others | Others | Others |
5153 | cholesterol sulfate | Lipid | Others | Others | Others |
5154 | CL(1′-[18:1(9Z)/18:2(9Z,12Z)],3′-[20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)]) | Lipid | Others | Others | Others |
5155 | CL(1′-[18:2(9Z,12Z)/0:0],3′-[18:2(9Z,12Z)/0:0]) | Lipid | Others | Others | Others |
5156 | CL(1′-[20:0/18:0],3′-[20:0/18:0]) | Lipid | Others | Others | Others |
5157 | CL(1′-[20:0/18:1(9Z)],3′-[18:2(9Z,12Z)/20:0]) | Lipid | Others | Others | Others |
5158 | CL(1′-[20:0/18:1(9Z)],3′-[20:0/20:0]) | Lipid | Others | Others | Others |
5159 | CL(1′-[20:0/18:1(9Z)],3′-[20:4(5Z,8Z,11Z,14Z)/20:0]) | Lipid | Others | Others | Others |
5160 | CL(1′-[20:0/20:0],3′-[18:2(9Z,12Z)/20:0]) | Lipid | Others | Others | Others |
5161 | CL(1′-[20:4(5Z,8Z,11Z,14Z)/20:0],3′-[20:0/18:2(9Z,12Z)]) | Lipid | Others | Others | Others |
5162 | CL(1′-[20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)],3′-[20:4(5Z,8Z,11Z,14Z)/18:1(9Z)]) | Lipid | Others | Others | Others |
5163 | CL(1′-[22:1(13Z)/22:1(13Z)],3′-[22:1(13Z)/14:1(9Z)])[rac] | Lipid | Others | Others | Others |
5164 | CoA(24:6(6Z,9Z,12Z,15Z,18Z,21Z)(3OH)) | Lipid | Others | Others | Others |
5165 | CPA(16:0) | Lipid | Others | Others | Others |
5166 | CPA(18:0) | Lipid | Others | Others | Others |
5167 | CPA(18:1(9Z)) | Lipid | Others | Others | Others |
5168 | Cucurbitacin I | Lipid | Others | Others | Others |
5169 | Delphinidin 3-(2 »-galloylgalactoside) | Lipid | Others | Others | Others |
5170 | DG(14:0/18:0/0:0)[iso2] | Lipid | Others | Others | Others |
5171 | DG(14:0/20:1(11Z)/0:0)[iso2] | Lipid | Others | Others | Others |
5172 | DG(16:0/18:2(9Z,12Z)/0:0)[iso2] | Lipid | Others | Others | Others |
5173 | DG(17:1(9Z)/19:0/0:0)[iso2] | Lipid | Others | Others | Others |
5174 | DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] | Lipid | Others | Others | Others |
5175 | DG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)[iso2] | Lipid | Others | Others | Others |
5176 | DG(19:0/22:0/0:0)[iso2] | Lipid | Others | Others | Others |
5177 | DG(19:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)[iso2] | Lipid | Others | Others | Others |
5178 | DG(P-14:0/18:1(9Z)) | Lipid | Others | Others | Others |
5179 | DGTS(16:0/16:0) | Lipid | Others | Others | Others |
5180 | Dinorlithocholic acid | Lipid | Others | Others | Others |
5181 | Dioctyl hexanedioate | Lipid | Others | Others | Others |
5182 | Diospolysaponin A | Lipid | Others | Others | Others |
5183 | DL-Acetylcarnitine | Lipid | Others | Others | Others |
5184 | Docosanamide | Lipid | Others | Others | Others |
5185 | Ecalcidene | Lipid | Others | Others | Others |
5186 | Elaidic carnitine | Lipid | Others | Others | Others |
5187 | Eriotriochin | Lipid | Others | Others | Others |
5188 | Erybraedin E | Lipid | Others | Others | Others |
5189 | Estradiol dipropionate | Lipid | Others | Others | Others |
5190 | Etioline | Lipid | Others | Others | Others |
5191 | Exiguaflavanone J | Lipid | Others | Others | Others |
5192 | Falcarindiol | Lipid | Others | Others | Others |
5193 | Fluoxymesterone | Lipid | Others | Others | Others |
5194 | Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Lipid | Others | Others | Others |
5195 | fumagillin | Lipid | Others | Others | Others |
5196 | Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
5197 | Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
5198 | Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Lipid | Others | Others | Others |
5199 | Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
5200 | GalCer(d18:1/18:0) | Lipid | Others | Others | Others |
5201 | GalCer(d18:1/24:0) | Lipid | Others | Others | Others |
5202 | GalCer(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
5203 | GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
5204 | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
5205 | Gangetin | Lipid | Others | Others | Others |
5206 | Gibberellin A51 | Lipid | Others | Others | Others |
5207 | Ginkgolide A | Lipid | Others | Others | Others |
5208 | GlcCer(d14:1(4E)/24:1(15Z)(2OH)) | Lipid | Others | Others | Others |
5209 | GlcCer(d14:1/24:0) | Lipid | Others | Others | Others |
5210 | GlcCer(d15:1/20:0) | Lipid | Others | Others | Others |
5211 | GlcCer(d16:1(4E)/22:0(2OH)) | Lipid | Others | Others | Others |
5212 | GlcCer(d16:1/24:0) | Lipid | Others | Others | Others |
5213 | GlcCer(d16:2(4E,6E)/24:0(2OH)) | Lipid | Others | Others | Others |
5214 | GlcCer(d16:2(4E,6E)/24:0) | Lipid | Others | Others | Others |
5215 | GlcCer(d18:1/23:0) | Lipid | Others | Others | Others |
5216 | GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
5217 | Grandiflorone | Lipid | Others | Others | Others |
5218 | Hexacosanedioic acid | Lipid | Others | Others | Others |
5219 | Homomurideoxycholic acid | Lipid | Others | Others | Others |
5220 | Homo-omega-muricholic acid | Lipid | Others | Others | Others |
5221 | Hydrocortisone caproate | Lipid | Others | Others | Others |
5222 | Isorhamnetin 3-(6 »-malonylglucoside) | Lipid | Others | Others | Others |
5223 | Kaempferol 3-rhamnosyl-(1->2)-[glucosyl-(1->3)-(4 »’-p-coumaroylrhamnosyl)-(1->6)-galactoside] | Lipid | Others | Others | Others |
5224 | Kushenol D | Lipid | Others | Others | Others |
5225 | LacCer(d18:0/18:0) | Lipid | Others | Others | Others |
5226 | LacCer(d18:0/20:0) | Lipid | Others | Others | Others |
5227 | LacCer(d18:0/22:0) | Lipid | Others | Others | Others |
5228 | LacCer(d18:1/12:0) | Lipid | Others | Others | Others |
5229 | LacCer(d18:1/14:0) | Lipid | Others | Others | Others |
5230 | Lespedezaflavanone F | Lipid | Others | Others | Others |
5231 | Leucadenone B | Lipid | Others | Others | Others |
5232 | LysoPC(20:4(8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
5233 | LysoPE(0:0/16:0) | Lipid | Others | Others | Others |
5234 | LysoPE(0:0/18:0) | Lipid | Others | Others | Others |
5235 | LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5236 | Manbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
5237 | Manniflavanone | Lipid | Others | Others | Others |
5238 | Megalomicin B | Lipid | Others | Others | Others |
5239 | methyl 4-[2-(2-formyl-vinyl)-3-hydroxy-5-oxo-cyclopentyl]-butanoate | Lipid | Others | Others | Others |
5240 | methyl 5-hydroperoxy-6,8,9,11-bisepidioxy-12,14-eicosadienoate | Lipid | Others | Others | Others |
5241 | MG(16:0/0:0/0:0) | Lipid | Others | Others | Others |
5242 | MG(18:0/0:0/0:0)[rac] | Lipid | Others | Others | Others |
5243 | MGDG(18:2(9Z,12Z)/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
5244 | Myrigalon B | Lipid | Others | Others | Others |
5245 | N,N-dimethyl-Safingol | Lipid | Others | Others | Others |
5246 | N-amyl arachidohoyl amine | Lipid | Others | Others | Others |
5247 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) | Lipid | Others | Others | Others |
5248 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
5249 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
5250 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Lipid | Others | Others | Others |
5251 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) | Lipid | Others | Others | Others |
5252 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
5253 | NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
5254 | Nonadecyl palmitoleate | Lipid | Others | Others | Others |
5255 | Norlithocholic acid | Lipid | Others | Others | Others |
5256 | OH-Chlorobactene glucoside laurate | Lipid | Others | Others | Others |
5257 | Oleyl alcohol | Lipid | Others | Others | Others |
5258 | PA(12:0/21:0) | Lipid | Others | Others | Others |
5259 | PA(13:0/0:0) | Lipid | Others | Others | Others |
5260 | PA(13:0/16:1(9Z)) | Lipid | Others | Others | Others |
5261 | PA(14:0/18:0) | Lipid | Others | Others | Others |
5262 | PA(17:1(9Z)/0:0) | Lipid | Others | Others | Others |
5263 | PA(17:1(9Z)/13:0) | Lipid | Others | Others | Others |
5264 | PA(18:0/0:0) | Lipid | Others | Others | Others |
5265 | PA(18:1(9Z)/0:0) | Lipid | Others | Others | Others |
5266 | PA(18:3(6Z,9Z,12Z)/14:1(9Z)) | Lipid | Others | Others | Others |
5267 | PA(18:3(9Z,12Z,15Z)/0:0) | Lipid | Others | Others | Others |
5268 | PA(18:4(6Z,9Z,12Z,15Z)/0:0) | Lipid | Others | Others | Others |
5269 | PA(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5270 | PA(20:2(11Z,14Z)/20:0) | Lipid | Others | Others | Others |
5271 | PA(20:3(8Z,11Z,14Z)/18:0) | Lipid | Others | Others | Others |
5272 | PA(20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z)) | Lipid | Others | Others | Others |
5273 | PA(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z)) | Lipid | Others | Others | Others |
5274 | PA(21:0/13:0) | Lipid | Others | Others | Others |
5275 | PA(22:1(11Z)/16:0) | Lipid | Others | Others | Others |
5276 | PA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0) | Lipid | Others | Others | Others |
5277 | PA(O-16:0/20:3(8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5278 | PA(O-16:0/22:2(13Z,16Z)) | Lipid | Others | Others | Others |
5279 | PA(O-18:0/21:0) | Lipid | Others | Others | Others |
5280 | PA(O-20:0/21:0) | Lipid | Others | Others | Others |
5281 | PA(P-16:0/0:0) | Lipid | Others | Others | Others |
5282 | PA(P-16:0/20:1(11Z)) | Lipid | Others | Others | Others |
5283 | PA(P-18:0/16:0) | Lipid | Others | Others | Others |
5284 | PA(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5285 | PA(P-20:0/12:0) | Lipid | Others | Others | Others |
5286 | PA(P-20:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
5287 | PA(P-20:0/18:4(6Z,9Z,12Z,15Z)) | Lipid | Others | Others | Others |
5288 | Palmitoylcarnitine | Lipid | Others | Others | Others |
5289 | Panaxynol | Lipid | Others | Others | Others |
5290 | Pantothenol | Lipid | Others | Others | Others |
5291 | PC(0:0/18:0) | Lipid | Others | Others | Others |
5292 | PC(0:0/18:1(6Z)) | Lipid | Others | Others | Others |
5293 | PC(15:1(9Z)/0:0) | Lipid | Others | Others | Others |
5294 | PC(16:0/9:0(CHO)) | Lipid | Others | Others | Others |
5295 | PC(16:0/9:0(COOH)) | Lipid | Others | Others | Others |
5296 | PC(16:1(9Z)/2:0) | Lipid | Others | Others | Others |
5297 | PC(20:1(11Z)/0:0) | Lipid | Others | Others | Others |
5298 | PC(20:3(8Z,11Z,14Z)/21:0) | Lipid | Others | Others | Others |
5299 | PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
5300 | PC(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
5301 | PC(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)) | Lipid | Others | Others | Others |
5302 | PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) | Lipid | Others | Others | Others |
5303 | PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5304 | PC(6:2(3E,5E)/14:2(11E,13E)) | Lipid | Others | Others | Others |
5305 | PC(O-11:1(10E)/2:0) | Lipid | Others | Others | Others |
5306 | PC(O-15:0/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5307 | PC(O-16:0/18:1(9Z)) | Lipid | Others | Others | Others |
5308 | PC(O-16:0/O-1:0) | Lipid | Others | Others | Others |
5309 | PC(O-17:0/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5310 | PC(O-18:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
5311 | PC(O-20:0/17:2(9Z,12Z)) | Lipid | Others | Others | Others |
5312 | PC(O-20:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
5313 | PC(O-8:0/O-8:0) | Lipid | Others | Others | Others |
5314 | PC(P-18:0/17:2(9Z,12Z)) | Lipid | Others | Others | Others |
5315 | PC(P-18:0/19:0) | Lipid | Others | Others | Others |
5316 | PC(P-18:0/20:0) | Lipid | Others | Others | Others |
5317 | PC(P-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
5318 | PC(P-20:0/20:1(11Z)) | Lipid | Others | Others | Others |
5319 | PE(17:1(9Z)/0:0) | Lipid | Others | Others | Others |
5320 | PE(18:0/20:4(5Z,8Z,10E,14Z)(12OH[S])) | Lipid | Others | Others | Others |
5321 | PE(18:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)(14OH)) | Lipid | Others | Others | Others |
5322 | PE(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5323 | PE(20:4(5Z,8Z,11Z,14Z)/0:0) | Lipid | Others | Others | Others |
5324 | PE(22:2(13Z,16Z)/22:2(13Z,16Z)) | Lipid | Others | Others | Others |
5325 | PE(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5326 | PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(11Z)) | Lipid | Others | Others | Others |
5327 | PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
5328 | PE(O-16:0/20:1(11Z)) | Lipid | Others | Others | Others |
5329 | PE(O-16:0/22:5(7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5330 | PE(O-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5331 | PE(O-18:0/18:0) | Lipid | Others | Others | Others |
5332 | PE(O-18:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
5333 | PE(O-18:0/18:3(6Z,9Z,12Z)) | Lipid | Others | Others | Others |
5334 | PE(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5335 | PE(O-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
5336 | PE(O-20:0/20:3(8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5337 | PE(O-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5338 | PE(P-16:0/0:0) | Lipid | Others | Others | Others |
5339 | PE(P-16:0/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5340 | PE(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
5341 | PE(P-16:0/22:1(11Z)) | Lipid | Others | Others | Others |
5342 | PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5343 | PE(P-18:0/0:0) | Lipid | Others | Others | Others |
5344 | PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5345 | PE(P-19:1(12Z)/0:0) | Lipid | Others | Others | Others |
5346 | PE(P-20:0/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5347 | PE(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5348 | PE-Cer(d14:1(4E)/24:0) | Lipid | Others | Others | Others |
5349 | PE-Cer(d14:1(4E)/24:1(15Z)) | Lipid | Others | Others | Others |
5350 | PE-Cer(d14:2(4E,6E)/16:0) | Lipid | Others | Others | Others |
5351 | PE-Cer(d15:1(4E)/22:0(2OH)) | Lipid | Others | Others | Others |
5352 | PE-Cer(d15:1(4E)/24:0) | Lipid | Others | Others | Others |
5353 | PE-Cer(d16:1(4E)/20:0) | Lipid | Others | Others | Others |
5354 | PE-Cer(d16:1(4E)/24:0(2OH)) | Lipid | Others | Others | Others |
5355 | PE-Cer(d16:1(4E)/24:1(15Z)) | Lipid | Others | Others | Others |
5356 | PE-Cer(d16:2(4E,6E)/22:0(2OH)) | Lipid | Others | Others | Others |
5357 | PG(13:0/0:0) | Lipid | Others | Others | Others |
5358 | PG(13:0/21:0) | Lipid | Others | Others | Others |
5359 | PG(18:0/18:0) | Lipid | Others | Others | Others |
5360 | PG(18:2(9Z,12Z)/22:0) | Lipid | Others | Others | Others |
5361 | PG(19:0/21:0) | Lipid | Others | Others | Others |
5362 | PG(20:1(11Z)/18:0) | Lipid | Others | Others | Others |
5363 | PG(20:2(11Z,14Z)/22:0) | Lipid | Others | Others | Others |
5364 | PG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) | Lipid | Others | Others | Others |
5365 | PG(22:1(11Z)/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5366 | PG(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
5367 | PG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5368 | PG(22:2(13Z,16Z)/21:0) | Lipid | Others | Others | Others |
5369 | PG(22:2(13Z,16Z)/22:0) | Lipid | Others | Others | Others |
5370 | PG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5371 | PG(O-18:0/18:3(9Z,12Z,15Z)) | Lipid | Others | Others | Others |
5372 | PG(O-18:0/22:1(11Z)) | Lipid | Others | Others | Others |
5373 | PG(O-20:0/20:0) | Lipid | Others | Others | Others |
5374 | PG(P-16:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
5375 | PG(P-18:0/14:0) | Lipid | Others | Others | Others |
5376 | PG(P-18:0/18:0) | Lipid | Others | Others | Others |
5377 | PG(P-18:0/18:1(9Z)) | Lipid | Others | Others | Others |
5378 | PGB3 | Lipid | Others | Others | Others |
5379 | phenolic phthiocerol | Lipid | Others | Others | Others |
5380 | PI(12:0/12:0) | Lipid | Others | Others | Others |
5381 | PI(16:0/18:0) | Lipid | Others | Others | Others |
5382 | PI(16:0/22:0) | Lipid | Others | Others | Others |
5383 | PI(18:0/0:0) | Lipid | Others | Others | Others |
5384 | PI(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5385 | PI(19:0/18:0) | Lipid | Others | Others | Others |
5386 | PI(20:3(8Z,11Z,14Z)/18:0) | Lipid | Others | Others | Others |
5387 | PI(20:4(5Z,8Z,11Z,14Z)/0:0) | Lipid | Others | Others | Others |
5388 | PI(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z)) | Lipid | Others | Others | Others |
5389 | PI(21:0/20:0) | Lipid | Others | Others | Others |
5390 | PI(22:0/17:0) | Lipid | Others | Others | Others |
5391 | PI(22:1(11Z)/17:0) | Lipid | Others | Others | Others |
5392 | PI(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)) | Lipid | Others | Others | Others |
5393 | PI(O-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
5394 | PI(P-16:0/0:0) | Lipid | Others | Others | Others |
5395 | PI(P-20:0/12:0) | Lipid | Others | Others | Others |
5396 | PI(P-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
5397 | PI-Cer(d18:0/16:0(2OH)) | Lipid | Others | Others | Others |
5398 | PI-Cer(d18:0/16:0) | Lipid | Others | Others | Others |
5399 | PI-Cer(d18:0/18:0(2OH)) | Lipid | Others | Others | Others |
5400 | PI-Cer(d18:0/22:0) | Lipid | Others | Others | Others |
5401 | PI-Cer(d18:1/22:0) | Lipid | Others | Others | Others |
5402 | PI-Cer(d20:0/16:0) | Lipid | Others | Others | Others |
5403 | PI-Cer(d20:0/18:0) | Lipid | Others | Others | Others |
5404 | PI-Cer(d20:0/26:0) | Lipid | Others | Others | Others |
5405 | PIM1(16:0/16:1(9Z)) | Lipid | Others | Others | Others |
5406 | PIM1(19:0/18:1(9Z)) | Lipid | Others | Others | Others |
5407 | PnE(16:0/18:1(9Z)) | Lipid | Others | Others | Others |
5408 | PPA(18:1(9Z)/18:1(9Z)) | Lipid | Others | Others | Others |
5409 | PS(15:0/20:0) | Lipid | Others | Others | Others |
5410 | PS(16:0/17:0) | Lipid | Others | Others | Others |
5411 | PS(18:0/18:0) | Lipid | Others | Others | Others |
5412 | PS(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
5413 | PS(20:0/18:1(9Z)) | Lipid | Others | Others | Others |
5414 | PS(20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
5415 | PS(20:3(8Z,11Z,14Z)/0:0) | Lipid | Others | Others | Others |
5416 | PS(20:5(5Z,8Z,11Z,14Z,17Z)/17:0) | Lipid | Others | Others | Others |
5417 | PS(22:0/18:0) | Lipid | Others | Others | Others |
5418 | PS(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
5419 | PS(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5420 | PS(22:4(7Z,10Z,13Z,16Z)/17:1(9Z)) | Lipid | Others | Others | Others |
5421 | PS(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
5422 | PS(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
5423 | PS(22:4(7Z,10Z,13Z,16Z)/21:0) | Lipid | Others | Others | Others |
5424 | PS(22:4(7Z,10Z,13Z,16Z)/22:0) | Lipid | Others | Others | Others |
5425 | PS(22:4(7Z,10Z,13Z,16Z)/22:1(11Z)) | Lipid | Others | Others | Others |
5426 | PS(O-16:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
5427 | PS(O-16:0/20:1(11Z)) | Lipid | Others | Others | Others |
5428 | PS(O-16:0/21:0) | Lipid | Others | Others | Others |
5429 | PS(O-16:0/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
5430 | PS(O-18:0/15:1(9Z)) | Lipid | Others | Others | Others |
5431 | PS(O-18:0/22:1(11Z)) | Lipid | Others | Others | Others |
5432 | PS(O-18:0/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
5433 | PS(O-20:0/14:0) | Lipid | Others | Others | Others |
5434 | PS(O-20:0/17:1(9Z)) | Lipid | Others | Others | Others |
5435 | PS(P-16:0/13:0) | Lipid | Others | Others | Others |
5436 | PS(P-16:0/18:0) | Lipid | Others | Others | Others |
5437 | PS(P-16:0/19:1(9Z)) | Lipid | Others | Others | Others |
5438 | PS(P-16:0/20:2(11Z,14Z)) | Lipid | Others | Others | Others |
5439 | PS(P-16:0/22:0) | Lipid | Others | Others | Others |
5440 | PS(P-18:0/20:1(11Z)) | Lipid | Others | Others | Others |
5441 | PS(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5442 | PS(P-20:0/18:4(6Z,9Z,12Z,15Z)) | Lipid | Others | Others | Others |
5443 | PS(P-20:0/19:0) | Lipid | Others | Others | Others |
5444 | PS(P-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
5445 | PS(P-20:0/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
5446 | PS(P-20:0/22:1(11Z)) | Lipid | Others | Others | Others |
5447 | PS(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
5448 | psychosine sulfate | Lipid | Others | Others | Others |
5449 | Ptilosteroid C | Lipid | Others | Others | Others |
5450 | Quercetagetin 7-(6 »-acetylglucoside) | Lipid | Others | Others | Others |
5451 | Quercetin 5,7,3′,4′-tetramethyl ether 3-galactoside | Lipid | Others | Others | Others |
5452 | Quercetin 7-methyl ether 3,3′,4′-trisulfate | Lipid | Others | Others | Others |
5453 | Quinestrol | Lipid | Others | Others | Others |
5454 | Scillirosidin | Lipid | Others | Others | Others |
5455 | SM(d16:1/22:0) | Lipid | Others | Others | Others |
5456 | SM(d16:1/22:1) | Lipid | Others | Others | Others |
5457 | SM(d16:1/23:0) | Lipid | Others | Others | Others |
5458 | SM(d18:0/16:0) | Lipid | Others | Others | Others |
5459 | SM(d18:0/18:2) | Lipid | Others | Others | Others |
5460 | SM(d18:1/16:0) | Lipid | Others | Others | Others |
5461 | SM(d18:1/22:0) | Lipid | Others | Others | Others |
5462 | SM(d18:1/22:1) | Lipid | Others | Others | Others |
5463 | SM(d18:1/23:0) | Lipid | Others | Others | Others |
5464 | SM(d18:1/24:0) | Lipid | Others | Others | Others |
5465 | SM(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
5466 | SM(d18:2/15:0) | Lipid | Others | Others | Others |
5467 | SM(d18:2/21:0) | Lipid | Others | Others | Others |
5468 | SM(d18:2/23:0) | Lipid | Others | Others | Others |
5469 | SM(d18:2/24:1) | Lipid | Others | Others | Others |
5470 | SM(d19:1/18:0) | Lipid | Others | Others | Others |
5471 | Tetrahydrodeoxycorticosterone | Lipid | Others | Others | Others |
5472 | TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso3] | Lipid | Others | Others | Others |
5473 | TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3] | Lipid | Others | Others | Others |
5474 | Theasinensin A | Lipid | Others | Others | Others |
5475 | trans-Hexadec-2-enoyl carnitine | Lipid | Others | Others | Others |
5476 | Tricosanedioic acid | Lipid | Others | Others | Others |
5477 | PA(16:1(9Z)/22:1(11Z)) | Lipid | Others | Others | Others |
5478 | PA(20:3(8Z,11Z,14Z)/16:1(9Z)) | Lipid | Others | Others | Others |
5479 | PE(P-18:0/19:0) | Lipid | Others | Others | Others |
5480 | PI(18:0/18:4(6Z,9Z,12Z,15Z)) | Lipid | Others | Others | Others |
5481 | PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/19:1(9Z)) | Lipid | Others | Others | Others |
5482 | PE(P-20:0/18:0) | Lipid | Others | Others | Others |
5483 | 6,8-Diprenylpratensein | Lipid | Others | Others | Others |
5484 | PG(22:4(7Z,10Z,13Z,16Z)/14:0) | Lipid | Others | Others | Others |
5485 | PC(18:0/19:0) | Lipid | Others | Others | Others |
5486 | Dynorphin B | Neuropeptides & Neurotransmitter | Others | Others | Others |
5487 | Neoendorphin | Neuropeptides & Neurotransmitter | Others | Others | Others |
5488 | Leu-Enk-Arg-Arg | Neuropeptides & Neurotransmitter | Others | Others | Others |
5489 | Leu-Enk-Arg | Neuropeptides & Neurotransmitter | Others | Others | Others |
5490 | Noradrenaline | Neuropeptides & Neurotransmitter | Others | Others | Others |
5491 | GABA gamma-Aminobutyric acid | Neuropeptides & Neurotransmitter | Others | Others | Others |
5492 | Dopamine | Neuropeptides & Neurotransmitter | Others | Others | Others |
5493 | Glutamate | Neuropeptides & Neurotransmitter | Others | Others | Others |
5494 | Serotonin | Neuropeptides & Neurotransmitter | Others | Others | Others |
5495 | Aspartate | Neuropeptides & Neurotransmitter | Others | Others | Others |
5496 | Acetylcholine | Neuropeptides & Neurotransmitter | Others | Others | Others |
5497 | Tyrosine | Neuropeptides & Neurotransmitter | Others | Others | Others |